Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
RABL2B		ENSG00000079974	RAB, member of RAS oncogene family like 2B	Q9UNT1	22	50767501-50783663	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		epididymis: 59.0	Cell type enriched	Detected in many	4	Ciliated cells: 167.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA042642, HPA042700, HPA044007	Approved		Approved	Vesicles,Centrosome						Centrosome	Vesicles	HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770	unprognostic (2.09e-1)	unprognostic (1.47e-2)	unprognostic (1.86e-3)	prognostic favorable (5.58e-4)	unprognostic (7.85e-2)	unprognostic (9.98e-2)	prognostic unfavorable (4.58e-5)	unprognostic (3.14e-1)	unprognostic (6.97e-2)	unprognostic (7.33e-2)	unprognostic (1.19e-2)	unprognostic (7.51e-2)	unprognostic (3.71e-3)	unprognostic (7.43e-3)	unprognostic (1.37e-1)	unprognostic (1.25e-1)	unprognostic (8.37e-3)	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13	8.4	12.7	12.6	7.9	13.9	59	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10	11	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.3	12.1	20.8	16.2	23.3	18.6	15.2	10	11.1	8.1	11.1	3.4	11.8	8.6	8.9	14.3	13.2	17.5	9.4	11.7	8.8	7.4	13.4	7.4	20.9	8.8	9.7	20.9	8	15.8	16	10.6	13.4	24.1	9	15.5	5.6	10.9	16.1	16.8	10.4	9.2	7.9	8.2	9.1	17.6	12	9	15.7	13.3	8.9	16.2	12.2	10.8	7.5	15	10.7	6.5	13.8	7.8	15.6	6.6	6.7	9.2	4.2	4.2	14.7	5.2	10.9	1	10.9	9.2	16.8	17.4	12.2	11.2	13	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5	11.9	11.2	10.4	10.3	4.7	14.6	3.6	12.7	167.3	29.6	21	29.5	10.4	11.6	17.3	17	7.3	7.8	0	9.5	9.3	8.5	7.5	3.5	6.4	10.7	15.9	5.2	5.5	10.1	16.3	13	8.5	16.9	15.4	7.2	12.9	9	3.5	10.3	12.2	37.4	6.5	10.3	27.4	27	5	5.6	15.8	10.1	6.3	Ciliated cells
WHRN	CIP98, DFNB31, PDZD7B, USH2D	ENSG00000095397	Whirlin	Q9P202	9	114402080-114505450	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Hearing		Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		adrenal gland: 58.2	Cell type enriched	Detected in some	4	Ciliated cells: 14.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		MAIT T-cell: 2.0;memory CD8 T-cell: 2.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HDLM-2: 16.3;Karpas-707: 47.6;U-266/70: 29.9;U-266/84: 30.7	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (6.06e-3)	unprognostic (1.02e-1)	unprognostic (9.96e-2)	unprognostic (4.27e-3)	unprognostic (4.59e-1)	unprognostic (7.07e-2)	unprognostic (3.66e-2)	unprognostic (7.25e-2)	unprognostic (6.13e-3)	unprognostic (3.43e-2)	prognostic favorable (2.28e-4)	unprognostic (1.03e-1)	unprognostic (1.71e-3)	unprognostic (3.21e-2)	unprognostic (1.92e-1)	unprognostic (1.25e-2)	unprognostic (3.44e-1)	3.3	58.2	11.7	4.1	24.5	3.2	4.9	7.6	18.1	8.3	5.4	31.7	2.9	8.3	17.8	8.4	4.7	9.5	4.1	3.6	12	9.1	4	2.2	3.7	4.5	26	7.6	12.6	9.8	10.2	19.3	3.2	20	7.8	2.9	13	10.9	6.9	1.3	7.3	8	9.5	14.4	17.8	6.5	23.6	29.8	11	5.7	1.5	2.4	4	7.2	0.3	0	0.2	0	0.7	2	0.1	0.6	1	1.6	6	0.6	0.2	3.2	0.4	0.9	0.6	0.4	0.1	0.3	0	1.2	0.4	7.9	3.6	0.3	0.6	0.1	16.3	2.7	0	11.5	1.3	0.2	0	0.4	0.5	1.9	2.2	0.2	4.4	0	0.8	3.3	47.6	0.6	6	0	0.2	2.1	0	9.9	0.8	0	12.5	1.6	0.3	7.4	0.5	3.5	4.2	12.5	1.9	4	0.1	1	2.1	1.2	2.3	2.9	29.9	30.7	0.2	0.8	0	1.2	0	0	0	0.3	0	2	0.1	0.5	2	0	0.3	0	0.6	0.2	0.7	0	0	1	0.1	11.7	24.5	7.6	18.1	12	9.1	26	7.6	20	29.8	0	1.1	0	0	0	0	0	0	14.7	2.3	0	0	2.5	0	1.6	0	0	0	0	1.8	1.9	0	0	2.3	0	2.9	0	0	0	0	0	0	0	0	1.8	0	0	1.5	0	0	0.8	0	0	0	0	0	0	3.5	0	0	0	Ciliated cells
CCDC114	CILD20, FLJ32926	ENSG00000105479	Coiled-coil domain containing 114	Q96M63	19	48296457-48321894	Disease related genes, Predicted intracellular proteins			Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		fallopian tube: 9.9;testis: 6.3	Cell type enriched	Detected in some	8	Ciliated cells: 109.7	Cancer enhanced	Detected in many		endometrial cancer: 5.4					Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CAPAN-2: 2.6;Karpas-707: 2.6;U-266/70: 4.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042524	Approved											HPA042524: AB_10795706	unprognostic (8.55e-2)	unprognostic (2.40e-2)	unprognostic (2.70e-5)	unprognostic (1.54e-2)	unprognostic (5.09e-4)	unprognostic (1.16e-1)	unprognostic (2.33e-2)	unprognostic (3.02e-2)	unprognostic (1.46e-1)	unprognostic (1.82e-1)	unprognostic (7.93e-2)	unprognostic (1.30e-1)	unprognostic (7.50e-3)	unprognostic (4.35e-2)	unprognostic (4.25e-2)	unprognostic (1.30e-1)	unprognostic (5.15e-2)	0	0	0.8	0	1.9	0.8	0.1	0	0.2	1.1	0			0	0.4	0.3	0	9.9	0	0	1.6	2.3	0	0	1.5	0.2	0		0.4	0	0.2	0.4	0.1		0.1	0		0.2	0.5	0	1.3	0	0	0.2	0.2	0.2	6.3			0.4		0	0	0	0.5	0.3	1	0.4	0.3	0.4	0	0.2	0.7	0.2	0.8	0	0	0.4	0	0	0	0	0.1	2.6	0.4	0.9	0	0.1	0.4	0.1	0	0	1.1	0.2	1.6	0.2	0	0	0.1	1.2	0	0	0.1	0.4	0.5	0	1.2	0.5	2.6	0	0.2	0.4	1.7	0	0.2	0	0.4	0	0.3	0.1	0	0.5	0.1	0.5	0.6	0.4	0	1.6	0.2	0	0.4	0.3	0	0.3	4.8	1.5	0	0.3	0.2	0	0.9	0.2	0.4	0.3	0	0.4	0.5	0.3	0.3	0	0.2	0.2	0.3	1	0.3	0.4	0.3	0	0											0	4.3	0	0.1	0.1	0.5	0.4	0	109.7	10.3	0	0	0.1	0	0.1	5.6	0	0	0	0	0	0.1	0.3	3.5	0	0	1.6	0	0	0	5.5	0	0.1	0	0	0	0.5	0	0	0	0	0.5	0	0	13.4	1.3	0.1	0	0	0	0	Ciliated cells
CAPS	CAPS1, MGC126562	ENSG00000105519	Calcyphosine		19	5911707-5915877	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		brain: 71.4;fallopian tube: 116.0	Cell type enriched	Detected in many	8	Ciliated cells: 1030.6	Cancer enriched	Detected in all	5	endometrial cancer: 171.3	Region enhanced	Detected in all		pons and medulla: 71.4	Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SK-BR-3: 36.6;U-266/70: 10.1					Low region specificity	Detected in many			HPA043520	Enhanced		Approved	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA043520: AB_10964138	unprognostic (2.06e-1)	unprognostic (1.13e-2)	unprognostic (7.94e-3)	prognostic favorable (7.63e-5)	unprognostic (5.18e-1)	prognostic favorable (8.60e-4)	unprognostic (7.07e-2)	unprognostic (2.46e-3)	unprognostic (1.51e-1)	unprognostic (1.82e-1)	unprognostic (4.70e-2)	unprognostic (9.99e-2)	unprognostic (4.01e-2)	unprognostic (8.47e-2)	unprognostic (3.25e-1)	unprognostic (6.86e-3)	unprognostic (5.96e-3)	2.6	4.1	8	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116	13.6	2	13.4	6.6	8.9	5	25.4	4.4	8	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2	3.3	7.7	12.7	2	5.7	5	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4	5.2	2.2	5.3	4.8	2.4	1.1	1.1	0.7	3.5	1.3	1.8	2.2	0.6	0.4	0.2	0.3	0.8	7.5	0.8	2.2	0.9	0.5	1.4	0.3	0.3	0.1	2.4	1	0.6	2.2	2	1.2	0.6	1.8	2.3	2.1	0.2	0.5	2.5	0.5	2.6	0.5	2.9	0.4	2.1	1.4	2	0.6	8.8	5.7	1.7	0.3	2.3	1	3.2	0.7	2.6	0.5	36.6	3.7	2	2.3	2.3	1	0.6	0.4	2.7	9.7	10.1	3.4	0.7	4.3	1	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3	3.6	2.1	4.9	2.4	2	5.2	5.3	1.6	4	3.2	2.4	8	14.7	1.4	3.3	13.4	6.6	8	7.8	71.4	17.9	11.9	16.8	0.8	29.9	4.2	2.2	1.9	0	1030.6	124	115.1	3.9	21.6	29.9	26.7	4.7	3.8	3.9	0	5.2	16.2	21.6	27.6	5.8	0	4.6	6.4	18.4	0	0	4	4.4	4.4	10.1	1.8	19.7	7.2	24.2	2.9	4.6	3.6	3.9	6.5	4.2	0.5	0.4	3.6	17.2	0	7.4	100.9	Ciliated cells
DNAH11	CILD7, DNAHBL, Dnahc11, DNHBL, DPL11	ENSG00000105877	Dynein axonemal heavy chain 11	Q96DT5	7	21543215-21901839	Disease related genes, Predicted intracellular proteins		Motor protein	Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 22.2;parathyroid gland: 62.2	Cell type enriched	Detected in some	9	Ciliated cells: 111.1	Low cancer specificity	Detected in some			Group enriched	Detected in many	4	basal ganglia: 5.5;pons and medulla: 15.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 7.6;HUVEC TERT2: 2.4;U-2 OS: 2.7;U-2197: 3.4	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA045880, HPA056474	Approved											HPA045880: AB_10962003, HPA056474: AB_2683145	unprognostic (2.24e-2)	unprognostic (2.28e-1)	unprognostic (1.01e-2)	unprognostic (5.17e-3)	unprognostic (4.15e-2)	unprognostic (1.51e-1)	unprognostic (9.01e-2)	unprognostic (6.32e-2)	unprognostic (1.95e-1)	unprognostic (1.12e-1)	unprognostic (2.79e-2)	unprognostic (3.10e-1)	prognostic unfavorable (1.49e-7)	unprognostic (9.25e-2)	unprognostic (1.55e-1)	unprognostic (3.86e-3)	unprognostic (4.79e-3)	3.2	4.6	0.8	0.5	5.5	0.4	0.4	0.2	1	1.6	0.9	6.7	3	0.4	0.8	22.2	2.5	9.3	0.5	1.1	2.5	1.2	0.5	0.8	7.7	0.4	0.2	0.6	7.2	0.5	62.2	0.8	2.9	15.5	1.1	0.5	0	0.4	1	1.5	0.9	0.6	0.4	0.3	0.4	0.5	0.9	2.1	0.7	5.2	0.3	0.5	0.4	3.4	0.6	0.9	0	0	0	0.1	0	0	0.1	0.1	0	0.2	0.7	0	0.6	0.9	0	0.1	0.1	0	0.4	0	0.1	7.6	0.1	0	0.7	1.5	0	1.7	0	0.5	0	0.7	0.3	0	0	0	0	0	0.1	2.4	0.3	0	0	0	0.1	0.1	0	0.9	0	0.4	0.7	0.2	0.3	0	0	0.6	0	0.1	0.7	0	1.4	0	0	1.7	0.7	2.7	3.4	0.4	0.2	0.1	0.3	1	0.4	0	0	0	0	0	0	0	0.3	0	0	0	0.6	0.1	0	0	0	0	0.9	0	0	0.8	5.5	0.2	1	2.5	1.2	0.2	0.6	15.5	2.1	6	3.8	0	3.5	2.2	0	3.3	0	111.1	12.5	0	0	0	0	0.1	2.5	0.3	0	0	0	1.3	0.2	2.3	0	0.2	0.1	6.4	0	0	0	1.5	0.3	0	1.7	1	0	0	0.2	0	0.4	0	0	0	0.2	0.7	0.4	0.3	1.4	0	0	0.7	Ciliated cells
RSPH4A	CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B	ENSG00000111834	Radial spoke head 4 homolog A	Q5TD94	6	116616479-116632985	Disease related genes, Predicted intracellular proteins			Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7	Cell type enriched	Detected in many	10	Ciliated cells: 365.4	Cancer enhanced	Detected in many		endometrial cancer: 4.6	Group enriched	Detected in many	4	basal ganglia: 9.4;pons and medulla: 19.8	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RPMI-8226: 7.6;U-266/84: 5.5	Low region specificity	Detected in many							HPA031196, HPA031197, HPA031198	Enhanced		Approved	Nucleoplasm		No				Nucleoplasm		HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025	unprognostic (9.83e-4)	unprognostic (1.26e-1)	unprognostic (6.94e-2)	unprognostic (9.69e-3)	unprognostic (9.37e-2)	unprognostic (1.13e-3)	unprognostic (4.52e-1)	unprognostic (1.07e-1)	unprognostic (1.06e-1)	unprognostic (5.08e-2)	unprognostic (9.56e-5)	unprognostic (2.87e-1)	unprognostic (2.69e-4)	unprognostic (1.96e-2)	unprognostic (2.51e-1)	unprognostic (3.55e-2)	unprognostic (5.21e-2)	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1	0.6	0.4	0.6	0.7	1	0.8	6.6	1.8	0	1	0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1	0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1	0.3	0.1	1.2	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0	0.8	1.1	0.4	0.2	1	0.2	0.1	0	0.9	0.2	0.1	0.6	0.2	0.7	0.1	0.6	0.1	0.1	0.8	1.6	7.6	3.2	0.4	2.8	1.2	0.2	0.2	0.5	0.3	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.5	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1	0.1	0.1	0.4	0.3	0	0	0.8	0.2	0.5	0	0.2	0.1	0.1	0	0	1.8	9.4	1.2	0.7	3	3.3	0.5	1.1	19.8	1.8	3	4.3	0	0	0	3	0.4	0	365.4	35.2	0	2	0	1.7	0.4	18.2	0.1	0	0	0.3	0.1	0	0.1	2.3	0	0.1	1.6	0	2.5	0	8.7	0.3	0	1.7	0	0	1.7	0.2	0	0	0	3.2	0	0.4	4.4	1.5	0.1	0.2	0	0	0	Ciliated cells
CCDC170	bA282P11.1, C6orf97, FLJ23305	ENSG00000120262	Coiled-coil domain containing 170	Q8IYT3	6	151494030-151621193	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 19.4;fallopian tube: 33.0	Cell type enriched	Detected in many	8	Ciliated cells: 481.8	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 16.1	Cell type enhanced	Detected in many		eosinophil: 8.6	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	MCF7: 14.2;T-47d: 8.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA027114, HPA027185	Enhanced		Approved	Golgi apparatus,Cell Junctions						Golgi apparatus	Cell Junctions	HPA027114: AB_2732435, HPA027185: AB_2672151	unprognostic (7.46e-2)	unprognostic (3.54e-2)	unprognostic (6.93e-2)	prognostic favorable (3.64e-4)	unprognostic (2.13e-1)	unprognostic (8.79e-3)	unprognostic (2.74e-3)	unprognostic (1.34e-1)	unprognostic (1.77e-1)	unprognostic (1.96e-1)	unprognostic (2.36e-1)	unprognostic (2.18e-2)	unprognostic (3.56e-2)	unprognostic (1.40e-2)	unprognostic (3.93e-2)	unprognostic (2.17e-1)	unprognostic (5.21e-2)	3	6.2	2.1	1.4	6.7	0.3	4	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0	0.2	0.5	0	0.5	0.4	0	0.1	0.5	0	0	0.3	0.4	0	0	0.3	0.1	0	0	0	0	0	0	0	0.1	2.1	0	0.1	0.1	1.5	0	0	0	0.7	0.3	0	0	0.1	0.1	14.2	0	0	0	0	0	0	0	0	0	0.3	0.9	0	0.1	0	0	0.1	8.3	0.1	0.9	0.3	0.1	0.1	0	0	0	0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0	0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5	3	1	0.5	0.2	0.6	0.3	0.8	0	481.8	62.6	0	21.6	0.1	0	0.2	38.6	0.3	0.4	0	1	0.1	1.7	1	3.5	1.1	9.6	0	0	1.3	14.3	64.1	6.6	18.9	0	1.8	0	2.5	1.7	2.9	0	3.5	0.7	0	1.2	2.4	1	0.9	0	0	0	0.4	Ciliated cells
FNDC11	C20orf195, MGC5356	ENSG00000125531	Fibronectin type III domain containing 11	Q9BVV2	20	63547891-63556708	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	testis: 52.5	Cell type enriched	Detected in some	5	Ciliated cells: 12.0	Low cancer specificity	Detected in some			Not detected	Not detected			Group enriched	Detected in some	5	memory B-cell: 3.2;naive B-cell: 6.6	Lineage enriched	Detected in many	6	B-cells: 6.6	Cell line enhanced	Detected in some		CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0	Not detected	Not detected			Not detected	Not detected			HPA041341			Approved	Nucleoplasm,Vesicles,Aggresome						Nucleoplasm, Vesicles	Aggresome	HPA041341: AB_10794991	unprognostic (2.01e-1)	unprognostic (6.63e-2)	unprognostic (6.06e-2)	unprognostic (1.26e-1)	unprognostic (1.51e-2)	unprognostic (1.15e-1)	unprognostic (2.36e-1)	unprognostic (9.99e-3)	unprognostic (7.94e-2)	unprognostic (8.30e-4)	unprognostic (3.68e-1)	unprognostic (8.33e-2)	unprognostic (3.56e-2)	unprognostic (1.18e-1)	unprognostic (1.05e-1)	unprognostic (3.75e-1)	unprognostic (6.81e-2)	0.1	0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0	0.1	2.2	0.2	1.1	0.2	0.1	0.1	0.3	0.2	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0	0.3	0.1	0.4	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.3	52.5	0.2	0.1	0.1	0.1	0.3	0.2	0.2	6.6	0	1	0	0	0.8	0.2	0.3	0	1.8	0	0.1	0.1	0	0.3	0.6	0	0	0.1	9.5	0.6	4.9	0.1	0.2	2.7	0.2	0.3	0	0	0	0.2	0.6	0	0.2	0	1.2	0	0.2	0.7	0	0	0.9	0	0.7	0	0	1	0	0.1	0.2	3.2	0.8	0	0	0.1	1.7	0	0.4	6	0	0	0.3	0.4	0.1	0	0.6	0.1	0.2	0	0	0	0.3	0.1	0	0.6	0.3	0	0	1	0.1	0	0	3.2	0.2	0.6	0	6.6	0.4	0.2	0	0	0	0	0.8	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.2	0	0	0	0	0	0	0	0	12	2.3	1.8	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Ciliated cells
OMG	OMGP	ENSG00000126861	Oligodendrocyte myelin glycoprotein	P23515	17	31272013-31297539	Plasma proteins, Predicted intracellular proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	40	brain: 89.6	Cell type enriched	Detected in some	5	Ciliated cells: 335.9	Group enriched	Detected in some	7	endometrial cancer: 3.5;glioma: 9.0	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.6	Lineage enriched	Detected in single	6	granulocytes: 1.6	Cell line enhanced	Detected in some		HAP1: 3.6;U-87 MG: 1.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008206, HPA012693	Enhanced				Intracellular and membrane							HPA008206: AB_1854240, HPA012693: AB_1854239	unprognostic (8.05e-4)	unprognostic (2.11e-2)	unprognostic (1.27e-1)	unprognostic (3.03e-3)	unprognostic (1.85e-1)	unprognostic (4.16e-2)	unprognostic (1.63e-1)	unprognostic (3.81e-2)	unprognostic (9.54e-2)	unprognostic (8.60e-2)	unprognostic (7.03e-2)	unprognostic (1.52e-1)	unprognostic (3.96e-13)	unprognostic (7.80e-3)	unprognostic (6.00e-2)	unprognostic (3.24e-1)	unprognostic (2.42e-2)	1.6	1.8	25.2	1.6	25.4	2.2	1.6	10.2	89.6	1.6	1.7	20.3	0	1.7	1.6	1.6	1.6	1.6	1.6	1.6	26.8	20.6	1.6	1.6	1.6	1.6	30.8	23.2	1.6	1.6	1.6	0.1	1.6	36.8	1.6	1.7	1.4	1.6	1.6	1.7	1.6	1.7	1.6	23	1.7	1.6	1.6	39.6	0	1.6	0	1.6	1.6	0	0	0.1	1.6	0	0	0.2	0	0	0.3	0	0	0	0	0.1	0	0	0	0.1	0.5	0.1	0	0	0.2	0	0.2	3.6	0	0	0	0	0.3	0.4	0.1	0	0	0.6	0.2	0	0.1	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0.2	0	0.2	0	0	0	0	0	0.4	0.1	0.5	0	0	0	0	0	0.1	0.1	0.2	0	0	0.6	1.4	0	0.7	1.6	0	0	0.2	0	0	0	0.1	0	0.1	0	0	0	0.6	0	0	0	0	0	25.2	25.4	10.2	34.1	26.8	20.6	30.8	23.2	36.8	39.6	0	3	0	0	0.3	3.7	0.7	0	335.9	6.8	0	0	0.1	0	0	0.1	0.2	0	0	0	0.4	0.4	0	0	0	0.4	0	0	1.3	11.2	0	0	0	0	0	0	68.6	0	0	0	0	1.8	0	0	0	0	0.1	9.8	0.7	0	0	Ciliated cells
CDHR3	CDH28, FLJ23834, FLJ44366	ENSG00000128536	Cadherin related family member 3	Q6ZTQ4	7	105876796-106033773	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Receptor	Asthma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 51.9;lung: 28.9;ovary: 22.3	Cell type enriched	Detected in many	6	Ciliated cells: 341.3	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 15.9	Group enriched	Detected in some	5	memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8	Group enriched	Detected in many	6	B-cells: 6.9;granulocytes: 1.8	Cell line enhanced	Detected in some		AF22: 7.9;Daudi: 10.1;WM-115: 6.8	Low region specificity	Detected in many							HPA011218	Supported		Approved	Nucleoli fibrillar center						Nucleoli fibrillar center		HPA011218: AB_1078886	unprognostic (4.38e-4)	unprognostic (9.18e-2)	unprognostic (8.16e-3)	unprognostic (8.08e-3)	unprognostic (5.23e-2)	unprognostic (1.55e-1)	unprognostic (3.43e-2)	unprognostic (1.18e-3)	unprognostic (2.99e-2)	unprognostic (1.92e-1)	unprognostic (2.28e-2)	unprognostic (1.73e-2)	unprognostic (1.16e-1)	unprognostic (3.18e-1)	unprognostic (2.77e-2)	unprognostic (3.70e-3)	unprognostic (3.51e-3)	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.9	1.4	2.8	2.7	0.2	0.7	0.6	0.3	0.2	0	0.1	10.1	0	0.5	1.1	0.1	1.9	0	0.3	0.9	1.2	0	0.2	0.7	0	0.2	0.4	1	0.3	0.5	0	0.2	0	0	0.1	0.3	0.3	0	0.2	0.1	1.8	2.8	0.6	0	0	0.4	0.1	0.1	0.6	2.9	0	0.8	0.5	1.4	0	0	0.4	1.4	0.5	1.5	0	0	0	3.3	0.2	0.3	6.8	0.1	0.1	0	0	0.1	0	2.9	0	0	0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2	3	7.2	0	1.6	2.4	4.5	1.2	2.5	341.3	55.7	0	0	0.5	5	0.5	5.4	1	2.8	0	0.5	0.2	1.5	0.5	3.5	1.7	0.1	0	28.7	0	0	2.5	2.6	0.6	8.5	0	3.6	9.5	0.2	2.9	1.4	4.4	1	6.5	1.7	1.4	3.1	1.8	0.2	0.7	2.9	0.4	Ciliated cells
CALML4	MGC4809, NY-BR-20	ENSG00000129007	Calmodulin like 4	Q96GE6	15	68190705-68206110	Predicted intracellular proteins, RAS pathway related proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 44.0;gallbladder: 28.4;intestine: 91.6	Cell type enriched	Detected in many	5	Ciliated cells: 174.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	6	intermediate monocyte: 39.2;non-classical monocyte: 44.0	Lineage enriched	Detected in many	10	monocytes: 44.0	Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA051109	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Cytosol		Yes	No			Golgi apparatus	Nucleoplasm, Cytosol	HPA051109: AB_2681346	unprognostic (1.69e-2)	unprognostic (1.78e-1)	unprognostic (4.97e-2)	unprognostic (8.50e-2)	unprognostic (1.63e-1)	unprognostic (3.71e-2)	unprognostic (4.05e-2)	unprognostic (6.53e-2)	unprognostic (6.77e-2)	unprognostic (2.10e-1)	unprognostic (4.19e-3)	unprognostic (6.24e-2)	unprognostic (3.85e-2)	unprognostic (7.92e-3)	unprognostic (2.46e-1)	unprognostic (7.49e-2)	unprognostic (1.32e-1)	2.4	2.5	1.8	12	1.1	0.8	2.2	2.6	1	3.2	40.3	2.2	7.7	34	1.5	7.8	5.1	7.3	28.4	1.4	2.6	0.7	12.6	12.3	3.1	2.6	0.9	1.3	2.3	5.3	0	3.1	2.1	8.4	4.3	21.8	3.1	1.9	6.7	1.4	1.7	91.6	2.7	1	5.3	5.4	2.4	0.6	1.1	1.5	1.3	1.3	1.9	2	0	4.5	1.8	44	0	0	2.8	2.5	7.8	5.7	3.5	0.6	1	4	1.6	1.5	2.6	2.6	14.9	16.1	2.5	2	1.1	2.3	10.8	12.8	2.3	1	2.1	12.4	4.1	13.3	5.2	2.3	3.5	5.5	1.1	3.4	1.5	2.2	2.1	2.9	5.2	3.9	2.9	0.6	7.2	5.7	7.7	4.9	12	2.3	8.5	5.6	5.1	0.9	4.3	2.9	3.4	2.5	2.3	6.8	1.8	1.7	3.4	2.5	3.8	3.5	6.6	6.3	10.6	6.3	7	2.4	6.9	1.3	0	6.5	0	0	39.2	0	0	0	0	4.5	0	0	0	1.8	0	44	0.2	0	2.8	1.8	1.1	2.6	1	2.6	0.7	0.9	1.3	8.4	0.6	0	1	0.9	0.6	1.3	8.8	0.3	15.3	174	26.1	3.5	0	0.4	0	2	4.8	1.9	38.6	0	3.9	0.4	1	1.2	0	7.2	3.1	7.9	7.5	6.7	11.9	0	3.4	3.4	0	0	15	1.7	1.8	38.6	6.3	5.8	2.2	0	0.3	0	0.5	1.8	0.1	1.8	18.3	1.1	Ciliated cells
FOXJ1	FKHL13, HFH-4, HFH4	ENSG00000129654	Forkhead box J1	Q92949	17	76136333-76141299	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Cilium biogenesis/degradation, Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes, Ciliopathy, Disease mutation, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 19.9;epididymis: 20.4;fallopian tube: 45.9	Cell type enriched	Detected in many	5	Ciliated cells: 93.7	Cancer enhanced	Detected in many		endometrial cancer: 73.7	Low region specificity	Detected in many			Cell type enhanced	Detected in single		naive CD8 T-cell: 2.6	Lineage enriched	Detected in single	9	T-cells: 2.6	Group enriched	Detected in some	9	BEWO: 23.0;CAPAN-2: 19.2	Low region specificity	Detected in many			Region enhanced	Detected in many		midbrain: 55.6	HPA005714	Enhanced											HPA005714: AB_1078902	prognostic favorable (9.39e-4)	unprognostic (4.97e-3)	unprognostic (1.22e-1)	unprognostic (2.77e-3)	unprognostic (1.19e-1)	unprognostic (2.54e-3)	unprognostic (1.71e-3)	unprognostic (6.15e-2)	unprognostic (1.00e-2)	unprognostic (7.84e-3)	unprognostic (1.43e-2)	unprognostic (1.63e-1)	prognostic unfavorable (2.03e-5)	unprognostic (7.49e-2)	unprognostic (1.94e-1)	unprognostic (2.27e-1)	unprognostic (1.91e-1)	0.4	0.4	4.1	0.5	8.9	0.6	0.4	0.1	2.2	5.1	0.9	19.9	0.4	0.6	2.4	20.4	0.4	45.9	0.4	0.4	6.5	6.6	1.5	0.4	17	0.4	2	1.2	14.7	1.2	0.4	1.2	0.4	19.6	0.6	0.6	0.1	0.4	2.8	0.4	0.8	0.6	0.5	1.8	0.4	0.9	15.2	3.4	0	2.9	0	0.4	1.1	0.2	0	0	0	0	0.2	2.6	0.1	0	0.4	1.3	0	0	0	23	0	0	0	0	2.3	19.2	0	0.3	0	0	0	0	0	0	0.2	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.2	0	0.4	0	0	0.1	0	0.1	0.7	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0	0	0.6	2.6	0	0.2	0	0	0	0.1	4.1	8.9	0.1	2.2	6.5	6.6	2	1.2	19.6	3.4	8.9	1.9	0.9	1	0.7	0.4	0.8	2.5	93.7	13.6	8.7	3.9	0.1	0	0.5	19.5	0.1	0	0	0	0.5	0.3	0.3	1.1	0	0.1	0	1.7	0.6	0	11.7	0.3	0	0	0	1.1	2.5	0.2	0	0.4	0.7	6.7	0	0	8.8	1.7	0.6	0.2	1.3	1.8	0	Ciliated cells
IQCA1	DRC11, FLJ22527, IQCA	ENSG00000132321	IQ motif containing with AAA domain 1	Q86XH1	2	236324147-236507542	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 27.8;thyroid gland: 30.0	Cell type enriched	Detected in many	5	Ciliated cells: 163.3	Cancer enhanced	Detected in many		thyroid cancer: 9.4	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD8 T-cell: 4.4	Group enriched	Detected in many	4	NK-cells: 1.2;T-cells: 4.4	Cell line enhanced	Detected in some		EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA057320			Uncertain	Nucleoplasm						Nucleoplasm		HPA057320: 	unprognostic (1.73e-2)	unprognostic (6.38e-2)	unprognostic (3.75e-3)	unprognostic (1.62e-2)	unprognostic (6.27e-3)	unprognostic (1.73e-2)	unprognostic (3.23e-5)	unprognostic (1.55e-1)	unprognostic (7.23e-3)	unprognostic (1.39e-1)	unprognostic (3.03e-2)	unprognostic (1.62e-1)	prognostic favorable (2.54e-4)	unprognostic (1.19e-3)	unprognostic (1.67e-3)	unprognostic (1.91e-3)	unprognostic (5.30e-2)	1.8	2.7	13.4	1.4	19.2	0.8	3.5	3.8	11.6	2.2	1	6.7	0.4	0.9	3.4	9.1	1.6	17.8	3.5	1.1	12.9	10	6.6	0.8	5.1	1.3	8.8	9.3	4.7	2.4	0.9	27.8	1.1	13	3.1	1	2.7	2.6	2.8	0.8	0.9	1.2	1.5	3.2	5.5	1.1	7.4	8	1.4	30	0	1.6	3	1	0.7	0	0	0	1.2	4.4	0.1	0	0	0.3	0.2	0	0	0.4	0.2	0	0.1	0.3	0.1	0	0	4	0	1.1	0	0	3.7	0	0	0.1	0	4.4	0	0.1	0	0	0.3	2	0	0	8.7	0.9	0	0	0	0	0	0	0	1.8	0	0.4	0	0	0	0	0.8	0	0	0	0.1	0	5.5	0	0	0.1	0	15.3	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	1.3	0.5	0.2	0.8	0	0.7	1.1	4.4	0	1.2	0	0	0.3	0.1	13.4	19.2	3.8	10	12.9	10	8.8	9.3	13	8	14.9	15.9	0	6.7	0.5	20.3	0.8	12.7	163.3	30.7	3.5	15.7	0.4	0	10.2	19.7	3.8	0	0	1.4	3.6	0.9	1.1	1.1	0	0.3	0	0	1.3	0	11	2	0.5	0	0	0	0.2	1.7	0	5.6	7.9	1.8	0	0.3	23.3	27.1	0.3	0.2	0	0	2.6	Ciliated cells
STOML3	Epb7.2l, SRO	ENSG00000133115	Stomatin like 3	Q8TAV4	13	38965925-38991066	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2	Cell type enriched	Detected in some	24	Ciliated cells: 133.8	Cancer enhanced	Detected in some		endometrial cancer: 2.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	39	AF22: 19.0	Region enriched	Detected in some	6	olfactory region: 29.0	Low region specificity	Detected in all			HPA012892, HPA071011	Enhanced		Supported	Plasma membrane						Plasma membrane		HPA012892: AB_1857610, HPA071011: AB_2732169		unprognostic (2.64e-1)	unprognostic (1.91e-2)	prognostic favorable (1.49e-4)	unprognostic (1.82e-1)	unprognostic (1.17e-1)		unprognostic (4.24e-2)	unprognostic (1.19e-1)	unprognostic (2.14e-1)	unprognostic (2.14e-1)	unprognostic (1.07e-2)	unprognostic (1.35e-2)	unprognostic (3.07e-2)	unprognostic (1.74e-1)		unprognostic (1.22e-1)	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0	0.2	1.7	0.2	6.6	0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0	0	7.6	0.1	0.1	0	0.3	9.7	0.2	0.2	0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0	0.1	0.4	0.1	0.1	0	0	0	0	0	0	0	0	0	0	19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	3.8	0	0.2	4.4	4.1	0	0	9.7	2.1	0	1	0	0	0.1	0	0	0	133.8	5.7	0	0	0.4	0	0	0.2	0	0	0	0	0.4	0	0.2	0	0	0.1	0	0	0	0	1.1	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.6	0	0	0	Ciliated cells
DYDC2	bA36D19.6, MGC16186	ENSG00000133665	DPY30 domain containing 2	Q96IM9	10	80344745-80368073	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 16.3;fallopian tube: 56.4	Cell type enriched	Detected in some	9	Ciliated cells: 337.3	Cancer enhanced	Detected in some		endometrial cancer: 3.2	Group enriched	Detected in many	5	amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3	Cell type enhanced	Detected in some		basophil: 2.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 4.4;NTERA-2: 7.0;SCLC-21H: 6.0;SH-SY5Y: 4.0;U-2197: 4.4					Low region specificity	Detected in all			HPA038006, HPA038007	Enhanced											HPA038006: AB_10672734, HPA038007: AB_2675783	unprognostic (1.60e-3)	unprognostic (7.35e-2)	unprognostic (1.89e-2)	unprognostic (9.26e-3)	unprognostic (8.85e-2)	unprognostic (3.26e-1)	unprognostic (1.25e-1)	unprognostic (1.26e-2)	unprognostic (1.55e-1)	prognostic favorable (3.54e-4)	unprognostic (1.87e-2)	unprognostic (2.43e-1)	unprognostic (2.34e-2)	unprognostic (5.28e-2)	unprognostic (1.41e-4)	unprognostic (9.86e-2)	unprognostic (5.40e-2)	0.2	0.2	6.3	0.2	9.1	0.6	0.4	0.1	1.7	1.6	0.3	3	0.1	0.3	1.3	10	0.5	56.4	0.4	0.2	7.7	6.8	0.3	0.3	3.6	0.2	0.2	0.4	4.3	0.6	0.2	0.1	0.4	16.3	0.3	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.4	5.2	0.7	0.1	0.3	0.1	0.2	0.2	0.1	0.6	0.6	2.4	0.3	1.2	0.4	0	0.2	0.1	4.4	0.1	0.5	0	0.1	0	0.6	0.4	0.1	0.4	0.7	0.1	0.9	0.1	1	0.2	0.3	0.1	0.1	0.2	0.6	0.3	0.2	1.5	0	0	0.4	0.2	1.1	0	0.1	0	0	1.4	0.2	0.3	0.3	0.3	0.7	0	7	0	0	1.8	0.5	1.6	0	0.1	6	4	0.2	0	0.7	1.7	0	2.7	0.1	0.1	0.3	4.4	0	0.1	0.1	0.3	0.4	0	0	2.4	0.3	0.1	0.3	0.1	0.4	0.3	0.3	0.2	0	0.6	0.3	0.4	0.5	1.2	0.2	0.6	0	0	6.3	9.1	0.1	1.6	7.7	6.8	0.2	0.4	16.3	0.7	0	1.9	0	0	0	0	0.2	0	337.3	30.7	0	0	0	1.7	0.4	35.5	0	0	0	0.4	0	0	0.2	0	0.6	0.1	0	0	0	0	24.4	1.1	0.1	0	0	0	0	0.1	0	0.7	0	0	0	0	1.9	2.2	0	0	0	0	0.1	Ciliated cells
LCA5	C6orf152	ENSG00000135338	LCA5, lebercilin	Q86VQ0	6	79484991-79537458	Disease related genes, Predicted intracellular proteins	Protein transport, Transport		Disease mutation, Leber congenital amaurosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		parathyroid gland: 42.4	Cell type enriched	Detected in many	4	Ciliated cells: 121.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		naive CD4 T-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HEL: 15.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029053, HPA029055	Supported											HPA029053: AB_10602020, HPA029055: AB_2672889	unprognostic (8.96e-2)	unprognostic (1.04e-1)	unprognostic (3.06e-2)	unprognostic (2.65e-1)	unprognostic (1.13e-1)	unprognostic (1.45e-1)	unprognostic (6.58e-2)	unprognostic (1.34e-3)	unprognostic (6.83e-2)	unprognostic (2.73e-2)	unprognostic (4.11e-1)	unprognostic (1.51e-1)	prognostic unfavorable (4.69e-4)	unprognostic (7.09e-3)	unprognostic (1.39e-1)	unprognostic (5.39e-2)	unprognostic (3.21e-2)	5.2	3.4	8.8	2.9	9.9	4.7	7.4	16.4	9.7	7.6	4.3	5.7	9.1	2.2	8.2	6	4.9	13.9	4.9	3.9	9.1	7.8	4.8	2.4	6.2	2.6	7.4	7.7	11	4.3	42.4	11.4	5.1	17.2	7.5	3	4.4	7.6	9.3	2.7	2	2.5	6.6	13.6	2.9	2.9	9.5	8	0.1	13.4	2.1	2.2	7.6	8.8	0.3	0.1	0	0.6	0	1	0.2	1.8	1.4	4.3	2.4	5.3	6	1.9	3.1	3.8	2	4	10.4	2	0.5	4.3	2.5	3.7	2	3.2	1.9	3.6	0	2.4	15.3	2.1	1.4	5.6	0.3	1.3	5.6	2.2	3.4	4.4	7.7	5.9	0.1	2.3	0.9	3.2	0	0	0	1.2	1.1	1.6	0	7.4	0.7	4.2	0.6	3.2	3.8	2.9	0.5	2	5.5	0.3	0.9	4.1	2.1	2.5	0.6	2.7	4	1.4	0	1	0	1.6	0	0.2	0	0.5	0.6	0	0	0.2	0	0.1	0.3	1	0.6	0	0	0	0	0	0.2	8.8	9.9	16.4	9.7	9.1	7.8	7.4	7.7	17.2	8	14.9	7.8	0.5	10.9	0.9	11.4	4.6	7.6	121.8	26.1	10.4	21.6	6.6	0	12.2	7.7	12.2	0	0	4.3	3.1	6.9	4.6	1.1	0	0.9	9.5	2.4	8.6	1.3	3.6	16.7	0.9	3.3	0	0	12.8	6.3	0	14.9	2.2	28	6.5	9.2	14	2.9	0.9	10.3	0	0	9	Ciliated cells
SHISAL1	KIAA1644	ENSG00000138944	Shisa like 1	Q3SXP7	22	44243667-44312851	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9	Cell type enriched	Detected in single	4	Ciliated cells: 1.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No			Vesicles, Cytosol		HPA051178: AB_2681374	unprognostic (4.07e-3)	unprognostic (9.01e-2)	unprognostic (1.83e-1)	unprognostic (1.14e-1)	unprognostic (6.54e-2)	unprognostic (1.22e-1)	unprognostic (7.79e-2)	unprognostic (2.64e-2)	unprognostic (8.10e-3)	unprognostic (1.93e-3)	unprognostic (1.33e-1)	unprognostic (1.99e-1)	unprognostic (1.51e-7)	unprognostic (1.48e-2)	unprognostic (2.41e-1)	unprognostic (1.99e-4)	unprognostic (1.10e-4)	0.7	1.3	13.8	1.3	3.6	0	0.5	1.6	13	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0	0.1	0.7	0	0.2	0.1	0	0	0.1	1.7	0.6	0	0	0	0.4	1.1	1.1	0.6	0	0	0	0	1	7	0	2.3	0.1	0.1	0	1	0	5.7	0	0	0	0	0	0.2	2.1	0.9	5.4	0.2	0	0	0	0	0	0.1	0	1.6	0	0.4	0	0	0	0	0	6.2	0	17	0	0.1	0.2	0	0.1	0	6.4	1	38.7	0.2	0	0	0	22.5	0	12.9	0.7	0	0.1	0	0	0	0	0	0.1	0	0	0	0.1	0.4	0.2	0	0.1	0	0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AK7	FLJ32864	ENSG00000140057	Adenylate kinase 7	Q96M32	14	96392111-96489427	Enzymes, Predicted intracellular proteins	Cilium biogenesis/degradation	Kinase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 29.0	Cell type enriched	Detected in many	7	Ciliated cells: 175.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	17	basophil: 10.6	Lineage enriched	Detected in single	22	granulocytes: 10.6	Cell line enhanced	Detected in some		BEWO: 10.6;CAPAN-2: 9.2;MCF7: 29.4;REH: 20.9	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA003543	Enhanced											HPA003543: AB_1078117	unprognostic (4.18e-3)	unprognostic (1.14e-1)	unprognostic (9.40e-3)	prognostic favorable (3.18e-4)	unprognostic (4.98e-5)	unprognostic (8.41e-2)	unprognostic (9.81e-3)	unprognostic (1.29e-1)	unprognostic (9.02e-2)	unprognostic (3.65e-4)	unprognostic (8.64e-2)	unprognostic (1.89e-1)	prognostic favorable (1.14e-4)	unprognostic (2.00e-2)	unprognostic (1.23e-2)	unprognostic (4.01e-2)	unprognostic (2.25e-3)	1.5	3.4	4	0.9	12.6	2	2.1	0.7	3.1	2.7	2.8	8.4	5.1	2.5	2.8	13.1	2.4	29	5	1.2	6.7	9.2	7.6	3	9.2	1.4	2.3	2.6	4.9	2.9	11.7	17.5	0.9	16.7	1.4	2.2	1.5	1.6	2.9	0.5	7.5	3.1	1.6	2.7	4.3	3.5	17.6	4.2	1.1	4.8	1.3	0.8	1.1	1.5	0.4	0.1	10.6	0.3	0.3	0.4	0.2	0.1	2.9	1.2	1	0.5	1.8	10.6	0.2	0.3	0.2	0.1	0.3	9.2	0.2	0.2	0.1	0.2	1.1	2.9	0.1	0.1	1.3	0.2	0.2	1.4	0.1	0.5	0.1	0.2	0.1	0.4	1.5	0	0.5	0.1	0.9	0.1	0.2	0.2	29.4	0.2	0.2	0.5	1.3	0.6	20.9	0.3	0.3	4.6	0.2	2	4.2	1.1	0.4	0	1.2	2.5	0.1	0	0.3	0.1	0.3	0.1	0.4	1.3	0.1	0.1	0	0.4	10.6	0.2	0.1	0.2	0	0.1	0.1	0.1	0.4	0.1	0.4	0.2	0.2	0.6	0.3	0.3	0.1	0.1	0.2	4	12.6	0.7	3.1	6.7	9.2	2.3	2.6	16.7	4.2	6	2.6	0.5	0.7	1.5	0	0.3	2.5	175.3	18.2	7	2	0.7	3.3	2.4	14.5	0.9	1.1	0	1	1.5	0.4	0.4	0	0.6	0.2	0	1.2	0.6	0.3	2.2	0	0.6	1.7	0	0.4	0.9	0.3	0	0	3	1.5	0	0.2	24.1	9.4	2.6	2.4	0	1.3	0.4	Ciliated cells
RABL2A		ENSG00000144134	RAB, member of RAS oncogene family like 2A	Q9UBK7	2	113627229-113643396	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		fallopian tube: 29.3	Cell type enriched	Detected in many	6	Ciliated cells: 119.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		MOLT-4: 12.2									HPA042642, HPA042700, HPA044007	Approved		Approved	Vesicles,Centrosome						Centrosome	Vesicles	HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770	unprognostic (7.76e-3)	unprognostic (7.79e-3)	unprognostic (7.00e-2)	unprognostic (2.94e-2)	unprognostic (1.99e-1)	unprognostic (4.23e-2)	unprognostic (4.89e-2)	unprognostic (6.77e-3)	unprognostic (6.61e-2)	unprognostic (7.36e-2)	unprognostic (5.78e-3)	unprognostic (4.29e-2)	prognostic unfavorable (1.20e-4)	unprognostic (1.89e-2)	unprognostic (1.50e-1)	unprognostic (7.87e-2)	unprognostic (3.19e-5)	2.2	1.7	6	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9	2.7	29.3	2.8	3.3	7	6	3.5	3.4	12.9	1.8	4	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2	5.5	2	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.6	4.3	6	4.8	5	7.3	4.6	2.4	2	3.5	2.5	3.8	1.6	3.7	10.4	0.8	2.5	2.7	3	0.3	2.3	5.1	5.8	1.8	0.1	0.5	4.1	0.8	1.3	2.6	5.2	0.7	1.5	5.1	2.5	5.5	1.7	0.9	2.1	2.1	12.2	0.9	3.3	2.2	1.5	2.3	2.3	1.6	2.4	0.6	2.5	8.5	2.3	2.6	2.2	1.9	0.5	3.5	0.6	0.5	0.8	0.9	1.7	3.6	3.8	0.8	7.1	2.7	1.2	0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8	8.6	6.8	0.5	12.2	7.2	9.8	5	5.5	6	9.5	6.3	20.9	7	6	4	7.5	6.4	4.3	8.9	7.2	7.5	4.3	3.9	7	4	0	119.1	12.5	7	9.8	2.8	11.6	6.7	9.4	3	5.2	0	2.7	2.2	7.3	3	11.5	3.9	3.1	15.9	6.9	6.7	2.8	9.8	7.5	4.6	6.8	6.4	3.7	6.5	4	3.5	6.7	5	17.6	0	6.6	20.4	8.3	4.3	2.1	5.7	4.3	3.4	Ciliated cells
C2orf50	FLJ25143	ENSG00000150873	Chromosome 2 open reading frame 50	Q96LR7	2	11133053-11146790	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 17.3;fallopian tube: 21.1	Cell type enriched	Detected in some	5	Ciliated cells: 38.8	Low cancer specificity	Detected in some			Region enriched	Detected in many	4	pons and medulla: 17.3	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 4.1;JURKAT: 3.3;T-47d: 3.6					Not detected	Not detected			HPA062894	Enhanced											HPA062894: AB_2684897	unprognostic (6.29e-2)	unprognostic (1.33e-1)	unprognostic (3.53e-4)	unprognostic (1.92e-3)	unprognostic (3.35e-2)	unprognostic (6.19e-2)	unprognostic (3.55e-1)	unprognostic (1.31e-1)	unprognostic (3.32e-1)	unprognostic (2.98e-2)	unprognostic (2.00e-2)	unprognostic (2.45e-1)	unprognostic (3.97e-4)	unprognostic (7.03e-2)	unprognostic (2.92e-1)	unprognostic (8.25e-3)	unprognostic (7.36e-2)	0.4	0.5	2.1	0.5	2.7	0.7	0.6	0.5	4	1.2	0.3	2.2	0	0.6	0.7	5.5	0.2	21.1	0.4	0.2	4.1	3.2	0.6	0.3	4	0.6	1	1.7	5	0.5	0.3	3.8	0.4	17.3	0.5	0.3	0	1.1	0.3	0.4	0.6	0.4	0.4	0.6	0.6	0.4	0.6	0.5	0	0.5	0	0.5	0.2	0	1.1	0.8	2	0.7	1.3	2.4	0.4	0.3	1.7	0.8	0.4	0.1	0.2	0.8	0.2	0.4	0.6	0.5	0.8	4.1	0.3	0.6	0.3	0.6	0.8	2.5	0.2	0.5	1.7	0.5	0.3	0.2	0.5	0	0.2	0.8	0.1	0.3	0.1	0.3	0.6	0	3.3	0.2	1.4	0	2.9	0.7	0.4	0.6	0.7	0.5	1.7	0	0.3	0.4	0.6	1.2	0.7	0.2	0.8	0.6	0.6	3.6	0.7	1.2	0.4	0.5	0.2	0.4	1.2	0.4	0.2	0.6	0.2	0.6	1.8	0.6	0.5	0.5	0.3	0.4	0.9	0.8	0.7	0.8	1.1	2.4	0.7	2	1.3	0.7	0.5	0.8	0.4	2.1	2.7	0.5	4	4.1	3.2	1	1.7	17.3	0.5	0	2.6	0	0.4	0	0.2	0.3	0	38.8	5.7	0	7.9	0	0	0.2	0.2	0	0	0	0.2	0	0.1	0.1	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0.9	0.3	0	1.4	0	3.2	0	0	0.4	1.4	0	0	0	0	0.1	Ciliated cells
ENKUR	C10orf63, CFAP106, enkurin, MGC26778	ENSG00000151023	Enkurin, TRPC channel interacting protein	Q8TC29	10	24981979-25062279	Predicted intracellular proteins		Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 18.7;fallopian tube: 46.2	Cell type enriched	Detected in many	8	Ciliated cells: 400.2	Cancer enhanced	Detected in some		glioma: 4.7	Low region specificity	Detected in all			Cell type enriched	Detected in single	5	neutrophil: 4.1	Lineage enriched	Detected in single	9	granulocytes: 4.1	Cell line enhanced	Detected in some		AN3-CA: 4.1;CAPAN-2: 7.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA037593, HPA037594, HPA061503	Enhanced											HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543	unprognostic (2.33e-3)	unprognostic (4.86e-2)	unprognostic (1.13e-2)	unprognostic (6.52e-3)	unprognostic (3.31e-2)	unprognostic (2.91e-2)	unprognostic (1.38e-2)	unprognostic (7.35e-2)	unprognostic (1.18e-1)	unprognostic (8.69e-2)	unprognostic (6.85e-2)	unprognostic (3.17e-1)	unprognostic (1.20e-6)	unprognostic (3.94e-1)	unprognostic (3.35e-2)	unprognostic (3.45e-3)	unprognostic (8.43e-3)	0.7	1.1	8.4	1.2	13.4	1	0.7	1.1	10.6	2.2	0.9	6.2	0	2	2.5	7	0.7	46.2	1	0.8	8.8	10.8	1.2	2.4	6.7	0.7	9.2	3.5	6.5	0.6	0.8	10.4	1.4	18.7	0.7	0.8	0	0.8	0.7	0.9	0.8	4.6	0.9	6.5	1	0.9	8.4	8.6	0	1.2	0	0.8	0.7	0	0	0.4	4.1	0.3	0	0	9.9	0.4	1.2	1.2	4.1	0.2	0.3	0.1	0.4	0	0	0	0.7	7.1	0.7	1	0.2	1.2	0.6	0	0.7	0.1	0.4	0.5	0.8	1	0.4	0.1	0	0.2	0	0	0.4	0.6	0.1	0.1	0	0.1	0.1	0.2	0	0	0	0	0.9	0	0.1	0	0	1.1	0.3	1	2.3	0.4	0.2	0.2	0.3	0.6	0	0.2	0.4	1.2	0.6	1	0	0.1	0	2.1	0.2	0.1	0.1	0.3	0.9	0	0	0	0	0	0	0.2	0	0	0	4.1	0	0.1	0.4	0	9.9	8.4	13.4	1.1	5.2	8.8	10.8	9.2	3.5	18.7	8.6	0	0.6	0	0.5	0	0.3	0.3	0	400.2	38.7	1.8	0	0.2	0	2	50.2	0.3	1.3	0	4.5	1.5	0.4	0.5	1.1	0	0	0	2.4	0	0	6.6	1.1	0	0	1	0.1	17.6	8.5	0	0.7	0.7	1.8	0	0.1	10.8	4.8	0.1	0.2	0	0.2	0.1	Ciliated cells
SPEF2	CT122, FLJ23577, KPL2	ENSG00000152582	Sperm flagellar 2	Q9C093	5	35617844-35814611	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Ciliated cells: 327.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	6	gdT-cell: 5.2;MAIT T-cell: 6.5;memory CD4 T-cell: 3.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 4.1	Group enriched	Detected in many	8	NK-cells: 4.1;T-cells: 6.5	Cell line enhanced	Detected in many		HDLM-2: 14.2;T-47d: 8.4					Low region specificity	Detected in many			HPA039606, HPA040343	Enhanced											HPA039606: AB_10671044, HPA040343: AB_2676930	unprognostic (3.81e-2)	unprognostic (3.17e-1)	unprognostic (6.23e-2)	unprognostic (8.71e-2)	unprognostic (4.55e-2)	unprognostic (8.23e-2)	unprognostic (8.11e-4)	unprognostic (1.23e-1)	unprognostic (2.35e-1)	unprognostic (9.96e-2)	unprognostic (1.01e-4)	unprognostic (4.50e-2)	unprognostic (6.34e-3)	unprognostic (1.53e-2)	unprognostic (1.63e-1)	unprognostic (2.52e-2)	unprognostic (2.12e-2)	2.4	5.4	5.9	4.1	14.5	2.1	7.6	3.6	10.3	15.8	2.6	5.3	8.8	1.5	17.3	19.1	1.8	21.7	4.5	2.8	4.7	7	10.9	2.1	6.8	2.7	3	6.1	9.1	6.4	13.3	22.5	6.5	12.9	8.3	3.1	4.9	4.7	9.4	1	1.9	2.3	6.4	3	3.6	3.3	9	3.1	2.3	11.9	0.6	1.5	3.7	7.9	0.6	0.6	0.4	0.5	4.1	6.5	1.3	0.9	1.4	1.7	4.7	1.2	1.4	0.2	2.2	1.4	5.3	3.5	0	2.5	0	1.2	3.1	5.9	0.1	1.5	2.1	5.3	14.2	0.5	0	6.2	0.5	1.6	3.7	0	2.1	3.8	2.9	1.6	6.4	0.1	0.9	1.7	0.9	0.8	2.4	0	0	0.1	3.4	1.3	3.2	0	0	3.7	0.4	0.1	1.3	0	2.6	0.4	1	8.4	7.2	0	1.5	2	3	0.8	0	0	0.3	4.3	0.1	0	0	0.5	0	5.2	0.5	6.5	0.2	3.1	5.4	0.6	0.6	3.5	4.2	0.4	4.1	0.2	0.2	0.7	1.3	5.9	14.5	3.6	10.3	4.7	7	3	6.1	12.9	3.1	8.9	5.4	0	2.5	1.4	15	5.3	5.1	327.9	46.6	5.2	35.3	1.3	5	3.1	59.7	3.2	0.4	0	1.5	0.7	6.8	2.4	5.7	0.9	1	19.1	2.4	6.2	0.6	15.5	9.5	2.4	1.7	34.3	3.4	14.6	1.3	0	6.7	9.9	39.9	0	1.9	18.2	9.1	0.9	0.7	7.5	2.6	0.2	Ciliated cells
TCTEX1D1	FLJ40873	ENSG00000152760	Tctex1 domain containing 1	Q8N7M0	1	66752459-66778787	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 28.4;fallopian tube: 18.2;liver: 13.5	Cell type enriched	Detected in some	4	Ciliated cells: 97.7	Cancer enriched	Detected in single	10	glioma: 3.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	HEL: 14.1;HUVEC TERT2: 14.2;THP-1: 15.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028420	Uncertain											HPA028420: AB_10603995	unprognostic (3.54e-2)	unprognostic (2.32e-2)	unprognostic (3.72e-4)	unprognostic (1.22e-1)	unprognostic (9.65e-3)	unprognostic (1.81e-2)	unprognostic (1.40e-1)	unprognostic (3.60e-2)	unprognostic (1.01e-1)	unprognostic (2.15e-1)	unprognostic (2.09e-2)	unprognostic (1.97e-1)	unprognostic (3.53e-6)	unprognostic (9.28e-4)	unprognostic (2.78e-2)	unprognostic (6.13e-3)	unprognostic (3.65e-2)	1.8	1.1	5.3	1.2	7.2	7.4	1.1	2.1	3.7	1.5	1	9.5	0	0.8	0.8	7.5	0.8	18.2	1.1	1.9	8.2	10.4	0.7	13.5	4	0.4	3.3	2.4	3.4	0.8	0.7	0.9	11.5	28.4	0.8	1.1	0.7	0.5	1.7	1.9	1.3	1.1	1.3	2.6	0.4	0.8	0.5	2.2	0	0.6	0.2	0.6	1.5	0.8	0	0.1	0.9	0.6	0	0	0.6	0	0	0.2	0	0.3	2.5	0	0.3	0.7	0.3	0.3	0	0	0	0	1.4	0	0	0	0	0.8	0	0	14.1	0	0	0	0	0	1.6	0	0.6	0	0	14.2	0	0	0	2.4	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9	1.3	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	0	0.4	0	0	0	0	0.1	0	0	0	0.9	0	0.5	0	0	0.6	5.3	7.2	2.1	3.7	8.2	10.4	3.3	2.4	28.4	2.2	0	2.7	0	0	1.1	0	0.4	0	97.7	15.9	0	0	0	1.7	0	0.2	6.7	0	0	0	0	0.5	0.3	24.4	3.4	2.3	0	0	0.6	0	0	0	3.3	0	0	0	5.7	0	0	0.4	0	0.2	0	0	0	0	0.5	0	0	0	0.1	Ciliated cells
FAM92B	FLJ44299	ENSG00000153789	Family with sequence similarity 92 member B	Q6ZTR7	16	85098358-85112508	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 14.2;fallopian tube: 50.7;lung: 13.8	Cell type enriched	Detected in some	10	Ciliated cells: 281.1	Group enriched	Detected in some	5	endometrial cancer: 5.4;lung cancer: 1.5	Low region specificity	Detected in many			Cell type enhanced	Detected in some		NK-cell: 2.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		SCLC-21H: 7.6;TIME: 2.2	Low region specificity	Detected in some			Low region specificity	Detected in single			HPA041022	Enhanced											HPA041022: AB_10795500	unprognostic (1.77e-4)	unprognostic (7.44e-3)	unprognostic (1.61e-1)	unprognostic (2.11e-3)	unprognostic (5.09e-3)	unprognostic (1.14e-3)	unprognostic (1.13e-1)	unprognostic (1.28e-1)	unprognostic (9.81e-2)	unprognostic (3.70e-1)	unprognostic (3.84e-2)	unprognostic (2.05e-1)	unprognostic (5.10e-13)	unprognostic (2.76e-2)	unprognostic (1.56e-1)	unprognostic (2.47e-1)	unprognostic (1.29e-1)	0.1	0.9	2	0.7	8.3	0.3	0.3	0.7	0.6	2	0.5	6.3	0	0.9	0.9	10.8	0.1	50.7	0.2	0.1	2.7	5	0.1	0.1	13.8	0.3	0	0	8.8	0.1	0.1	13.5	0.1	14.2	0.2	0.4	0	0.3	0.2	0.1	0.3	0.5	0.1	0.4	0.6	0.3	0.7	1.8	0	0.1	0	1.2	1.3	0	1.2	0.2	0.9	0.3	2.5	0.4	0.2	0.4	0	0.5	0.3	0	0	0.7	0.2	0.1	0.2	0	0.4	0.3	0.6	0.3	0.1	0.6	0	0	0	0.2	0.1	0.3	0.2	0.1	0.2	0	0.2	0.3	0.1	0	0	0	0.4	0.2	0.1	0	0.3	0	0.6	0	0.1	0.5	0.1	0.2	0.2	0.5	0.2	0.3	0.4	7.6	0.9	0	0.1	0.2	0.3	0.8	0.7	2.2	0.6	0.5	0.1	0.2	0.2	0.2	0.4	0.4	0.2	1.6	0.1	0.2	0.1	0.4	0.3	0.2	1.2	0.2	0.1	0.2	0.3	0.2	0.2	0.9	2.5	0.1	0.2	0	0.2	2	8.3	0.7	0.6	2.7	5	0	0	14.2	1.8	0	2.4	0	0	0	0	0.2	0	281.1	27.3	0	0	0	0	0	1.8	0	0	0	0	0	0	0.1	1.1	0	0.1	0	3.4	0	0.3	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
CHST9	GALNAC-4-ST2, GALNAC4ST-2	ENSG00000154080	Carbohydrate sulfotransferase 9	Q7L1S5	18	26906481-27185317	Predicted intracellular proteins, Predicted membrane proteins	Carbohydrate metabolism	Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		salivary gland: 23.4	Cell type enriched	Detected in many	5	Ciliated cells: 422.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 6.4;Hep G2: 9.5;RPTEC TERT1: 30.0;SCLC-21H: 6.5	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA011393	Uncertain				Intracellular and membrane							HPA011393: AB_1846733	unprognostic (9.24e-3)	unprognostic (1.13e-2)		unprognostic (4.81e-3)	unprognostic (6.63e-3)	unprognostic (4.53e-3)	unprognostic (9.98e-3)	unprognostic (9.21e-3)	unprognostic (7.92e-2)	unprognostic (1.61e-1)	unprognostic (2.04e-2)	unprognostic (3.54e-2)	unprognostic (2.72e-2)	unprognostic (2.17e-2)	unprognostic (1.38e-1)		unprognostic (3.93e-3)	0.3	0.4	1.7	0.3	2.4	0.2	3.7	1	2.6	4	2.1	4.5	0.7	0.4	0.3	0.9	2.2	13.6	4.5	3.4	3.7	2.7	2.4	12.1	8.6	0.1	2.6	0.8	1.2	11.9	0.1	4.3	0.1	4.9	4.8	0.4	5.3	23.4	2.7	0.4	0.4	0.7	0.3	5.3	7.1	1	8.5	4.2	0	0.3	3.9	7	2.6	10.5	0.5	0.1	0.8	0.1	0.3	0.3	0	0	0	1.3	0	0	0	0	0	0	0	0	6.4	0.1	0	0.1	0	0	0	0	0.1	0	0	1.5	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	30	0	6.5	0.3	0	0	0	1.5	0	0	0	0	0.2	0	0	0	0	0	0	0	0.5	0.8	0	0.2	0.1	0.1	0	0.1	0.1	0.2	0	0.5	0.2	0.3	0.5	0.3	0	0.1	0.1	0	1.7	2.4	1	2.6	3.7	2.7	2.6	0.8	4.9	4.2	0	2.4	0	29.8	0.6	1.3	7.7	38.2	422.9	93.3	5.2	0	0.2	10	8.9	6.1	0	0	0	0.5	0.1	1.1	6.5	4.7	8.9	0.3	0	3.4	0	0	2.4	0.6	0	6.8	0	0	72.3	2.1	0	0.4	0.1	1.8	0	0.5	0.7	0.7	0	0.2	0	0	37.1	Ciliated cells
DNAAF1	CILD13, FLJ25330, LRRC50, ODA7, swt	ENSG00000154099	Dynein axonemal assembly factor 1	Q8NEP3	16	84145287-84178767	Disease related genes, Predicted intracellular proteins			Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 21.3;testis: 49.6	Cell type enriched	Detected in many	4	Ciliated cells: 520.6	Cancer enhanced	Detected in many		endometrial cancer: 3.1	Group enriched	Detected in many	5	amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1	Cell type enhanced	Detected in some		neutrophil: 5.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8	Low region specificity	Detected in single			Low region specificity	Detected in some			HPA041166, HPA074239	Enhanced		Approved	Nuclear speckles,Plasma membrane,Cytosol						Plasma membrane, Cytosol	Nuclear speckles	HPA041166: AB_10794190, HPA074239: AB_2732250	unprognostic (5.25e-3)	unprognostic (2.40e-2)	unprognostic (2.77e-2)	prognostic favorable (2.14e-4)	unprognostic (1.42e-1)	unprognostic (9.99e-2)	unprognostic (1.25e-1)	unprognostic (4.48e-2)	unprognostic (7.71e-2)	unprognostic (1.58e-1)	unprognostic (3.31e-5)	unprognostic (2.70e-2)	unprognostic (4.61e-3)	unprognostic (1.77e-1)	unprognostic (1.56e-1)	unprognostic (1.27e-4)	unprognostic (7.51e-4)	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1	7.2	0.5	49.6	1.2	0	1.2	0	0.4	0.8	0	0.5	1	5.5	0.8	0.9	2.1	0.9	0	0	0.7	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0.3	0	0	0	0	0	0	0.2	0.7	3.5	0	0.5	0	0	0	0	0	0	0	0	0	8.8	0	0	0	0	0	0	2.7	0	0.3	0	0.1	1.3	0.2	0	0	2.5	0.1	0.1	0.9	0	0	0.4	0	0	0	7.4	4.8	0.7	0.2	0.4	0	3.6	0.8	0.4	0.4	0.6	0.1	0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2	0	17.2	2.2	1.6	0.6	1.4	0.6	2.5	520.6	108.1	3.5	51.1	0.2	0	1	67.6	1.4	0	0	0.3	0.4	0.9	0.8	3.5	0.4	1.9	0	0	3.1	2.7	16.2	1.1	4.8	82.7	1	0	2.1	1.3	0	0.4	0.7	53.5	0	0.4	118.6	19.6	0.3	0.3	0	0	0.7	Ciliated cells
CFAP70	FLJ25765, TTC18	ENSG00000156042	Cilia and flagella associated protein 70	Q5T0N1	10	73253759-73358859	Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 27.2;testis: 22.3	Cell type enriched	Detected in many	5	Ciliated cells: 329.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		PC-3: 9.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA037582, HPA070304	Enhanced											HPA037582: AB_2675560, HPA070304: AB_2732153	unprognostic (2.29e-3)	unprognostic (4.42e-2)	unprognostic (1.12e-1)	unprognostic (1.43e-2)	unprognostic (2.41e-1)	unprognostic (9.94e-2)	unprognostic (2.81e-1)	unprognostic (4.60e-2)	unprognostic (2.97e-2)	unprognostic (1.32e-2)	unprognostic (1.67e-3)	unprognostic (5.95e-3)	unprognostic (1.98e-1)	unprognostic (1.05e-1)	unprognostic (2.10e-2)	unprognostic (1.02e-1)	unprognostic (2.16e-1)	1.6	3.8	3.8	1.1	7.1	0.6	3.9	3.3	4.3	2.6	0.8	8.2	8.7	1.6	2.1	13.8	0.9	17.3	1.8	1.4	4.2	5.3	4	2.2	3.3	1	3.7	3.8	4	2.4	10.1	27.2	0.8	14.7	4.2	0.9	4	2.9	8.5	1.2	3.5	0.8	1.3	4.4	1.4	1.7	22.3	6.5	0.5	6.1	0.5	1.1	0.8	1	2.7	1.2	1.1	0.5	1.5	4.1	1	1.8	2.1	2.5	2.1	4.2	3.6	0.7	0.9	0.3	0.6	0.6	1.7	7.7	0.9	1.3	0.3	1.6	1.2	1.3	1.7	0.9	1.7	3.7	1.5	1.9	1.8	0.4	0.8	0.9	2.2	4.1	1.3	1.1	3.1	0	5.2	0.7	5	0.7	3	2	1.6	0.8	1.7	9	1.3	2	3.9	3.8	0.6	3.4	0.3	0.8	1.6	1.3	1.5	3.1	1.3	1.4	0.6	2.1	0.9	2.2	5.1	2.8	2.2	2.9	1.7	0.6	0.2	0.1	1.1	1	0.5	2.2	1.8	2	1.6	0.6	2.7	4.1	3.6	0.3	1.5	0.4	1.2	1.8	1	3.8	7.1	3.3	4.3	4.2	5.3	3.7	3.8	14.7	6.5	8.9	6.7	0.5	3.6	0	14.8	1.9	2.5	329.2	67.1	5.2	27.5	1	3.3	1.1	45.6	1.1	0	0	0.5	0.1	0.4	6	2.3	1.1	0.4	6.4	4.7	1.8	0.3	32.5	4.4	0.4	0	0	0.6	23.4	0.3	0	2.8	1.8	30.3	6.5	0.2	52.5	12.2	0	0.2	0	0.8	2.5	Ciliated cells
WDR66	CaM-IP4, MGC33630	ENSG00000158023	WD repeat domain 66	Q8TBY9	12	121917862-122003927	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0	Cell type enriched	Detected in many	5	Ciliated cells: 228.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	10	plasmacytoid DC: 4.9	Lineage enriched	Detected in single	10	dendritic cells: 4.9	Cell line enhanced	Detected in some		HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA039902, HPA040005	Supported		Uncertain	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA039902: AB_10795236, HPA040005: AB_10795160	unprognostic (4.92e-3)	unprognostic (9.05e-2)	unprognostic (7.99e-3)	prognostic favorable (3.11e-4)	unprognostic (5.58e-3)	unprognostic (6.89e-3)	unprognostic (1.44e-2)	unprognostic (2.45e-1)	unprognostic (2.89e-1)	unprognostic (2.34e-1)	unprognostic (7.72e-2)	unprognostic (1.55e-1)	unprognostic (2.43e-2)	unprognostic (4.29e-2)	unprognostic (1.37e-1)	unprognostic (1.79e-2)	unprognostic (1.35e-1)	1.3	1.2	6.3	1	13.2	0.4	1.7	0.4	4	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1	0.9	2	0.8	35	2.4	0	6.7	0	1.2	0.8	1.7	0.2	4.9	0.4	0	0.1	0.3	0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.1	0.2	0.9	0.1	2.5	0.1	0.5	0.6	0.2	21.9	3.1	0.1	0.3	0.1	0.4	0.2	2.6	0	6	1.2	20.7	1.7	14	0.4	0.9	0.3	5	0	1.3	0.6	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0	3.8	0.3	1.7	0.1	0.2	0	0.1	0.6	0.5	0.1	0.7	1.8	2.7	0.3	0.3	0.3	0.1	2.6	2	0	0.4	0.4	0	0	0.1	0	0.1	0.1	0.2	0.2	0	0.2	0.1	0.1	0.4	0.1	0	4.9	0.3	0	6.3	13.2	0.4	4	6.4	3.7	0.7	3.2	18	2.4	6	10	1.5	5.9	5.5	5	2.2	5.1	228.8	36.4	10.4	29.5	0.2	3.3	3.1	38.6	1.3	0	0	0.4	0.1	1.9	1.9	8.1	0.8	0.5	7.9	1.7	28.3	2.2	49.3	6.9	1.8	1.7	1	0	1.8	0.7	0	7.1	1.1	16.8	6.5	1	34.9	14.4	3.1	0.5	0.8	0	2.2	Ciliated cells
DZIP1L	DZIP2, FLJ32844	ENSG00000158163	DAZ interacting zinc finger protein 1 like	Q8IYY4	3	138061990-138115818	Disease related genes, Predicted intracellular proteins			Ciliopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Ciliated cells: 93.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	13	classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5	Group enriched	Detected in many	17	dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030404	Approved		Supported	Nucleoplasm,Microtubules,Cytokinetic bridge		Yes	No			Microtubules	Nucleoplasm, Cytokinetic bridge	HPA030404: AB_10601548	unprognostic (3.65e-2)	unprognostic (8.37e-2)	unprognostic (2.87e-2)	unprognostic (3.71e-2)	unprognostic (8.22e-2)	unprognostic (6.50e-2)	unprognostic (6.47e-4)	unprognostic (1.54e-1)	unprognostic (3.21e-2)	unprognostic (3.13e-1)	unprognostic (3.26e-1)	unprognostic (1.69e-1)	unprognostic (1.51e-2)	unprognostic (2.35e-3)	unprognostic (2.72e-1)	unprognostic (9.98e-2)	unprognostic (2.77e-2)	5.3	2	2.2	6.1	2.5	10.9	5.5	12.1	3.3	17.4	5.1	5.3	3.1	2.9	14.8	6.5	4.3	15.2	7.9	3.8	2.4	2.1	5.1	1.2	6.4	2	2.6	1.6	12.4	8.3	6.2	5.6	2.7	6.1	9.3	2.1	10.9	2.5	5	1.7	10.4	2.3	11.3	3.4	3.1	10	4.2	3.4	0.1	4.2	4.2	2.5	8	17.8	0	1.5	1.7	1.8	0	0	0.4	5.2	3.1	6.2	5.2	4	5.3	1.4	8.6	5.2	5.1	6.5	2.1	0.4	0	4.4	7.9	7.1	1.7	4.5	2	2.5	1.1	4.4	2.3	6.4	0.3	3.2	1.7	4	5.6	2.1	5.6	2.7	5.2	2.8	1.4	1.7	0	6.9	0.3	0	0.7	7.5	0	1.1	0	7.2	0	2.3	8.4	2.2	4.9	8.8	0	4.4	3.6	2.3	3.6	2.1	12.7	5.8	6.1	4.4	0	0	0.1	5	2.5	4.9	0	1.8	1.7	0	1.3	0	0	0	0	1.5	0	0	0	0.1	0	0	0	0	0.4	2.2	2.5	12.1	3.3	2.4	2.1	2.6	1.6	6.1	3.4	3	1.3	0	0.6	3.2	6.5	2.7	2.5	93.7	11.4	1.8	7.9	0	5	3.1	15.6	1.8	0	0	1.1	0.1	3.5	0.5	0	0	1.4	3.2	0	0	1	1	5.8	2.7	0	1	0	2.3	3.7	0	3.9	0.5	17.8	0	4.7	0.4	1.5	3.8	0	0	0	0.1	Ciliated cells
CCDC17	FLJ33084	ENSG00000159588	Coiled-coil domain containing 17	Q96LX7	1	45620044-45624057	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6	Cell type enriched	Detected in many	12	Ciliated cells: 291.7	Cancer enhanced	Detected in many		endometrial cancer: 4.4	Region enriched	Detected in single	4	pons and medulla: 1.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0	Low region specificity	Detected in some			Not detected	Not detected			HPA028338	Enhanced											HPA028338: AB_10669641	unprognostic (3.53e-5)	unprognostic (7.40e-2)	unprognostic (3.08e-3)	unprognostic (3.55e-3)	unprognostic (3.31e-1)	unprognostic (9.21e-3)	unprognostic (6.97e-2)	unprognostic (1.30e-2)	unprognostic (8.55e-2)	unprognostic (1.07e-1)	unprognostic (4.46e-3)	unprognostic (2.91e-1)	unprognostic (8.37e-7)	unprognostic (1.20e-1)	unprognostic (1.96e-1)	unprognostic (2.92e-1)	unprognostic (5.91e-3)	0	0	0.1	0.1	0.2	0.4	0	0	0	3.2	0.1	0.4	0	0.2	0.5	24.5	0	31	0	0	0.2	0.1	0	0.1	23	0.1	0	0	9.6	0.1	0	1.6	0.2	1.4	0.1	0.1	0	0	0	0.2	0.1	0.1	0.3	0	0.1	0.1	1.1	0.3	0	0	0.2	0.2	0	0	0.4	0	0.1	0.4	0	0.6	0	0	0	0.7	0	0	0	0.5	2.3	0.1	0.4	1	1.3	0.3	0	0.1	0	0.4	0.3	2.3	1.1	0	0	0	0.8	0	0	0.6	0	0.3	0.2	0	0	0	0.1	0.4	0	0	0.1	0.1	0.3	1.8	0.1	1	0.2	0	0.1	0	3	1.1	0	0.2	0.4	0	0	0.2	0.3	0.9	0	0	2	1.2	0.7	0	0	0.4	1.5	0	0	0.1	0	0	0	0.6	0.4	0.4	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0.2	0.1	0	0	1.4	0.3	3	2.6	0	0.2	1	0	1.6	0	291.7	25	0	0	0.3	5	0.4	0	0.7	3.2	0	0.8	0.1	0.4	0.4	1.1	0.9	0.6	0	1.2	0.6	0.8	0.2	1.1	1.4	0	1	1.6	0.3	0.9	1.9	2.1	0.6	0.5	0	0	0.5	0	0.5	0.5	0	1.5	0.3	Ciliated cells
RSPH1	CILD24, FLJ32753, RSP44, RSPH10A, TSGA2	ENSG00000160188	Radial spoke head 1 homolog	Q8WYR4	21	42472486-42496354	Disease related genes, Predicted intracellular proteins	Meiosis		Ciliopathy, Disease mutation, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 38.4;fallopian tube: 85.5	Cell type enriched	Detected in many	8	Ciliated cells: 938.2	Cancer enhanced	Detected in many		endometrial cancer: 15.2	Low region specificity	Detected in all			Cell type enriched	Detected in single	11	plasmacytoid DC: 6.7	Lineage enriched	Detected in single	11	dendritic cells: 6.7	Group enriched	Detected in some	4	MCF7: 7.6;OE19: 27.9;RPTEC TERT1: 11.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016816, HPA017382	Enhanced		Supported	Centrosome						Centrosome		HPA016816: AB_1858393, HPA017382: AB_1858392	unprognostic (1.76e-3)	unprognostic (2.34e-1)	unprognostic (3.02e-2)	unprognostic (1.12e-3)	unprognostic (5.48e-2)	unprognostic (2.43e-1)	unprognostic (7.59e-3)	unprognostic (1.97e-1)	unprognostic (2.53e-1)	unprognostic (1.46e-1)	unprognostic (4.37e-3)	unprognostic (2.77e-1)	unprognostic (1.10e-2)	unprognostic (8.41e-2)	unprognostic (2.58e-2)	unprognostic (5.22e-3)	unprognostic (1.99e-1)	0.6	2.5	11.5	0.9	16.4	0.7	1.7	1.2	4.7	4.5	2.6	15.9	3.1	4.5	3.6	22.5	1	85.5	3.8	0.6	11.6	15	3.8	0.8	17.4	0.7	4.8	4.5	12.9	2.2	4.8	21.4	0.6	38.4	2.2	2.5	1	0.9	2.4	0.9	2.4	4.1	1.1	4.6	0.6	3.4	21.9	7.7	0.2	4.8	0	0.7	1.5	0.2	0.6	6.7	0.5	0.3	0	0.3	0.3	1.1	0.9	0	2.8	0	0	0.1	0	0	0	0	0.2	2.4	0.1	0.4	0	0.3	1.4	0	0.4	0	0.1	0	3.8	0.4	0	0	0	0.1	0.2	0.7	0	0	0	0	0.6	0	0.2	0	7.6	0.1	0.2	0.2	27.9	0.4	0	0.2	0	11.4	0.9	1.8	0.7	1.8	2.7	0.2	0	3.1	0.3	0.1	0	0.1	0.1	0	0.3	1.7	0.1	0	0	0	0.1	0.3	0.5	0.3	0.2	0.1	0.4	0.3	0.3	0.3	0.6	0.3	0.2	0.2	0	0.1	6.7	0.2	0.3	11.5	16.4	1.2	4.7	11.6	15	4.8	4.5	38.4	7.7	0	3.8	0.5	4.2	4.5	10.6	0.6	22.9	938.2	117.2	17.4	35.3	0	33.2	9.3	60	0.8	10.6	0	3.4	0	0.4	12.6	0	0	0.1	3.2	8.6	0	0	85.8	1.7	0.3	0	1.8	9.8	10.5	2.3	10.5	2.5	14.3	26.5	0	0.3	90.5	12.3	4	0.7	0	8.5	5.8	Ciliated cells
CFAP157	C9orf117	ENSG00000160401	Cilia and flagella associated protein 157	Q5JU67	9	127706989-127716002	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5	Cell type enriched	Detected in some	6	Ciliated cells: 348.0	Low cancer specificity	Detected in many			Group enriched	Detected in many	4	basal ganglia: 19.8;pons and medulla: 30.2	Cell type enriched	Detected in single	11	MAIT T-cell: 1.2	Lineage enriched	Detected in single	12	T-cells: 1.2	Cell line enhanced	Detected in many		A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA021474, HPA021786	Enhanced		Enhanced	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA021474: AB_1845801, HPA021786: AB_1845802	unprognostic (1.69e-1)	unprognostic (2.80e-2)	unprognostic (2.41e-2)	prognostic favorable (1.45e-4)	unprognostic (3.02e-1)	unprognostic (1.58e-1)	unprognostic (4.71e-3)	unprognostic (1.49e-1)	unprognostic (3.14e-4)	unprognostic (7.72e-2)	unprognostic (4.93e-4)	unprognostic (9.32e-3)	unprognostic (4.95e-3)	unprognostic (5.71e-4)	unprognostic (4.34e-2)	unprognostic (7.38e-2)	unprognostic (1.28e-1)	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7	1.6	0.2	1	24	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0	0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0	0.4	0	0.2	0.9	0	0	0	0	0	0	1.2	0	1.5	9.3	0.9	1.2	0	0	1.2	1.2	0	0	0	0.9	1.3	1.4	1.4	0	2.3	4.6	0	0	0	3.4	1.1	0.9	7.6	2.3	0	0.7	2.1	0	0	0	0	0.5	0	2.8	3.1	0.7	0	6.6	1.3	0.5	0.9	1.7	4.9	2	0.9	1.5	0	0.4	6.4	1.1	1.9	3.6	0.7	0.2	3.2	0.3	1.7	1.9	1.5	5	0.8	1	2.6	1.2	0.8	0.7	1.2	0	0	0	0	0	1.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	3.1	19.8	0.1	0.3	4.6	5.8	0	0	30.2	3.5	8.9	10.9	0	0.2	0	0.6	0	0	348	51.2	0	0	0	1.7	0.3	44.7	0	0	0	0	0.1	0	0.3	2.3	0.2	0.2	0	0	0	0.3	61.4	0.3	0.4	0	0	0.6	0.8	0	0	0.7	0.3	0.2	0	0	11.4	1.1	0	0	0	0.2	0.1	Ciliated cells
ALOX15	15-LOX-1	ENSG00000161905	Arachidonate 15-lipoxygenase	P16050	17	4630902-4642294	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Dioxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 27.9;blood: 89.8;lung: 24.4	Cell type enriched	Detected in some	15	Ciliated cells: 210.1	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in single	183	eosinophil: 89.8	Lineage enriched	Detected in single	183	granulocytes: 89.8	Group enriched	Detected in some	7	HMC-1: 16.5;MCF7: 14.3;T-47d: 4.4	Not detected	Not detected			Low region specificity	Detected in many			CAB004962, CAB004963, HPA013859	Approved											CAB004962: , CAB004963: , HPA013859: AB_1844758	unprognostic (5.31e-4)	unprognostic (1.43e-2)	unprognostic (2.81e-2)	unprognostic (8.36e-3)	unprognostic (2.22e-1)	unprognostic (8.60e-2)	unprognostic (2.36e-1)	unprognostic (2.66e-2)	unprognostic (1.70e-2)	unprognostic (1.84e-2)	unprognostic (2.51e-2)	unprognostic (3.77e-1)	unprognostic (1.31e-3)	unprognostic (1.88e-2)	unprognostic (1.30e-1)	unprognostic (2.78e-1)	unprognostic (1.59e-1)	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3	0.2	0	6.3	1.5	0.4	0.3	0.9	0.2	1	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1	1.4	0.4	2	0.2	0.2	0.4	1.9	0.2	0	0.4	89.8	0	0	0	0	1.6	0	0	0	0	0	0.2	0	0	0.1	0	0.4	0	0.6	0	0	0	0.7	0	0	0	0.1	0.2	0	0	0.2	0.1	0	16.5	0	0	0	0	0	0	1.2	0	0.2	0	14.3	0	0.3	1.2	1.4	0	0	0	0.5	0	0	0	0	0	1.4	0	0	4.4	0.6	0	0	0	0	0	0	0.1	0.5	0	0.1	0	0	0	89.8	0	0	0	0	0	0	0.4	0	0	0	0.1	0	0	0.4	0	0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4	0	0.6	0	0	1.3	0	0.4	0	210.1	5.7	0	0	1.6	0	0	13.6	0	0	0	0	0.1	0.2	0.1	1.1	0	0.4	0	0	0	0	1.3	0	0.6	0	6.4	0	0	0	0	0	0	0	0	0.1	0.2	1.1	0.6	6.2	0	0	0.2	Ciliated cells
CCDC78	C16orf25, FLJ34512	ENSG00000162004	Coiled-coil domain containing 78	A2IDD5	16	722582-726954	Disease related genes, Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3	Cell type enriched	Detected in some	10	Ciliated cells: 57.6	Cancer enhanced	Detected in many		endometrial cancer: 7.9	Low region specificity	Detected in many			Cell type enhanced	Detected in some		MAIT T-cell: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HDLM-2: 8.8;RPMI-8226: 10.3;SCLC-21H: 12.4;U-266/70: 10.2																						unprognostic (1.10e-1)	unprognostic (6.48e-2)	unprognostic (2.62e-4)	unprognostic (1.02e-2)	unprognostic (1.24e-1)	unprognostic (2.58e-2)	unprognostic (3.47e-2)	unprognostic (2.06e-2)	unprognostic (9.39e-2)	unprognostic (1.48e-1)	unprognostic (7.82e-3)	unprognostic (6.14e-2)	unprognostic (2.02e-2)	unprognostic (2.45e-3)	unprognostic (5.20e-1)	unprognostic (1.44e-1)	unprognostic (7.22e-3)	0.3	1.1	3.6	1.1	11.3	1.2	0.5	2	1.2	2.5	0.4	6.4	1.3	0.3	1.1	21.3	0.3	47.9	0.6	0.4	4.3	4.7	0.4	0.4	13.3	1.1	1.9	0.1	5.7	0.3	0.7	2.3	0.6	20.1	0.6	0.5	0.3	0.7	1	0.4	0.4	0.6	0.4	2.6	0.9	0.9	1.1	1.7	0.2	0.5	0.1	1.6	1	0.1	0.4	1.2	1.3	0	1.2	3.2	0.1	0.5	1	1.2	2.9	1.3	1.2	1.4	1.1	2.5	0.6	0.4	0.4	4.8	1	1.1	0.6	0.8	0.8	2.7	1.5	0.1	8.8	0	2.4	1.4	0	1.5	0.8	1.6	3.8	0.9	0.4	4.4	3.1	0.4	2.9	0.3	3.3	0.9	6.1	0	2.1	1.8	2.2	0.3	2.1	0.9	10.3	4.2	1.8	12.4	1.2	1.1	7.3	0.6	0.6	4.7	1.6	1	1	0.4	0	0.1	10.2	0.2	2.7	1	1.2	2.8	0	0	1.3	0.2	0	3.2	0.4	0.1	1.9	0	0.1	0	0	0	1.2	0	1.2	0.1	0.1	3.6	11.3	2	1.2	4.3	4.7	1.9	0.1	20.1	1.7	0	0	0.5	0.1	0	3.2	0.4	0	57.6	5.7	0	0	0	1.7	0	0	0	0	0	0.2	0.1	0.2	0.4	0	0	0.8	3.2	0	0	0.3	0	0.3	0	0	0	0	0.5	0.2	0	0	0	0.1	0	0	0.7	0.7	0.1	0	1.3	0	0	Ciliated cells
WDR63	DIC3, FLJ30067, NYD-SP29	ENSG00000162643	WD repeat domain 63	Q8IWG1	1	84999147-85133138	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 21.3;brain: 39.7;testis: 31.0	Cell type enriched	Detected in some	5	Ciliated cells: 167.3	Cancer enhanced	Detected in some		melanoma: 2.9	Region enriched	Detected in many	9	pons and medulla: 39.7	Cell type enhanced	Detected in some		gdT-cell: 2.2	Lineage enriched	Detected in single	4	T-cells: 2.2	Cell line enhanced	Detected in some		ASC TERT1: 10.9;HBEC3-KT: 5.4;HSkMC: 7.2;hTCEpi: 8.7;LHCN-M2: 7.8	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA038526	Enhanced											HPA038526: AB_2676063	unprognostic (3.12e-2)	unprognostic (1.33e-1)	unprognostic (1.34e-1)	unprognostic (1.61e-2)	unprognostic (1.09e-4)	unprognostic (1.10e-3)	unprognostic (2.34e-1)	unprognostic (1.69e-1)	unprognostic (3.56e-1)	unprognostic (2.53e-1)	unprognostic (1.82e-3)	unprognostic (2.31e-1)	unprognostic (1.14e-5)	unprognostic (8.57e-3)	unprognostic (2.60e-1)	unprognostic (2.35e-2)	unprognostic (1.82e-1)	0.3	21.3	2	0.4	4.6	0.1	0.9	0.1	0.9	1.3	0.6	4.2	1	0.3	0.7	11.7	0.6	14	0.4	0.9	3	2.9	2.5	0.1	3.7	0.3	0.4	0.9	4.9	0.5	3.9	14.6	0.5	39.7	0.3	0.6	0.3	1.8	0.3	0.3	1.9	0.2	0.4	0.9	0.2	0.2	31	1.9	0	1.1	1	0.2	0.7	0.3	0	0.5	0	0	0	2.2	0.4	0.2	0.5	0.1	0.4	3.9	10.9	2	2.1	4.3	0.7	1.1	0	0.6	0.5	0	0.4	2.6	0	0.4	5.4	0.9	0.1	0.4	0.3	0	0	0.6	0	0	7.2	8.7	3.6	0.2	0.4	0.1	0.6	0	0	7.8	0.1	0.2	0	0.1	0.1	0	0	0.1	0	1.8	0.2	0.2	0	0	0.2	1.3	2.2	0	3.4	0	0.6	0.3	0	0.5	0	0	0.4	4.2	0.2	1.4	0	0	0	2.2	0	1.3	0	1.2	0.9	0.1	0	0.8	1.9	0	0	0	0.5	0	0.4	2	4.6	0.1	0.9	3	2.9	0.4	0.9	39.7	1.9	0	1.7	0	0.4	0.9	0	0.7	0	167.3	18.2	0	3.9	0.1	3.3	0	12.4	0	0	0	0	0	0.3	0.2	0	0	0.4	0	5.1	0	0	3.6	1.7	0	18.6	4.6	0	0.5	0	0	0	0.7	0.4	0	0	36.6	2.9	0.1	0.1	0	0	0.1	Ciliated cells
CDC20B	FLJ37927	ENSG00000164287	Cell division cycle 20B	Q86Y33	5	55112995-55173175	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3	Cell type enriched	Detected in some	12	Ciliated cells: 33.5	Cancer enhanced	Detected in some		endometrial cancer: 4.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 4.5;T-47d: 3.3;U-87 MG: 1.3	Region enriched	Detected in single	4	hypothalamus: 0.4					HPA053900	Uncertain											HPA053900: AB_2682299	unprognostic (7.39e-3)	unprognostic (1.02e-1)	unprognostic (8.19e-2)	unprognostic (1.78e-3)	unprognostic (9.94e-2)	unprognostic (1.59e-2)	unprognostic (3.12e-1)	unprognostic (1.59e-2)	unprognostic (5.60e-2)	unprognostic (7.84e-3)	unprognostic (2.83e-2)	unprognostic (3.06e-1)	unprognostic (5.15e-4)	unprognostic (1.99e-2)	unprognostic (2.27e-1)	unprognostic (6.10e-2)	unprognostic (1.29e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0.2	0	0.2	0	0.1	0	0.3	0	0	0	0.5	0	0	0	0	0.2	0.7	0.2	0	0	0.1	0	0.4	0.5	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.4	0.3	0	3.3	0	0.4	0	0.2	0.8	0.1	0	0	0	1.3	0	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.8	0.1	0	0	0.4	0	33.5	0	0	0	0	0	0	0.1	0	0.9	0	0	0	0.2	1	0	0	0.1	0	0	0	0.3	0	0	0.2	1.7	0	0	0	0	2.9	0	0.5	0	0	0	0.7	0.5	0.1	0.1	0	0.2	0.1	Ciliated cells
C7orf57		ENSG00000164746	Chromosome 7 open reading frame 57	Q8NEG2	7	48035511-48061304	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 20.0;fallopian tube: 20.9;testis: 11.4	Cell type enriched	Detected in some	6	Ciliated cells: 143.2	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 20.0	Cell type enhanced	Detected in single		MAIT T-cell: 2.3	Lineage enhanced	Detected in single		T-cells: 2.3	Cell line enhanced	Detected in some		GAMG: 6.2;hTERT-HME1: 9.8;U-266/70: 5.8;U-698: 3.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021286	Enhanced											HPA021286: AB_1845760	unprognostic (1.74e-2)	unprognostic (4.82e-2)	unprognostic (3.13e-2)	unprognostic (1.28e-2)	unprognostic (2.77e-3)	unprognostic (3.22e-2)	unprognostic (1.21e-2)	unprognostic (1.32e-1)	unprognostic (3.29e-1)	unprognostic (1.37e-1)	unprognostic (4.98e-2)	unprognostic (2.88e-1)	unprognostic (3.93e-5)	unprognostic (5.17e-3)	unprognostic (6.18e-2)	unprognostic (3.42e-3)	unprognostic (1.20e-1)	0.2	0.2	2.3	0.2	5	0.5	0.3	0.1	1	0.8	0.2	3.5	0	0.3	0.9	7.1	1.4	20.9	0.2	0.3	3.7	4	0.3	0.2	4.3	0.3	0.1	0.4	1.6	0.1	0.7	0.4	0.2	20	0.2	0.2	0	0.2	0.2	0.2	0.3	0.2	0.2	0.7	0.2	0.2	11.4	2.1	0	0.5	1.8	0.4	0.2	0.5	0	0.1	0	0	0.6	2.3	0.1	0.7	0.2	0.1	0.1	0	0	0.2	0.1	0.5	0.3	0.4	0	2.4	0	0.2	0.1	6.2	0.3	0	1	0.7	0	0.3	0	0.2	0	0	0	0	0	0	0.2	9.8	0.1	0	0	0	0.1	0.4	0.1	0.1	0	0.2	0	1	0	0	0	0.1	0.1	0.9	0.1	0.1	0	0.3	0.8	0	0	0.1	0.6	0.9	0.4	0.6	5.8	0.8	3.3	1.4	0	0.9	0	0	0	0.6	0	2.3	0	0.6	0.6	0.1	0	0.4	0.2	0	0.6	0	0	0	0.1	2.3	5	0.1	1	3.7	4	0.1	0.4	20	2.1	0	4.8	0	0	0	0	0.8	0	143.2	22.7	0	0	0	0	0	3.4	0	0	0	0	0.1	0.2	0.1	2.3	0	0.1	0	0	0	0	2.7	0	0.2	0	0	0	0.9	0	0	0	0	0.8	0	0	9.4	0.4	0	0	0	0	0	Ciliated cells
DEUP1	CCDC67, FLJ25393	ENSG00000165325	Deuterosome assembly protein 1	Q05D60	11	93329971-93438487	Predicted intracellular proteins, Predicted membrane proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	fallopian tube: 6.0;pituitary gland: 13.0;testis: 19.9	Cell type enriched	Detected in some	12	Ciliated cells: 40.2	Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 1.4;Karpas-707: 1.0;NTERA-2: 4.0;SCLC-21H: 1.6;SuSa: 1.2;U-2 OS: 2.0	Low region specificity	Detected in single			Low region specificity	Detected in all																unprognostic (4.68e-1)	unprognostic (3.25e-1)	unprognostic (3.93e-1)	unprognostic (7.24e-3)	unprognostic (2.09e-1)	unprognostic (4.13e-1)	unprognostic (2.29e-1)	unprognostic (1.79e-2)		unprognostic (1.16e-1)	unprognostic (1.84e-1)	unprognostic (1.25e-1)	unprognostic (1.41e-3)	unprognostic (1.33e-1)	unprognostic (6.03e-3)	unprognostic (8.59e-2)	unprognostic (2.25e-1)	0	0.7	0.2	0	0.8	0	0.4	0	0.2	0.1	0.1	0.8	0.8	0	0.2	1.5	0.2	6	0.1	0	0.3	1	1	0	0.6	0	0.3	0	1.6	0.9	0.1	13	0	0.7	1.1	0.1	0.1	1.6	1.8	1.3	0.2	0.1	0.1	1	0	0.1	19.9	0	0	1.2	0	0	0	0	0	0.3	0	0.7	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0.2	0	0.4	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0	0	0	0	0.2	1	0	0	0	0.2	4	0.1	0	0.2	0.2	0	0	0	1.6	0.1	0	0	0	1.2	0	0.8	0	0	2	0	0	0.9	0	0.3	0	0	0	0	0.6	0	0	0.7	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.2	0.8	0	0.2	0.3	1	0.3	0	0.7	0	0	0	0	0	0	0	0	0	40.2	3.4	0	0	0	3.3	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
SPACA9	C9orf9, Mast	ENSG00000165698	Sperm acrosome associated 9	Q96E40	9	132878027-132890201	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	epididymis: 55.8;fallopian tube: 29.1;testis: 53.8	Cell type enriched	Detected in some	4	Ciliated cells: 116.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enriched	Detected in many	4	JURKAT: 32.5	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA022243, HPA051600	Enhanced		Approved	Mitochondria		No	No			Mitochondria		HPA022243: AB_1845844, HPA051600: AB_2681546	unprognostic (2.69e-1)	unprognostic (2.14e-3)	unprognostic (8.00e-3)	prognostic favorable (8.61e-4)	unprognostic (1.59e-1)	unprognostic (5.73e-2)	unprognostic (3.76e-3)	unprognostic (2.60e-1)	unprognostic (6.43e-2)	unprognostic (1.12e-1)	unprognostic (1.15e-2)	unprognostic (9.51e-2)	prognostic favorable (8.31e-4)	unprognostic (5.11e-2)	unprognostic (1.22e-2)	unprognostic (1.20e-1)	unprognostic (1.22e-2)	2.7	6	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7	7	8.9	7	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3	2.9	3.8	6	3	5.6	3.3	7.8	3.5	1.6	1.9	2.1	3.2	2.7	4.6	5.9	3.9	1.2	2.3	1.7	1.9	0.5	6.1	0.5	2.9	5.7	3.7	2.8	1.3	3.6	1.6	2.3	2.6	0.5	1.5	0.7	6.7	1.4	0.2	6.7	7.7	4.3	4.8	7.3	2	32.5	0.5	1.7	4.7	4.2	4.9	5.6	0.7	3.7	2	2.3	0.7	1.4	7.1	0.7	0.9	3.2	5.3	0.9	4.2	2.5	7	0.5	1.9	3.8	2.6	3.6	0.5	0.7	1.1	1.7	7	0.5	1.8	5.6	2.2	3.6	2.2	2	2.5	6	2.4	1.3	3	4.7	2.9	2.6	3.1	7.8	3.3	1	3.5	1.6	7.8	8.4	4.3	9.3	7	8.9	7.2	7.3	6.9	5.1	3	1.3	0	0	0	0	0	0	116.4	9.1	22.7	0	14.2	28.2	6.2	0	0	0	0	6.2	10.9	0	0	0	0	5.8	0	0	0	0	0	0	0	0	1.8	0	0	5.4	0	0	16.2	0	0	0	0	0	0	6.1	0	0	0	Ciliated cells
STOX1	C10orf24, FLJ25162	ENSG00000165730	Storkhead box 1	Q6ZVD7	10	68827541-68895432	Disease related genes, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 17.8;fallopian tube: 19.1	Cell type enriched	Detected in many	4	Ciliated cells: 48.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5	Group enriched	Detected in many	4	dendritic cells: 3.5;T-cells: 3.0	Cell line enhanced	Detected in many		AN3-CA: 10.9;HAP1: 10.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA037844, HPA037845	Uncertain		Supported	Nucleoplasm,Nucleoli fibrillar center,Cytosol	Intracellular and membrane	No				Nucleoplasm	Nucleoli fibrillar center, Cytosol	HPA037844: AB_2675700, HPA037845: AB_10671369	prognostic favorable (3.37e-5)	unprognostic (5.53e-3)	unprognostic (6.62e-2)	unprognostic (1.06e-1)	unprognostic (4.63e-3)	unprognostic (1.95e-2)	unprognostic (2.24e-3)	prognostic favorable (2.08e-4)	unprognostic (1.52e-1)	unprognostic (2.45e-3)	unprognostic (5.33e-3)	unprognostic (5.29e-2)	unprognostic (3.87e-2)	unprognostic (8.77e-2)	unprognostic (3.06e-2)	unprognostic (2.33e-1)	unprognostic (3.46e-2)	8.7	6.4	17.8	1.7	13.4	0.6	4.8	1.8	13.4	2	2.6	6.8	1.3	2	2.8	11.9	2.5	19.1	1.7	0.9	16.1	9.3	4.5	0.9	2.2	1.8	11.5	10.2	1.9	1.6	6.1	8.8	1.5	5.6	2.3	2.8	5	2.6	2.1	1.9	1.4	2.8	2.5	2.4	0.9	2.2	3.8	7.3	3.3	8.7	0	1.7	1.6	0.9	0.7	3.5	0	0	0.2	3	0.2	2.2	2.4	5.4	10.9	2.3	0	3.2	0.2	0.1	1.6	1.7	2.3	3.3	2.1	3.1	0	4.2	0.6	10.1	0	0.8	2.5	4.2	0.2	0.5	3.1	0.3	2.7	3.9	0.2	0.2	0.3	0	0.3	0.1	5.6	0.5	0.3	0.2	2.2	4.6	3.4	1.8	0.5	1.5	3.4	0.1	0	3.2	5.8	1.7	5	3.9	1	0.7	3.6	2.4	2.2	0	0	0.3	0	1.5	1	1.9	2.2	0	0.6	0.1	0	0	0	0.3	0	0.7	0.4	0.8	0.6	0	0.7	3	1.4	0	0.2	0	3.5	0.3	0.2	17.8	13.4	1.8	12.5	16.1	9.3	11.5	10.2	5.6	7.3	0	0.3	0.5	3.2	1.3	0.9	0.3	0	48.2	9.1	1.8	0	1.1	3.3	0	0.2	0.1	0.4	0	0.3	0.2	0.6	1.8	2.3	0	0.1	0	0	0	0.3	0	1.1	0	0	0	1.6	1.5	0.2	0	0	1.2	0.3	6.5	5.7	1.6	11.1	0.4	1	0	5.6	1.7	Ciliated cells
AGBL2	CCP2, FLJ23598	ENSG00000165923	ATP/GTP binding protein like 2	Q5U5Z8	11	47659591-47715389	Enzymes, Predicted intracellular proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 34.0	Cell type enriched	Detected in some	5	Ciliated cells: 107.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 6.1;T-47d: 3.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA007718	Uncertain											HPA007718: AB_1078110	unprognostic (3.44e-5)	unprognostic (1.16e-1)	unprognostic (5.84e-2)	unprognostic (5.33e-4)	unprognostic (1.13e-1)	unprognostic (3.00e-1)	unprognostic (2.05e-1)	unprognostic (1.38e-2)	unprognostic (9.83e-3)	unprognostic (4.11e-2)	unprognostic (5.56e-2)	unprognostic (1.79e-1)	unprognostic (8.24e-6)	unprognostic (1.01e-2)	unprognostic (1.28e-1)	unprognostic (9.62e-2)	unprognostic (1.17e-3)	0.4	1.7	0.8	6.6	2.7	0.7	1.1	3.6	1.1	1.9	2	2.8	1.5	1.1	1.6	11.2	0.5	12.2	2.4	0.4	1.3	1.4	1.8	3	6.4	1.4	0.3	0.3	2.1	4.7	1.2	3.8	0.7	3.4	1.6	0.8	0.7	1.1	1.7	0.4	0.6	3.3	0.6	0.7	1.7	0.8	34	0.7	4.4	1.9	0.5	2.6	2.1	1.4	2.6	1.5	0.4	0.2	1.4	2.2	0.6	1.2	0	0	0	0.3	1.7	0.1	0.4	0.8	0.5	1.7	0.6	6.1	0.1	0.4	0.4	0.8	1.6	0	0.1	0.8	1.8	0.4	0.3	2.9	2.2	0.9	0	1	1.8	0.7	0.9	0.5	0.6	0.1	2.1	0.4	1.3	0.9	2.4	1.2	0.6	0	0.3	0.1	1.7	0.1	0.5	0.9	2.7	2.2	0.5	0.7	0	0.7	0	3.5	0	0.2	0.2	0.5	0.3	0	0	0.1	0.1	0.3	0.3	0.3	0	0.1	0	1.5	0	1.3	1	1.6	1.2	0.1	2.6	1.9	1.7	0.4	1.4	0.2	1.5	2.2	0.6	0.8	2.7	3.6	1.1	1.3	1.4	0.3	0.3	3.4	0.7	0	2.4	0	1.2	0.1	0	0.4	0	107.1	10.3	7	0	0.4	0	0.2	23.4	0	1	0	0	0.2	0.6	0.3	0	0.6	0.1	0	1.2	0.6	0.3	6.6	0.3	0.3	0	1.8	0.6	0.5	0.2	0	1.4	0	0.4	0	0.1	19.6	1	0	0.3	0.7	0.8	0.3	Ciliated cells
CFAP52	FLJ37528, WDR16, WDRPUH	ENSG00000166596	Cilia and flagella associated protein 52	Q8N1V2	17	9576627-9643459	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 29.5;fallopian tube: 46.9;testis: 26.8	Cell type enriched	Detected in some	6	Ciliated cells: 149.9	Low cancer specificity	Detected in some			Region enhanced	Detected in many		pons and medulla: 29.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA023247, HPA030635	Enhanced		Approved	Nucleoplasm,Mitochondria						Mitochondria	Nucleoplasm	HPA023247: AB_1858797, HPA030635: 	unprognostic (1.76e-2)	unprognostic (2.31e-1)	unprognostic (1.38e-1)	unprognostic (1.68e-2)	unprognostic (2.09e-1)	unprognostic (2.04e-1)	unprognostic (3.99e-1)	unprognostic (3.16e-2)	unprognostic (2.11e-1)	unprognostic (3.66e-1)	unprognostic (2.22e-2)	unprognostic (2.66e-1)	unprognostic (7.85e-2)	unprognostic (1.85e-1)	unprognostic (9.23e-2)	unprognostic (4.50e-2)	unprognostic (7.09e-2)	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0	0.8	0	0.3	0.5	0	0	0.7	0	0.2	0	0	0	1.6	1.9	0	0.7	1.3	0.9	0.9	0	0.1	0	0	0.1	3.9	0	0.4	0	1.4	2.2	0	0	0	0.5	0	0	2.6	0.4	0.1	0.1	0	0.2	0	0.5	0	0	0	0.5	0	0	0.2	4.8	0	0.7	0.3	6.2	0.2	3.3	0	0.1	0.4	0.9	0.8	0	0.7	1.3	0	0.9	2.9	0.2	0	0.1	0.5	0	0	0.1	0.3	0	0.2	0.9	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	3.7	8.4	0.3	2.5	5.9	6	0.5	0.5	29.5	3.5	0	2.9	0	0.2	0	0.4	0.3	0	149.9	18.2	0	5.9	0.5	1.7	0	21.1	0	0	0	0.2	0.1	0	0.3	0	0	0.1	0	0	0	0	3.6	1.7	0	0	0	0	0.5	0.1	0	1.8	0.2	2	0	0	25.2	0.3	0	0.8	0	0	0.1	Ciliated cells
CCDC103	CILD17, FLJ13094, FLJ34211, PR46b	ENSG00000167131	Coiled-coil domain containing 103	Q8IW40	17	44899142-44905390	Disease related genes, Predicted intracellular proteins	Cilium biogenesis/degradation		Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	fallopian tube: 19.6;testis: 35.5	Cell type enriched	Detected in single	14	Ciliated cells: 13.4	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 12.8;RPTEC TERT1: 10.0;U-87 MG: 11.3									HPA043131			Approved	Cytosol						Cytosol		HPA043131: AB_10796686	unprognostic (9.40e-3)	unprognostic (1.75e-1)			unprognostic (5.60e-2)	unprognostic (1.99e-2)		unprognostic (4.50e-2)	unprognostic (7.43e-2)	unprognostic (2.80e-1)	unprognostic (2.34e-1)	unprognostic (1.27e-1)	unprognostic (4.35e-2)		unprognostic (4.69e-1)	unprognostic (1.05e-1)	unprognostic (3.60e-1)	0.6	2.3	2.6	0.9	6.3	0.6	1.2	0.5	4.7	1.4	0.9	2.9	1.6	0.5	1.7	2.8	0.4	19.6	2.8	0.4	2.5	3	2.7	0.7	1.9	0.3	1.5	3.9	3.5	0.8	1.9	2.1	0.5	4.3	0.9	0.7	1.6	1.2	1.5	0.3	0.7	0.4	1.2	1	0.4	0.9	35.5	1	0.2	3.5	0.1	0.5	0.7	0.4	0.8	2.5	3	3.7	0.7	0.4	2.4	2.2	12.8	1.9	2.4	2.8	2.3	1.6	1	3.8	1.8	1.3	2.4	4.2	0.3	2.1	0.9	5.5	3.9	0.8	1.8	1	7.9	1.4	0.6	2.7	0	1.8	1.6	0.3	1.6	3	1.9	0.7	3.7	1.3	0.9	1.7	0.3	0.1	2.4	0	0.7	0.4	2.1	1.9	0.3	0.7	0.5	10	1.3	5.1	1	0.5	0.4	2.3	1.1	3.4	1.7	1	0.8	2	1	1.9	0.4	0.5	0.4	11.3	0.8	0.3	1.2	3.7	3	0.3	1.9	0.4	0	0	0.4	2.5	0.8	0.4	0.3	0.5	0.7	1.7	0.8	0.1	2.4	2.6	6.3	0.5	4.7	2.5	3	1.5	3.9	4.3	1	0	0	0	0	0.1	0	0	0	13.4	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Ciliated cells
C22orf15	FLJ36561, N27C7-3	ENSG00000169314	Chromosome 22 open reading frame 15	Q8WYQ4	22	23763021-23765861	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enriched	Detected in some	6	fallopian tube: 22.3	Cell type enriched	Detected in some	13	Ciliated cells: 200.8	Cancer enhanced	Detected in single		endometrial cancer: 1.7					Cell type enhanced	Detected in some		plasmacytoid DC: 2.9	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 3.0;BJ: 2.2;BJ hTERT+: 4.8;HSkMC: 2.0;hTERT-RPE1: 6.5;MOLT-4: 3.0														Secreted in female reproductive system								unprognostic (2.37e-2)	unprognostic (3.28e-3)	unprognostic (1.28e-1)	prognostic favorable (8.53e-5)	unprognostic (1.86e-2)	unprognostic (2.07e-2)	unprognostic (4.38e-2)	unprognostic (6.14e-2)	unprognostic (3.60e-2)	unprognostic (7.70e-2)	unprognostic (4.58e-2)	unprognostic (2.60e-1)	unprognostic (9.79e-2)	unprognostic (2.29e-1)	unprognostic (3.02e-1)	unprognostic (3.28e-2)	unprognostic (3.08e-3)	0	0.1	1	0	1.7	0.4	0.1	0	0	0.8	0.1			0	0.2	0	0	22.3	0.2	0	1.4	1.9	0	0	2.7	0.2	0		0.5	0	0	1.5	0.2		0.1	0		0	0.2	0	0	0	0.2	0.1	0.1	0	3.6			0		0	0	0	0.6	2.9	0	0	0	1.8	0.2	0	0	3	0	0	0	0	2.2	4.8	0	0.5	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.6	0	0	2	0	0	0	6.5	0.8	0	0	0	0	0	3	0	0.3	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	1.5	0	1	0.6	1	0.8	0.4	0.5	1.8	0.5	0	0	0	2.9	0	0.2											0	2.6	0	0	0.1	0.5	0	0	200.8	15.9	0	0	0	0	0	4.7	0	0	0	0	0	0.6	0.1	2.3	0	0	0	0	1.3	0	2.8	0	0.2	0	0	0	0.2	0	0	0	0	1.8	0	0.1	12.7	3.8	0.3	0	0	0	0	Ciliated cells
FABP6	I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP	ENSG00000170231	Fatty acid binding protein 6	P51161	5	160187367-160238735	Predicted intracellular proteins	Lipid transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	68	intestine: 299.2	Cell type enriched	Detected in some	6	Ciliated cells: 208.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in single	8	neutrophil: 1.0	Lineage enriched	Detected in single	8	granulocytes: 1.0	Cell line enhanced	Detected in some		Daudi: 20.6;EFO-21: 19.8;HDLM-2: 8.7;NB-4: 8.1;RPMI-8226: 9.5;RT4: 9.1;U-2197: 8.6	Not detected	Not detected			Not detected	Not detected			HPA012601, CAB024713	Enhanced				Intracellular and membrane				650000			CAB024713: , HPA012601: AB_1848435	unprognostic (3.03e-2)	unprognostic (7.55e-2)	unprognostic (1.27e-1)	unprognostic (5.00e-3)	unprognostic (1.48e-2)	unprognostic (3.53e-1)	unprognostic (5.35e-7)	unprognostic (3.05e-1)	unprognostic (1.97e-1)	unprognostic (2.41e-2)	unprognostic (2.16e-1)	unprognostic (2.56e-1)	prognostic unfavorable (4.35e-9)	unprognostic (2.10e-2)	unprognostic (1.21e-2)	unprognostic (2.48e-1)	unprognostic (1.85e-3)	0.1	0.9	0.2	0.1	0.4	0	0.1	0.1	0.1	0.5	0.1	0.3	0.1	0.2	0.3	0.1	0.1	4.3	0.1	0.1	0.4	0.5	0.1	0.1	1.3	0.1	0.4	0.1	0.5	0.1	0	0.2	0.1	1	0.1	0	0.1	0.4	0.1	0.1	0	299.2	0.1	0.2	0.1	0	0.1	0.2	1.2	0.1	0.5	0.2	0.2	0.1	0.1	0	1	0	0	0	0	0.1	0.4	0	0.1	0	0	6.5	0	0	0	0	3.4	0.6	20.6	19.8	0	0.1	0	0	0	0	8.7	1.1	0	0	0	0	0	0	0	1.2	0	0.2	0	0	1.5	0.8	0.2	0	0	0	8.1	0	0	1.8	0	0.6	9.5	0	9.1	1.8	0.4	0	5.2	0.1	0.1	0	0.1	0	0	0	8.6	1	1.1	4.5	2.3	0.2	1.8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	1	0	0	0	0	0	0.2	0.4	0.1	0.1	0.4	0.5	0.4	0.1	1	0.2	0	1	0	0.2	0.5	0	2	0	208.8	34.2	0	0	0	0	0.9	0.3	0	2.6	0	0	0.1	0.2	0.1	0	0	0.1	1.6	0	0	0	0	0.3	0.5	0	1	0	0	0.2	0	0	0	0.5	0	0	0.1	0.2	0.1	0	0	0.6	1.4	Ciliated cells
OR10A2	OR10A2P, OST363	ENSG00000170790	Olfactory receptor family 10 subfamily A member 2	Q9H208	11	6863057-6874717	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 2.9	Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected							Cell type enhanced	Detected in some		neutrophil: 2.9	Low lineage specificity	Detected in single			Not detected	Not detected																																					unprognostic (5.04e-2)				0	0.3	0.2	0.4	0.6	1	0	0	0.3	0.2	0			0.5	0.2	0	0	0.2	0.3	0	0.2	0.3	0	0	0	0.5	0.1		0	0.2	0	0	0		0.1	0		0.1	0	0.5	0.8	0	0	0.2	0.4	0	0.6			0.1		0.1	0.3	0	0.6	0.8	2.9	0.4	0.5	0.3	0	0.3	0	0.1	0.4	0	0	0.3	0.1	0	0.1	0	0.3	0.1	0.8	0.1	0	0	0.5	0.1	0.3	0	0	0.6	0.3	0.5	0.3	0	0.8	0.4	0.1	0.1	0.2	0	0.1	0.1	0.1	0.8	0.2	0.1	0	0.1	0.1	0.4	0	0.3	0.2	0.2	0.1	0.1	0.8	0.3	0	0.4	0.6	0	0.4	0.5	0	0.3	0.1	0.4	0.2	0	0.4	0.2	0.2	0.4	0.1	0.3	1.2	0.4	0.3	0.3	0.2	0.2	0.4	0.2	0.1	0	0.6	0.3	0.3	2.9	0.5	0.3	0.8	0.2	0											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
DNAH12	DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19	ENSG00000174844	Dynein axonemal heavy chain 12	Q6ZR08	3	57293699-57544344	Cancer-related genes, Predicted intracellular proteins	Ubl conjugation pathway	Motor protein	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6	Cell type enriched	Detected in some	6	Ciliated cells: 439.0	Cancer enhanced	Detected in single		endometrial cancer: 0.6	Region enriched	Detected in many	8	pons and medulla: 23.0	Cell type enhanced	Detected in single		NK-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1									HPA037493, HPA058203, HPA061365	Enhanced											HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493	unprognostic (4.85e-2)	unprognostic (1.29e-2)	unprognostic (2.23e-1)	unprognostic (2.18e-3)	unprognostic (2.96e-2)	unprognostic (2.17e-1)	unprognostic (2.80e-2)	unprognostic (1.51e-3)	unprognostic (3.06e-2)	unprognostic (3.21e-1)	unprognostic (4.40e-2)	unprognostic (5.90e-2)	unprognostic (3.43e-5)	unprognostic (2.82e-2)	unprognostic (1.34e-1)	unprognostic (2.53e-2)	unprognostic (5.47e-2)	0.2	0.3	0.6	0.1	3	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0	7.6	3.1	0.1	8.9	0.1	23	0.2	0.2	0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1	0	0.3	0	0.1	0.2	0.2	0.5	0.5	0	0	1.2	0.9	0.1	0.3	0.7	0	0	0.9	0.3	0.1	0	0.2	0.3	0	3.1	0.3	0.1	0	0.4	1.9	0.4	0	0.3	0.2	0.7	0.2	0	0	0	0.3	0.2	0	0.2	0.6	0.1	0.4	0.4	0.2	0.6	0.2	0.1	2.1	0	0	0.4	0	0.4	0.5	0	0.2	0	0.4	0	0	0.1	0	0.1	0.1	0.2	0	0.1	0.3	0	0.9	0.1	0	0.8	0.3	0.1	0	0	0	0	0	0	0	0	0.9	0.3	0.1	0	0	0.5	0.2	0	0	1.2	0	0.5	0	0.1	0.6	3	0.2	0.3	2.9	0.8	0.4	0	23	1	3	1.4	0	0.2	0	0.2	0.8	0	439	70.5	0	0	0.1	0	0.1	38.2	0	0	0	0	0	0.1	0.3	1.1	0	0.1	0	1.7	0	0	5.6	0.9	0	0	0	0	1.5	0.1	0	0.4	0.4	0	0	0	24.4	2.6	0	0	0	0	0	Ciliated cells
AMY1B	AMY1	ENSG00000174876	Amylase, alpha 1B (salivary)	P04745	1	103687415-103696680	Enzymes, Predicted secreted proteins	Carbohydrate metabolism	Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	salivary gland: 302.4	Cell type enriched	Detected in some	10	Ciliated cells: 34.8	Cancer enhanced	Detected in single		ovarian cancer: 0.5	Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8									HPA045394, HPA045399, HPA046980	Supported				Secreted to digestive system				68000000			HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889					unprognostic (7.34e-2)			unprognostic (2.59e-1)		unprognostic (6.05e-2)				unprognostic (6.08e-2)		unprognostic (1.96e-1)		0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0	0.2	0.2	0.2	4	0.2	0.2	0.2	0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23	0	0.2	0.2	0.2	0.2	0	0.2	302.4	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0	1.1	0.7	0	0.3	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0.7	0	0	0	0.2	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0.5	1.2	0	0	0.7	0.1	0.4	0	0	0	2.1	0	0	0	0	0	0	0	0.2	0.3	0.2	0	1.8	0	0	0	0	0.1	0	0.3	0.3	0.2	0.6	0	0.1	1.1	0.1	0.3	0.1	0	0.7	0.2	0	0.5	0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	3	3.2	0	0.1	0.2	0	0.7	0	34.8	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	Ciliated cells
CD164L2		ENSG00000174950	CD164 molecule like 2	Q6UWJ8	1	27379176-27383380	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		fallopian tube: 26.8	Cell type enriched	Detected in some	8	Ciliated cells: 62.9	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA062915	Enhanced		Approved	Plasma membrane,Cytosol						Cytosol	Plasma membrane	HPA062915: AB_2684903	unprognostic (8.97e-3)	unprognostic (2.15e-2)	unprognostic (3.56e-2)	unprognostic (1.36e-2)	unprognostic (1.04e-1)	prognostic favorable (1.64e-5)		unprognostic (7.81e-3)	unprognostic (4.47e-2)	unprognostic (1.39e-1)	unprognostic (1.65e-2)	unprognostic (4.07e-2)	unprognostic (5.91e-6)	unprognostic (1.33e-2)	unprognostic (6.42e-2)	unprognostic (1.34e-2)	unprognostic (2.71e-2)	0.1	0.1	0.2	0.1	0.5	0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1	0.4	0.1	0.9	5.9	6	0.1	5.5	0	0	0	0	0	0.5	0	2.2	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	3.6	0	3.9	0	0	0	0	0	0	0	0	1.1	0	5.4	0	0.6	0	0	0	0.1	0	0	0.8	0	0	0.7	2	0.1	0	0	0.1	1	0	1	0	0	4.9	0	0	2.5	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4	0	3	0	8	2.6	0	0.6	0	62.9	4.5	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0	3.2	0	0	0.1	0	0	0	0	1.3	0	0	1.7	0	0	0	0.4	0	0	0	0	0	0	0.1	1	2.5	0	0	0	3.1	Ciliated cells
C11orf16		ENSG00000176029	Chromosome 11 open reading frame 16	Q9NQ32	11	8920076-8933006	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		fallopian tube: 19.1;lymphoid tissue: 10.8	Cell type enriched	Detected in some	17	Ciliated cells: 135.1	Cancer enhanced	Detected in some		endometrial cancer: 1.8	Region enhanced	Detected in some		pons and medulla: 2.9	Cell type enhanced	Detected in some		intermediate monocyte: 1.0;T-reg: 1.6	Group enriched	Detected in many	9	monocytes: 1.0;T-cells: 1.6	Cell line enhanced	Detected in some		BEWO: 1.5;CACO-2: 1.6;EFO-21: 1.6	Low region specificity	Detected in some																				unprognostic (5.32e-3)	unprognostic (1.03e-2)	unprognostic (4.09e-3)	prognostic favorable (3.32e-4)	unprognostic (1.73e-1)	unprognostic (1.35e-2)	unprognostic (1.94e-5)	unprognostic (6.40e-4)	unprognostic (1.58e-2)	unprognostic (9.99e-2)	unprognostic (4.87e-2)	unprognostic (1.05e-1)	unprognostic (1.84e-1)	unprognostic (1.39e-1)	unprognostic (1.23e-1)	unprognostic (1.71e-1)	unprognostic (1.13e-3)	0	0.2	0.5	0	0.8	0	0.2	0	0.3	2.3	0	0.7	0	0.1	0.6	3.1	0	19.1	0	0	0.8	1.3	0.4	0	5.2	0	0	0	2.8	0	0	1.6	0	2.9	0	0	0	1.4	0.1	0.1	0	0	0	0	0.1	0.2	2.7	0	10.8	0.1	0	0.3	0.1	0	0	0	0	1	0.1	1.6	0	0.9	1.3	1.3	0.5	0	0	1.5	0.4	0	0	0	1.6	0.2	0.1	1.6	0	0.1	0.4	0	0	0	0.4	0.4	0	0.7	0.2	0	0.3	0.1	0	0	0	0	0.2	0	0.6	1.2	0.1	0	0	0.6	0.9	0.6	0.2	0	0.2	0.1	0	0	0.1	0.7	0	1.1	0	0	0.3	0.4	0	0.7	1	0.5	0.3	0.2	0	0.3	0	0.2	0.6	1.1	0	0.1	0	0	1	0.3	0	0.1	0.2	0	0	0.1	0	0	0.1	0	0	1.6	0	0.5	0.8	0	0.3	0.8	1.3	0	0	2.9	0	0	0.6	0	0	0	0	0	0	135.1	7.9	5.2	0	0	0	0	1.3	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	Ciliated cells
CATSPERE	C1orf101, MGC33370	ENSG00000179397	Catsper channel auxiliary subunit epsilon	Q5SY80	1	244454377-244641177	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	testis: 26.9	Cell type enriched	Detected in some	5	Ciliated cells: 16.0	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC TERT1: 2.7;hTERT-RPE1: 2.6					Low region specificity	Detected in many																unprognostic (3.22e-1)	unprognostic (4.50e-2)	unprognostic (2.02e-1)	unprognostic (7.31e-2)	unprognostic (3.32e-1)	unprognostic (2.50e-3)	unprognostic (3.76e-3)	unprognostic (5.39e-4)	unprognostic (1.96e-2)	unprognostic (3.41e-2)	unprognostic (4.37e-4)	unprognostic (4.43e-2)	unprognostic (9.09e-2)	unprognostic (1.76e-1)	unprognostic (5.79e-2)	unprognostic (6.74e-3)	unprognostic (5.85e-2)	0.9	1.1	1.3	0.5	3.2	1.1	1.2	1.7	2.7	1.2	0.5	4.6	0.4	0.5	1.6	4.1	0.6	2.1	0.9	0.5	3.1	1.3	1.4	1.5	1	1.8	1.2	1.3	1.4	2.4	2.6	2.2	0.9	3.2	1	0.5	1.3	0.9	1.1	1	0.7	0.7	1.5	2.8	0.9	0.7	26.9	0.7	0.5	1.6	0	0.6	1	0.8	0.8	0.9	0.8	0.1	0.1	0.8	0.1	0.3	0	0.6	0	1.3	2.7	0.2	1.5	1.5	0.2	0.2	0	0.7	0.5	1.8	1.7	0	0.7	0.4	0.2	0.5	0	1.5	0	0.4	0.1	0.9	0	1.4	2.2	0.7	0.2	0	2.6	0.7	0.7	0.2	0.5	0.2	0	0.2	0.3	0.3	0	0.2	1.4	0	0	0.8	0	1.6	1	0.7	0	0.3	0.4	0.1	0.8	1.8	0.1	0	0	1	0.9	0.1	0	0	0.2	0	0.8	0	0	0.7	0	0.2	0.8	0.1	0.3	0	0.6	0.8	0.1	0	0.1	0.1	0.9	0.2	0.1	1.3	3.2	1.7	2.7	3.1	1.3	1.2	1.3	3.2	0.7	3	1.1	0	0	0	0	0	0	16	2.3	1.8	0	0.1	0	0.3	0	0	0	0	0.6	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	1.1	0	0	0	0	0	0	0.3	0	0	0	Ciliated cells
FAM216B	C13orf30, FLJ40919	ENSG00000179813	Family with sequence similarity 216 member B	Q8N7L0	13	42781550-42791549	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3	Cell type enriched	Detected in some	8	Ciliated cells: 348.0	Group enriched	Detected in some	10	endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9	Group enriched	Detected in many	5	basal ganglia: 9.5;pons and medulla: 21.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	12	U-87 MG: 6.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA040118	Uncertain											HPA040118: AB_10674429	unprognostic (1.03e-2)		unprognostic (2.24e-1)	prognostic favorable (9.77e-4)	unprognostic (4.35e-2)	unprognostic (1.32e-1)		unprognostic (1.19e-1)	unprognostic (2.54e-2)	unprognostic (5.44e-3)	unprognostic (1.32e-1)	unprognostic (2.27e-1)		unprognostic (8.14e-3)	unprognostic (1.37e-1)		unprognostic (1.30e-2)	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3	0.3	8	0	0.3	1.3	18.2	0.2	51.3	0.4	10	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0	18.3	0.3	0.2	2	0.2	21	0.2	0.5	0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1	1.7	0	0.2	0	3.9	0.4	0.1	0.1	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0.2	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0.5	0	0	0	0	6.5	0.1	0.1	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0	21	1.7	0	3.8	0	0	0	0	7.7	0	348	42.1	0	0	0	0	0	1.5	0	0	0	0	0	0	0.1	1.1	0	0.3	0	0	0	0	6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Ciliated cells
ABCA13	FLJ33876, FLJ33951	ENSG00000179869	ATP binding cassette subfamily A member 13		7	48171458-48647496	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4	Cell type enriched	Detected in some	7	Ciliated cells: 64.3	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Cell type enhanced	Detected in some		basophil: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2	Not detected	Not detected			Low region specificity	Detected in all			HPA063601			Approved	Vesicles,Centrosome,Cytosol						Vesicles	Centrosome, Cytosol	HPA063601: AB_2685057	unprognostic (8.97e-2)	unprognostic (5.82e-2)	unprognostic (3.18e-1)	unprognostic (6.48e-2)	unprognostic (2.65e-2)	unprognostic (5.59e-2)	unprognostic (5.19e-2)	unprognostic (2.33e-3)	unprognostic (1.90e-1)	unprognostic (1.86e-3)	unprognostic (6.03e-3)	unprognostic (3.26e-1)	unprognostic (1.89e-2)	unprognostic (1.99e-1)	unprognostic (1.25e-1)	unprognostic (2.04e-1)	unprognostic (3.62e-2)	0.3	0.2	0.1	0.3	1	35.4	0.7	0	1.1	1.2	0.3	0.4	0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1	0.4	0.2	0	0	0.4	0	0	0.4	0	0.3	1	0	0.3	0	0	0	2.2	0	1.9	0.6	1.2	2.1	0	8.7	0	0	0.1	0	0	0	0.1	0	0.2	0.1	1	0.8	0	0.3	0	0.1	3.7	0	0	0.1	0.1	0	2.1	0.3	0	0	0.5	0	0.7	0	0	0.7	0	0.1	0.1	0.1	0	0.6	10.4	0.4	1.5	3.1	4.2	0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1	0.3	0.6	0.1	0.2	0.1	1	0	1.1	1.8	0.2	0.1	0	0.4	0	0	0.3	0	0	0	0	9	0	64.3	9.1	1.8	0	0	0	0	7.8	0	0	0	0.3	0	0.1	0	0	0.8	0.2	0	0	0	0	3.6	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	1.5	3.2	0	0	0	0.3	0.1	Ciliated cells
CAPS2		ENSG00000180881	Calcyphosine 2	Q9BXY5	12	75275979-75390928	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		fallopian tube: 21.7	Cell type enriched	Detected in many	4	Ciliated cells: 96.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 1.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 12.1	Not detected	Not detected			Low region specificity	Detected in all			HPA039542, HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			Nucleoli	Nucleoplasm, Vesicles, Centrosome	HPA039542: , HPA040004: AB_10794758	unprognostic (1.38e-2)	unprognostic (1.21e-1)	unprognostic (7.26e-2)	unprognostic (5.10e-2)	unprognostic (3.05e-2)	unprognostic (1.55e-2)	unprognostic (2.66e-1)	unprognostic (2.36e-1)	unprognostic (9.61e-2)	unprognostic (1.24e-1)	unprognostic (2.02e-3)	unprognostic (1.01e-1)	unprognostic (1.32e-2)	unprognostic (3.07e-1)	unprognostic (1.75e-1)	unprognostic (4.52e-2)	unprognostic (2.69e-1)	2.6	4.2	8	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2	4.4	5.5	3.6	3.8	2.6	1.9	2	8.7	2.6	3.2	8	9.5	1.4	9.3	2.2	1.4	2.6	2	0.1	0.6	0	0.7	1.1	1.8	0.1	1.3	3.7	1	0.3	1.9	1.4	0.1	0.7	0.2	2	2.2	0	1.7	0.3	3.3	0.5	0.8	0.8	0	1.6	1.4	1.2	0.6	1.5	0.6	0	0	0.2	0	0.6	1	1.7	0.3	12.1	0.2	1.3	0.3	0.6	2.6	0	1.8	1.4	0.5	0	0.5	0	0	0.2	2.6	0	2.1	1	0.2	0.1	1.2	0.2	1.2	0.5	0.8	1.9	0.8	0.4	0.3	0.2	0	0	1.6	0	1.5	0	0	0	0.2	0.2	0.1	0	0.7	0	0	0.1	0.6	0.9	0	1.1	0.7	0.6	1.8	0.1	8	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5	8.9	3.2	0	2.5	1.5	0.7	7.1	2.5	96.4	17	5.2	3.9	1	5	0.8	21.6	1.7	0	0	1.5	0.5	1.7	1.5	0	1.5	0.5	1.6	0	2.5	1.8	11.5	5.8	0.9	0	0	1.7	5.8	0.4	0	6.7	2.5	20.8	0	1.4	9.1	0.9	0.5	0.2	0	0.6	0.5	Ciliated cells
OXTR		ENSG00000180914	Oxytocin receptor	P30559	3	8750408-8769628	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	breast: 42.5	Cell type enriched	Detected in some	8	Ciliated cells: 93.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.6	Lineage enriched	Detected in single	5	granulocytes: 1.6	Cell line enhanced	Detected in some		BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.18e-1)	unprognostic (7.94e-2)	unprognostic (4.76e-2)	unprognostic (1.29e-2)	unprognostic (2.02e-2)	unprognostic (2.02e-1)	unprognostic (1.46e-2)	unprognostic (2.56e-3)	unprognostic (2.12e-1)	unprognostic (3.42e-1)	unprognostic (2.76e-1)	unprognostic (3.80e-2)	unprognostic (4.24e-4)	unprognostic (8.25e-2)	unprognostic (4.60e-2)	unprognostic (2.71e-1)	unprognostic (1.84e-1)	0.5	0.4	1.8	0.3	6.5	0.6	42.5	0.9	2.2	0.5	0.3	0.1	0	0.3	2.8	0.5	1.1	2.7	1	0.6	1.8	4	0.6	0.4	1	0.4	8.6	0.8	2.8	0.3	0.3	0.3	1.3	3.7	0.9	0.3	1.6	0.4	0.9	0.3	0.4	0.4	0.6	2.5	0.5	0.3	0.5	1.2	0.1	0.4	0	0.4	0.4	0	0	0.2	1.6	0.1	0.1	0.3	1	0.2	0.8	0.4	0.1	0.1	0.2	0.1	81.2	24.9	23.6	12.6	0.1	2.1	0	0.1	81.3	0.3	0.1	0.3	0.1	18.4	0.7	0.4	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.1	0.3	0.1	7.1	0	0.2	0	0.1	13.1	0	0.1	0.6	0.5	0.2	3.6	0.1	0.3	4.8	0.9	0	0.1	0.1	0.1	0.1	0	1.6	0	0.1	0.1	1.1	0.3	0.2	0.2	0.1	0.2	0	0.1	0.2	0.2	0.5	0	0.1	0.2	0.1	0.2	0	0.2	0.2	0.2	0	0.2	0.3	1.6	0.1	0	0.1	0.1	1	1.8	6.5	0.9	2.2	1.8	4	8.6	0.8	3.7	1.2	8.9	1.4	0	0.4	0.3	0.2	1.2	0	93.7	11.4	0	0	0	0	2.6	0.9	0	0	0	0	0.1	0.5	1.7	0	0	0.2	0	0	0	0	1.5	0	0.2	0	0	0	5.8	1	0	0.4	0	0	0	0.5	0.7	1.3	0.1	0	0	0	0.1	Ciliated cells
MAPK15	ERK7, ERK8	ENSG00000181085	Mitogen-activated protein kinase 15	Q8TD08	8	143716259-143722458	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 26.9;epididymis: 27.6;fallopian tube: 29.5	Cell type enriched	Detected in some	6	Ciliated cells: 85.6	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 26.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA002704			Approved	Nucleoplasm,Cell Junctions,Cytosol						Nucleoplasm, Cytosol	Cell Junctions	HPA002704: AB_1079307	unprognostic (9.11e-2)	unprognostic (1.38e-1)	unprognostic (8.04e-3)	unprognostic (2.94e-1)	unprognostic (2.54e-2)	unprognostic (1.14e-2)	unprognostic (1.22e-1)	unprognostic (6.09e-2)	unprognostic (2.59e-2)	unprognostic (1.48e-1)	unprognostic (3.88e-1)	unprognostic (9.51e-2)	unprognostic (2.64e-2)	unprognostic (1.54e-2)	unprognostic (5.78e-1)	unprognostic (6.35e-2)	unprognostic (1.62e-2)	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0	0	0	0	0	0	0.4	0.4	1.7	0	0	0	0.6	1.3	0	0	0	0.2	7.2	0	1.3	0	0	5.4	0.1	0.2	0	1.1	1.6	0	14.3	0	0.1	0	0.1	0	0	0	0	1	0	0.3	2.7	0	0	13.9	0	0	2	1.2	1.1	0	3	0.4	0.9	1.3	4	4	0	2.8	0	0.2	12.5	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0	8.3	0	0.2	0.3	0	0.8	0	85.6	13.6	0	0	0	0	0.6	12.6	0	0	0	0	0.6	0	0.3	0	0	0.1	0	0	0	0	8.9	0	0	0	0	0.5	0	0.5	0	0	0.8	0	0	0	2.7	0.7	0.3	0.1	0	0.1	0	Ciliated cells
NME9	NM23-H9, TXL-2, TXNDC6	ENSG00000181322	NME/NM23 family member 9	Q86XW9	3	138261437-138329886	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 30.4	Cell type enriched	Detected in some	12	Ciliated cells: 64.3	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enhanced	Detected in some		MAIT T-cell: 4.2	Lineage enriched	Detected in single	4	T-cells: 4.2	Cell line enhanced	Detected in many		HMC-1: 4.9	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB020943, HPA040000, HPA043881	Enhanced		Approved	Centriolar satellite,Cytosol						Cytosol	Centriolar satellite	CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712	unprognostic (2.71e-5)	unprognostic (1.68e-1)	unprognostic (5.09e-2)	unprognostic (3.01e-3)	unprognostic (3.67e-1)	unprognostic (1.69e-3)	unprognostic (4.58e-2)	unprognostic (5.19e-2)	unprognostic (1.66e-1)	unprognostic (1.12e-2)	unprognostic (1.03e-2)	unprognostic (1.72e-2)	unprognostic (3.82e-2)	unprognostic (1.39e-2)	unprognostic (9.14e-2)	unprognostic (4.89e-2)	unprognostic (7.17e-3)	1	1.7	5.3	1.3	11.3	4.4	1	6.2	8.3	1.5	0.8	4.1	3.5	1.1	1.6	3.6	0.8	30.4	1.3	0.9	5.6	8.2	1.7	0.8	4	1.1	3.6	3.1	2.5	3.3	1.8	7.5	1.1	10.3	1.7	0.8	0.9	3.4	1.9	4.3	1.8	1.1	1	3.6	1.2	1.5	6	3.9	0.9	2.3	0	1	0.8	0.5	0.6	0.6	0.3	0.9	0.3	4.2	0.5	1.1	1.6	1.1	0.5	0	0	1.7	0.7	0	0.2	0.1	0.9	1.9	2.5	1.2	0	1.3	1.3	0.2	0	0	0.5	1.8	2.1	1.6	0.6	0	2.7	4.9	0.9	0	0.1	0	2.9	0.1	3.2	0.6	1.4	0.2	0.4	0.6	2.5	0.7	0.5	1.2	1	0	0.7	1.7	2.6	3.7	1	1.6	0.6	0.4	0.9	0.9	0.1	3	0.5	0.8	0.8	0.6	0.9	1.2	1.1	1	1.1	0.5	0.1	0.9	0	0.5	0	4.2	0.2	1.7	0.4	0.3	0.6	2.8	1.2	0.3	0.3	0.2	0.6	0.7	0.5	5.3	11.3	6.2	8.3	5.6	8.2	3.6	3.1	10.3	3.9	0	0.3	0	0.2	0	1.3	1.1	2.5	64.3	3.4	1.8	0	0.1	0	0.1	2	0	0	0	0	0	0	0.1	0	0	0	3.2	0	0	0	1.1	0.3	0	0	0	0	2.5	0	0	0	0.4	2.3	0	0	5.5	0.5	0	0.2	0	0	0	Ciliated cells
CABCOCO1	bA63A2.1, C10orf107, Em:AC022398.2, MGC44593	ENSG00000183346	Ciliary associated calcium binding coiled-coil 1	Q8IVU9	10	61662961-61766766	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 33.1;testis: 18.6	Cell type enriched	Detected in some	12	Ciliated cells: 163.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	MOLT-4: 24.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol						Centrosome	Nucleoplasm, Cytosol	HPA041398: AB_10794374	unprognostic (1.89e-3)	unprognostic (7.37e-2)	unprognostic (2.23e-1)	prognostic favorable (1.79e-4)	prognostic unfavorable (4.88e-4)	unprognostic (1.02e-1)	unprognostic (2.55e-1)	unprognostic (5.52e-2)	unprognostic (4.43e-2)	unprognostic (3.31e-1)	unprognostic (1.16e-1)	unprognostic (1.26e-2)	unprognostic (3.46e-1)	unprognostic (1.52e-3)	unprognostic (2.48e-1)	unprognostic (2.90e-2)	unprognostic (1.33e-2)	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3	1	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3	14.8	1.9	0.9	18.6	5.6	0	1.9	0	0.6	0.8	0.9	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	2.4	0	0.4	1.6	0.3	0.5	0	0	0	0	0.5	0.4	0	0	0	0	0	0.2	2.4	0	0	1.2	0	0	0.2	0	0.1	0.1	0.9	0.9	0.5	0.1	0	0.1	0	24	0	0	0	0	0	0	0	1.4	0	0	5.4	0.5	0	0	0.2	0	0	0	0.4	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6	3	0.6	0	0	0	0	0	0	163.3	13.6	3.5	0	0.2	0	0.4	0	0	0	0	0.2	0.2	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	Ciliated cells
C11orf88	FLJ46266	ENSG00000183644	Chromosome 11 open reading frame 88	Q6PI97	11	111514785-111537031	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 48.8;fallopian tube: 53.7	Cell type enriched	Detected in some	10	Ciliated cells: 1019.8	Cancer enhanced	Detected in some		endometrial cancer: 1.7	Region enriched	Detected in many	4	pons and medulla: 48.8	Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CACO-2: 4.6;Karpas-707: 4.9;SuSa: 3.7;U-266/70: 2.8	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (2.25e-1)	unprognostic (3.07e-5)	unprognostic (3.85e-4)	unprognostic (4.16e-2)	unprognostic (4.44e-5)	unprognostic (2.56e-3)	unprognostic (6.91e-2)	unprognostic (5.49e-3)	unprognostic (2.86e-1)	unprognostic (9.96e-3)	unprognostic (2.70e-1)	unprognostic (4.40e-2)	unprognostic (6.80e-3)	unprognostic (7.57e-2)	unprognostic (6.22e-2)	unprognostic (8.45e-2)	unprognostic (1.11e-1)	0.2	0.2	5.7	0.3	10.9	0.3	0.2	0.2	1	5.8	0.2	5.7	0	0.4	2.2	13.1	0.2	53.7	0.4	0.2	7.3	7.6	0.2	0.2	13.9	0.3	0.6	0.2	8.3	0.2	0.2	0.5	0.4	48.8	0.3	0.2	0	0.3	0.3	0.2	0.3	0.3	0.2	1.1	0.3	0.3	13.5	1.5	0.1	0.7	0	0.2	0.2	0	0.7	0.6	2.6	0.5	0.6	0.4	0	0.3	1	0.1	0.1	0	0	0.6	1.6	0	0.1	0	4.6	2.1	0.3	0.2	0.3	0.2	0.1	0	0	0	0.1	0.3	0	0.8	0	0	0.2	0.4	0.4	0	0.5	0	0.4	0	0.7	0.1	4.9	0	0.5	0.3	0.2	0.2	0	0.5	0	0.8	0	0.1	0.2	0.2	0.5	0.3	0.1	0	3.7	0.9	0	0	0.7	0.6	0.7	0.9	2.8	0.4	0.2	0.4	0.3	0.9	1.7	0.5	1.2	0.3	0.2	0.4	0.5	0.2	0.1	0.4	0.7	0.3	0.3	2.6	0.6	0.5	0.6	0.4	0	5.7	10.9	0.2	1	7.3	7.6	0.6	0.2	48.8	1.5	3	6.9	0	0.2	0	0	4.4	0	1019.8	70.5	0	0	0.1	0	0	106.5	0	0	0	0	0	0	0.1	2.3	0	0.1	0	0	0	0	31.2	1.4	0	0	0	0	0	0	0	1.8	0	0	0	0	12.1	7.1	0	0	0	0	0.5	Ciliated cells
CCDC190	C1orf110, MGC48998	ENSG00000185860	Coiled-coil domain containing 190	Q86UF4	1	162824458-162868815	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		esophagus: 8.3;lung: 7.2;tongue: 7.5	Cell type enriched	Detected in some	27	Ciliated cells: 48.2	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA028579, HPA028584, HPA028592	Uncertain		Approved	Vesicles						Vesicles		HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001	unprognostic (4.29e-1)	unprognostic (8.37e-2)		unprognostic (1.75e-1)	unprognostic (5.47e-2)	unprognostic (1.68e-2)		unprognostic (8.33e-3)		unprognostic (3.04e-2)	unprognostic (3.09e-2)	unprognostic (6.41e-2)	unprognostic (7.41e-5)	unprognostic (2.64e-1)	unprognostic (1.52e-1)	unprognostic (5.26e-1)	unprognostic (1.70e-1)	0.2	0.1	1.1	0.2	1.7	0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0	0.2	0.8	8.3	1.1	1.3	1	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.3	0.5	0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0	0	0	0	0.1	0	0	0	0.1	1.9	0	0.2	0.2	0.4	0.2	0	0	0	0.3	0.2	0.1	0.1	0	0	1.8	0	0	0	0	0	0	0	0	2.1	0	4.1	2.6	5.1	5	0	0	0	7.6	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	17.3	0.4	0	9.3	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.5	0	0	0	0	0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2	0	0.3	0	0.4	0	0	0	0	48.2	0	1.8	0	0	0	0	1.8	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0.6	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.3	Ciliated cells
CYP4X1	MGC40051	ENSG00000186377	Cytochrome P450 family 4 subfamily X member 1	Q8N118	1	47023568-47050751	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		cervix, uterine: 38.1	Cell type enriched	Detected in many	6	Ciliated cells: 156.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5	Low region specificity	Detected in all							HPA017661	Approved											HPA017661: AB_2669633	unprognostic (1.19e-1)	unprognostic (2.28e-2)	unprognostic (1.53e-1)	unprognostic (1.78e-2)	unprognostic (9.88e-2)	unprognostic (1.56e-3)	unprognostic (2.30e-1)	unprognostic (2.34e-2)	unprognostic (1.10e-2)	unprognostic (2.35e-2)	unprognostic (1.46e-1)	unprognostic (2.76e-2)	unprognostic (3.03e-2)	unprognostic (1.79e-3)	unprognostic (3.65e-2)	unprognostic (8.56e-2)	unprognostic (5.03e-2)	7.9	3.6	9	1.1	14.9	0.5	16	7.1	16.9	38.1	2	1.6	2.5	2.1	3.6	3.2	12	9.7	2	6.7	4.8	10.6	6.3	10	8.9	2	3.3	13.5	1.7	2	2	4.1	1.5	7.8	8	2.3	17.6	23.7	3.4	4.5	5	1.8	2.4	2	1	14.3	4.2	0.9	0	4	6.9	8.8	3.9	5.4	0	0	0	0	0	0.1	0	0	0	0	0	3.7	0.2	0.1	0	0.1	0	0	6.2	0	0	0.7	0	1.7	0	0	0	0	0.5	2.5	0	0	0	0	0	0	0.3	2.2	0	0	0.9	0.1	0	0.1	0.3	0	0	0	0	2.9	1	0	0	0.5	0	0.6	0.2	3.8	0	0	0.3	0	0.2	13.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	9	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9	20.8	10.5	0	23.5	2.3	0.9	1	0	156.6	27.3	0	0	0	0	0.3	6	2.3	0	0	0.6	0	1.9	10.7	0	2.5	2.9	0	0	0.6	0.3	5.6	9.8	0.6	5	0	0	0	0.2	0	19.4	1.3	0.7	0	14.5	0	1.5	1.3	0.1	0	0.6	26.2	Ciliated cells
FAM183A	hCG23177, LOC440585	ENSG00000186973	Family with sequence similarity 183 member A	A6NL82	1	43145153-43156396	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 25.5;fallopian tube: 55.8	Cell type enriched	Detected in many	7	Ciliated cells: 1011.8	Cancer enhanced	Detected in many		endometrial cancer: 19.3	Region enhanced	Detected in many		pons and medulla: 25.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 5.9;hTCEpi: 4.4;NTERA-2: 5.4;SCLC-21H: 4.6;SuSa: 9.1	Low region specificity	Detected in many							HPA043382, HPA049120	Approved											HPA043382: AB_2678456, HPA049120: AB_2680640	unprognostic (6.66e-2)	unprognostic (2.39e-1)	unprognostic (9.56e-2)	unprognostic (1.42e-3)	unprognostic (6.79e-2)	unprognostic (3.79e-2)	unprognostic (1.44e-2)	unprognostic (1.47e-1)	unprognostic (3.94e-2)	unprognostic (1.27e-1)	unprognostic (5.04e-3)	unprognostic (1.04e-1)	unprognostic (4.30e-2)	unprognostic (1.27e-2)	unprognostic (7.88e-2)	unprognostic (1.18e-3)	unprognostic (1.73e-2)	0.1	0.1	3.6	0.1	9.8	0.1	0.8	0	0.5	2.6	0.3	6.5	0	0.2	1.3	16.5	0.5	55.8	0.2	0.1	4.6	4.7	0.3	0.2	14.5	0.2	0.1	0.2	10.1	0.3	1	5.5	0.5	25.5	1.4	0.3	0	0.9	0.3	0.1	5.5	0.1	0.3	0.6	0.2	0.2	6.7	1.7	0	0.2	0	0.3	0.3	0.5	0	0	0	0	0	0	0	0.4	0	1.4	0	0	0	0.4	0	0.6	0.6	0.6	1	5.9	0	0.8	0.4	0.6	0.7	0	0.4	0.3	0	1.3	0	0	0	0	0	0	0	4.4	0	0.4	0	0	0	0.1	0	0	2.9	0	0	5.4	0.2	0	0	0	0	2.3	1.1	4.6	0	0	0.3	0	9.1	1.3	0	0.9	0	0.7	0.2	0.1	2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	9.8	0	0.5	4.6	4.7	0.1	0.2	25.5	1.7	0	6.1	0	12.9	1.6	0	0.1	0	1011.8	135.4	3.5	0	1.5	3.3	0	89.9	0.1	0	0	0	0.2	0.4	3.8	3.5	0	0.1	0	4.1	0	0	153.7	1.7	0	3.3	0	0.1	0.4	0.2	0	0.7	1.3	0	0	0	1.9	2.8	2.3	1.7	0	0.4	10.2	Ciliated cells
CDHR4	CDH29, VLLR9392	ENSG00000187492	Cadherin related family member 4	A6H8M9	3	49790732-49799835	Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		epididymis: 37.8;fallopian tube: 42.7	Cell type enriched	Detected in some	7	Ciliated cells: 132.5	Cancer enriched	Detected in some	6	endometrial cancer: 6.8	Region enhanced	Detected in some		pons and medulla: 5.7	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC TERT1: 4.7;HeLa: 4.5	Region enhanced	Detected in many		basal ganglia: 17.7	Low region specificity	Detected in single			HPA076277	Enhanced				Intracellular and membrane							HPA076277: AB_2732306	unprognostic (1.50e-4)	unprognostic (4.87e-2)	unprognostic (6.00e-2)	unprognostic (2.00e-3)	unprognostic (2.37e-2)	unprognostic (2.45e-3)	unprognostic (6.35e-7)	unprognostic (1.17e-1)	unprognostic (1.13e-2)	unprognostic (1.12e-1)	unprognostic (9.61e-2)	unprognostic (2.35e-1)	unprognostic (9.07e-11)	unprognostic (2.65e-1)	unprognostic (3.70e-2)	unprognostic (1.13e-2)	unprognostic (2.37e-1)	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0	0	4.9	0.2	1.9	0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0	0	8	0	0	0.8	0.6	5.7	0.1	0.1	0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0	0.1	3.9	0	0	0	0.5	0.2	0.2	0.1	1.1	1.5	3	4.1	1.3	0.4	5.8	0.5	1.8	0.5	0.3	0.5	4.7	0.3	0.4	0.1	1	1	0	2.7	0	0.2	1.1	0.6	0.5	0.1	0	0.3	0.3	0.3	0.8	4.5	1	0	0.3	0.5	0.7	1.5	0.8	0.3	1.2	0	0.3	0.2	0.7	0	0	0	0.8	0.3	0.6	0.2	0.8	0.2	0	0	0.3	0.1	0.1	1.6	1.1	0	0.1	0.2	0.1	0	0.6	0.2	0.7	0.1	0.7	2.4	0.1	2.2	1.3	0	3	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0	0	0.7	0.9	0	0	5.7	0	0	4.3	0	0.1	0.1	0	0.4	0	132.5	18.2	0	0	0	0	0	0.6	0	0	0	0.2	0	0.2	0.1	0	0	0.1	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	4.4	0.5	0	0	0	0	0.1	Ciliated cells
PLEKHG7	FLJ46688	ENSG00000187510	Pleckstrin homology and RhoGEF domain containing G7	Q6ZR37	12	92721462-92772455	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		epididymis: 5.6;fallopian tube: 7.9	Cell type enriched	Detected in some	5	Ciliated cells: 56.2	Low cancer specificity	Detected in single							Group enriched	Detected in some	31	memory B-cell: 4.5;naive B-cell: 1.6	Lineage enriched	Detected in single	45	B-cells: 4.5	Cell line enhanced	Detected in some		Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.1;RT4: 1.2;SK-BR-3: 4.2									HPA060632	Uncertain											HPA060632: AB_2684333	unprognostic (4.47e-3)	unprognostic (3.95e-2)	unprognostic (1.16e-1)	unprognostic (1.05e-3)	unprognostic (1.80e-2)	unprognostic (9.91e-5)	unprognostic (1.38e-1)	unprognostic (9.44e-2)	unprognostic (1.61e-1)	unprognostic (6.20e-2)	unprognostic (1.27e-1)	unprognostic (1.37e-1)	unprognostic (2.56e-1)	unprognostic (2.13e-1)	unprognostic (2.75e-1)		unprognostic (3.27e-5)	0	0	0	1.3	0	0	0	0	0	3.3	0.6			0.1	0.4	5.6	0.1	7.9	0.3	0	0	0	0.7	0.5	2.2	2	0		0	1.4	0	0	0		0.8	0.4		0.1	0.6	0	0	2.6	0	0	1.6	2.7	0.1			0		2.9	2.9	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.5	0	0.2	1.8	0	0.4	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0	0	0.1	0	5.1	0.1	1.2	0	0	0	4.2	0	0.5	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	1.6	0	0	0	0	0	0	0	0											0	0.3	6.9	0.1	0.1	0.3	0.6	0	56.2	11.4	1.8	0	0	0	0.4	0.9	0	0	0	0.2	0	0	0.4	1.1	0	0	0	1.2	0	0	0.5	0	0	1.7	0	0.2	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0.2	0.8	Ciliated cells
LRRC74B		ENSG00000187905	Leucine rich repeat containing 74B	Q6ZQY2	22	21045960-21064168	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 17.1;epididymis: 5.6;fallopian tube: 11.4	Cell type enriched	Detected in some	6	Ciliated cells: 132.5	Not detected	Not detected			Region enriched	Detected in many	7	pons and medulla: 17.1	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		U-138 MG: 1.7;U-87 MG: 3.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA049947	Uncertain											HPA049947: AB_2680966	unprognostic (3.43e-2)	unprognostic (1.76e-1)		unprognostic (3.28e-4)	unprognostic (1.06e-1)	unprognostic (6.44e-3)		unprognostic (2.23e-2)	unprognostic (1.93e-1)	unprognostic (1.66e-1)	unprognostic (1.64e-2)	unprognostic (1.18e-1)	unprognostic (7.57e-9)	unprognostic (4.20e-1)	unprognostic (1.23e-1)	unprognostic (2.10e-2)	unprognostic (4.92e-2)	0.2	0.2	2.1	0.2	2.3	0.2	0.2	0.4	1.6	1.5	0.2	3.7	0	0.4	0.3	5.6	0.2	11.4	0.2	0.2	1.5	1.2	0.2	0.2	1.9	0.2	0.1	0.7	1.9	0.2	0.2	0.9	0.2	17.1	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.3	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.4	0	0	0.1	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	2.3	0.4	1.6	1.5	1.2	0.1	0.7	17.1	0.3	0	2.6	0	0.6	0	1	0.4	0	132.5	22.7	0	3.9	0.1	0	0	2.8	0	0	0	0	0.1	0	0.4	0	0.2	0.1	1.6	0	0.6	0	0.4	0.3	1.1	0	0	0	0.4	0	0	0	0	1.4	0	0	2.7	2.1	0	0.2	0	0	0	Ciliated cells
NWD1		ENSG00000188039	NACHT and WD repeat domain containing 1	Q149M9	19	16719976-16817963	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 27.8;fallopian tube: 14.1	Cell type enriched	Detected in some	8	Ciliated cells: 101.7	Cancer enriched	Detected in many	6	prostate cancer: 9.5	Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	12	MCF7: 3.4;U-937: 7.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA075476			Approved	Nucleoli,Cytosol						Nucleoli, Cytosol		HPA075476: 	unprognostic (5.29e-3)	unprognostic (3.08e-2)	unprognostic (3.05e-2)	prognostic favorable (2.55e-4)	unprognostic (2.49e-1)	unprognostic (4.20e-4)	unprognostic (6.54e-2)	unprognostic (5.15e-2)	unprognostic (2.95e-1)	unprognostic (1.60e-1)	unprognostic (7.94e-2)	unprognostic (1.76e-1)	unprognostic (9.20e-2)	unprognostic (1.31e-1)	unprognostic (5.09e-2)	unprognostic (3.53e-2)	unprognostic (3.25e-1)	0.6	0.7	6.9	0.6	8.1	0.8	1	0.9	5.9	1.7	0.9	11.3	0.5	0.7	1.1	6.5	0.6	14.1	0.8	0.7	10.9	4.2	1	0.7	1.8	0.7	3.9	7.8	0.7	4.3	0.6	1.3	0.7	27.8	10.6	0.9	10.3	2.7	3.9	0.8	0.6	0.7	0.8	2.2	0.6	1	1.4	4.6	0	1.6	0	0.6	0.8	0.5	0.5	0.1	1.3	0.1	0.5	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.1	0.3	0	0.1	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	3.4	0.1	0	0	0	0.4	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	7.9	0	0.5	0.1	0.2	0.2	0.1	0.1	0	0	0	0	0.5	0	0.2	1.3	0.5	0	0.1	0	0.1	6.9	8.1	0.9	5.9	10.9	4.2	3.9	7.8	27.8	4.6	0	1	0	1.6	0.2	0.1	0.6	0	101.7	5.7	0	0	0.1	0	0	12	0	0	0	0	0.1	0	6.7	0	0	0.1	0	1.2	0	0	2.7	0.6	0.2	0	0	0.6	9.3	0.2	0	0	0	0	0	0	0	0.2	0.1	0.9	0	0.4	1.4	Ciliated cells
TCTEX1D4		ENSG00000188396	Tctex1 domain containing 4	Q5JR98	1	44805913-44806675	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	blood: 7.9;epididymis: 3.1;fallopian tube: 12.4	Cell type enriched	Detected in some	8	Ciliated cells: 45.5	Low cancer specificity	Detected in some							Cell type enriched	Detected in single	12	neutrophil: 7.9	Lineage enriched	Detected in single	12	granulocytes: 7.9	Cell line enhanced	Detected in some		BEWO: 3.4;EFO-21: 2.4;HDLM-2: 2.7;SK-MEL-30: 2.2;TIME: 3.4	Low region specificity	Detected in many			Low region specificity	Detected in single			HPA062652	Enhanced											HPA062652: AB_2684818	unprognostic (3.12e-1)	unprognostic (3.13e-1)	unprognostic (1.81e-1)	prognostic favorable (1.58e-4)	unprognostic (5.28e-2)	unprognostic (3.59e-2)	unprognostic (2.85e-2)	unprognostic (2.26e-1)	unprognostic (3.85e-1)	unprognostic (1.69e-2)	unprognostic (1.26e-2)	unprognostic (4.92e-2)	unprognostic (4.70e-3)	unprognostic (2.86e-1)	unprognostic (2.20e-1)	unprognostic (1.59e-1)	unprognostic (7.83e-3)	0	1.1	0.2	0.4	0.2	0.8	0.2	0	0.1	1	0.2			0.5	0.8	3.1	0.2	12.4	0.7	0.2	0.3	0.4	0.3	0.5	1.8	0	0		0	0.7	0	0.3	0		0.1	0		0.6	0.3	0.1	0.2	0.5	0	0.1	0	1.2	0.1			0.5		0	0.2	0	0	0	7.9	0.6	0	0.2	0.3	1.4	1.2	0.3	0	0	0	3.4	1.5	0	0	0.2	0	1.2	0	2.4	0	0.5	1.9	0	0	0	2.7	0	0.3	0.5	0	0	0	0.6	0	0	0	0	0.7	0.6	0.5	0.4	0	0	0	0.1	0	0.1	0	1	0.6	0	1.5	0	0	0	0.1	0	0.2	2.2	0.2	0	0	3.4	0.2	1.9	0.2	0.7	1.4	1.2	0	0.2	0.4	0.6	0	0.6	0	0	0.3	0	0	0.2	0	0	0	0	0	7.9	0	0	0	0	0.3											0	0.3	0	0.5	0.2	0	0.2	2.5	45.5	5.7	1.8	0	0.1	0	0.9	0	0	1.4	0	3.5	0.2	0.2	0.2	0	0.9	0.7	0	0	0	0	0	0.3	0.9	0	1	1.2	0	1.3	2.9	0	1	0	0	0	0	0.2	0	0.2	0	0.6	0.5	Ciliated cells
SNTN	FLJ44379, S100AL	ENSG00000188817	Sentan, cilia apical structure protein	A6NMZ2	3	63652668-63679020	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5	Cell type enriched	Detected in some	13	Ciliated cells: 823.1	Group enriched	Detected in some	6	endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		OE19: 3.1;RH-30: 2.4;SH-SY5Y: 3.4	Low region specificity	Detected in many			Not detected	Not detected			HPA043322, HPA058399	Enhanced											HPA043322: AB_10793945, HPA058399: AB_2683705	unprognostic (9.70e-3)	unprognostic (3.67e-1)	unprognostic (4.64e-2)	unprognostic (1.20e-3)				unprognostic (4.34e-3)		unprognostic (1.93e-1)	unprognostic (4.52e-2)	unprognostic (1.73e-1)		unprognostic (2.07e-2)	unprognostic (1.66e-1)		unprognostic (8.43e-3)	0	0	0.1	0	0.2	0	0	0	0	4.3	0	0.5	0	0	1.1	26.6	0	73.9	0	0	0.6	0.3	0	0	29.5	0	0	0	18.5	0.1	0	1.4	0.1	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	2	0	0.1	5.8	0	0.1	0	0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.4	0.5	0	0	0	0.3	0.2	0.8	0.3	0	0	0.4	0.3	0	0	0	0.1	0.3	0.1	0.4	0.1	0	0.1	0.1	0	0	0	0.1	0.1	0	0.3	0.1	0.5	0	0	0.2	0.4	0.2	3.1	0	0.3	2.4	0.2	0.1	0.3	0.3	3.4	0.1	0.3	0	0.6	0.1	0.3	0	0.6	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0	0	0.6	0.3	0	0	0.6	0	3	3.4	0	0	0	0	0.2	0	823.1	64.8	0	0	0.2	0	0	2.9	0	0	0	0.3	0	0	0.1	1.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0.4	0.1	Ciliated cells
CFAP126	C1orf192, Flattop, Fltp	ENSG00000188931	Cilia and flagella associated protein 126	Q5VTH2	1	161364731-161367874	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 53.4;fallopian tube: 85.7	Cell type enriched	Detected in some	7	Ciliated cells: 370.7	Not detected	Not detected			Region enriched	Detected in all	7	pons and medulla: 53.4	Cell type enhanced	Detected in single		memory CD8 T-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CAPAN-2: 7.4;RPTEC TERT1: 2.5;SCLC-21H: 2.5;T-47d: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045904	Enhanced											HPA045904: AB_10960411																		0.7	0.7	5.8	0.7	7.5	0.7	1.1	1.2	2.7	3	0.7	23.3	0	0.7	2.7	14.8	0.7	85.7	0.8	0.7	7	8	1.8	0.8	8.1	0.7	4.1	3.9	11.2	0.8	0.7	3.3	0.7	53.4	0.8	0.7	0	0.7	1.2	2.8	0.7	0.7	0.7	3.3	0.7	0.7	15.3	4.3	0	2.7	0.1	0.8	0.7	0	0	0.1	0.6	0.5	0	1.2	0.1	0.1	0	0	0.2	0	0	0	0	0	0	0	0	7.4	0	0.2	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	2.5	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.5	0	0	0.8	1.2	0	0	0	0	0	0	0	0.1	0	0.1	5.8	7.5	1.2	2.7	7	8	4.1	3.9	53.4	4.3	6	2.6	0	0.5	0	0.4	0	0	370.7	35.2	0	0	0	0	0.3	53.4	0	0	0	0	0.1	0	0.2	2.3	0	0	0	0	0	0	18.8	0.3	0.3	0	0	0	0.8	0	0	1.1	1	0.1	0	0	1.5	0.7	0	0	0	0	0.1	Ciliated cells
TOGARAM2	Crescerin-2, FAM179A, FLJ43249, LOC165186	ENSG00000189350	TOG array regulator of axonemal microtubules 2	Q6ZUX3	2	28956611-29061373	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2	Cell type enriched	Detected in some	5	Ciliated cells: 56.2	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 3.7	Lineage enriched	Detected in single	5	T-cells: 3.7	Cell line enhanced	Detected in some		HMC-1: 3.8;NB-4: 3.6	Low region specificity	Detected in many			Not detected	Not detected			HPA037561, HPA037562, HPA075216	Uncertain		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: 	unprognostic (8.35e-5)	unprognostic (2.85e-3)	unprognostic (1.41e-1)	unprognostic (7.01e-3)	unprognostic (6.41e-2)	unprognostic (1.23e-2)	unprognostic (1.11e-1)	unprognostic (2.53e-3)	unprognostic (3.93e-1)	unprognostic (6.83e-2)	unprognostic (2.32e-3)	unprognostic (5.92e-2)	unprognostic (3.94e-11)	unprognostic (3.75e-2)	unprognostic (4.46e-1)	unprognostic (2.01e-2)	unprognostic (2.81e-3)	0.3	2.3	3	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1	0.2	0.2	0.3	0.2	0.3	0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0	0.3	0.9	0.4	0	0.7	0.4	1.4	0.2	2	0.5	0.9	2	3.8	0.2	0.3	0	0	0.8	0.3	2.7	0.3	1	0.8	0.2	0.8	3.6	2.7	1.2	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2	0.2	0.6	2.9	0.1	0.3	0.4	1	0.6	0.6	0.2	0.3	1.5	1	3	8.4	3.4	1.2	3.3	3.9	2.1	2	15.3	6.1	0	5.1	0	0	0	0	0	0	56.2	10.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Ciliated cells
ALG1L	ALG1L1	ENSG00000189366	ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like	Q6GMV1	3	125929275-125937039	Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 11.4;urinary bladder: 12.5	Cell type enriched	Detected in many	5	Ciliated cells: 30.8	Low cancer specificity	Detected in all							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 11.0;CAPAN-2: 10.0;HaCaT: 10.7;MCF7: 20.7;OE19: 13.1;T-47d: 13.9									HPA036108	Uncertain											HPA036108: AB_10673344	unprognostic (7.06e-3)	unprognostic (1.50e-3)	unprognostic (1.47e-1)	unprognostic (4.14e-2)	prognostic favorable (3.00e-4)	unprognostic (2.40e-2)	unprognostic (1.86e-1)	unprognostic (1.15e-1)	unprognostic (2.10e-1)	unprognostic (1.47e-1)	unprognostic (4.37e-2)	unprognostic (5.79e-2)	unprognostic (4.50e-6)	unprognostic (1.35e-1)	unprognostic (3.30e-1)	unprognostic (1.57e-2)	prognostic favorable (6.24e-4)	0	0.5	2.3	0.8	1.6	0	1.1	0.3	1.8	0.8	0.9			0	0.9	11.4	1.3	2	0.4	0.1	1.6	2	1	1	0.7	0	2.2		1.7	0.7	0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1	0	1.1	0.5			1		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5	2.1	0.7	0.6	0.3	0	0	0.2	1.3	0	0	0.1	0.3	11	10	3	4.9	0	0.2	10.7	0.3	0	0.6	0.4	2.5	0.5	1.7	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0	2.9	0.8	1	0	20.7	0.6	0.2	4.5	13.1	2.6	0.1	0	5	0	0.6	1.7	0.7	0.4	0.1	0.5	2.4	13.9	0.2	0.2	0.1	1.7	0.1	0	7.8	1.1	4	0.1	0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0	1.9	2.3	1.6	0.8	5.3	0	2.4	5	2.1											0	0.3	0.8	1.6	3	0.2	0	0	30.8	3.4	1.8	0	2.8	1.7	0.3	1.5	0	0	0	0.3	1.8	1.5	0.6	1.1	0	0.2	0	1.7	0	0	1.5	1.7	0	1.7	0	0	0.6	0.4	0.8	2.8	0.7	0	0	1.2	1.7	1.6	4.4	1.1	0	0.2	6.4	Ciliated cells
NPIPB9		ENSG00000196993	Nuclear pore complex interacting protein family member B9	F8W1W9	16	28751787-28772807	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in many	4	testis: 13.6	Cell type enriched	Detected in some	5	Ciliated cells: 5.3	Not detected	Not detected							Cell type enhanced	Detected in some		memory B-cell: 3.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTCEpi: 8.0;U-266/70: 6.7									HPA011188, HPA053611	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA011188: AB_2668455, HPA053611: AB_2682206	unprognostic (7.38e-2)	unprognostic (6.63e-4)		unprognostic (6.63e-2)	unprognostic (5.05e-2)			unprognostic (5.53e-2)		unprognostic (4.44e-2)	unprognostic (1.53e-1)	unprognostic (9.36e-2)	unprognostic (7.52e-2)	unprognostic (2.84e-1)	unprognostic (2.86e-1)	unprognostic (2.31e-1)	unprognostic (4.71e-2)	0.6	0.3	1.7	0.9	1.8	1.6	0.4	2.7	1.4	0.4	1			0	1.1	2.4	0.4	1.5	0.6	0.2	2.2	1.3	0.4	0.4	0.4	1.5	1.7		1.4	0.2	0.5	1.4	0.4		1.2	0.8		0.9	0.9	1.1	2.8	0.8	0.8	2.2	1.1	0.5	13.6			1.7		1	0.3	0.7	3.1	0.1	0.5	0.2	1.8	0.7	0.3	0.4	4	1.1	0.6	0.5	1.3	3.3	0	0.1	0	0	0.4	2.1	1.6	1.1	0	0.5	0.4	0.7	0.2	0.1	0.4	1.9	0.7	0	0.8	0.1	2.5	2.7	0.2	8	0.6	1.5	0.8	0	2.9	0.4	2.5	0.2	3	0.9	3.3	1.6	0.2	0.9	3.3	0	1.6	0	0.4	0.1	0	0.2	0.4	0.2	2.2	2.2	1.1	0	0	2.8	1.9	0.6	6.7	2.9	2	0.1	0.9	0.5	0	0.2	0	0.7	0	0.2	3.1	0.4	0.1	0.1	1.2	0.3	0.1	0.5	1.8	0.2	0	0.3	0.3											0	0.3	0	0	0.3	0	0.1	0	5.3	1.2	0	0	0	0	0	0.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0.1	0.1	0	0	0	Ciliated cells
DTHD1	FLJ16686	ENSG00000197057	Death domain containing 1	Q6ZMT9	4	36281622-36345756	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 16.6;fallopian tube: 20.6;lung: 18.5	Cell type enriched	Detected in some	6	Ciliated cells: 286.4	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Cell type enhanced	Detected in some		gdT-cell: 6.8	Lineage enriched	Detected in many	6	T-cells: 6.8	Not detected	Not detected			Low region specificity	Detected in some			Low region specificity	Detected in many																unprognostic (9.79e-6)	unprognostic (4.04e-2)	unprognostic (1.15e-2)	unprognostic (5.54e-3)	unprognostic (2.85e-1)	unprognostic (5.45e-5)	unprognostic (5.12e-3)	unprognostic (9.11e-2)	unprognostic (1.82e-2)	unprognostic (7.59e-2)	unprognostic (1.03e-2)	unprognostic (1.32e-1)	unprognostic (5.05e-5)	unprognostic (1.19e-1)	unprognostic (2.16e-1)	unprognostic (5.65e-2)	unprognostic (7.12e-3)	0.7	0.5	1.9	5.8	14.8	0.9	0.4	0.3	0.3	2.1	1.1	2.8	1.4	0.7	1.1	11.9	0.7	20.6	3.5	0.4	3.1	2.9	0.4	0.7	18.5	5.4	0.4	0	8.1	0.3	0.2	0.8	0.2	16.6	0.5	0.7	0.1	0.6	0.3	0.2	0.2	1.3	0.4	0.7	8	0.8	2.2	4.5	0	0.6	1.2	4	3.1	0.5	0	0	0.1	0	1.1	6.8	0.7	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0.3	0	0	0.1	6.8	0	1.2	0	0.6	2.1	0	0	0	2.6	0	1.1	0	0	0	0.7	1.9	14.8	0.3	0.2	3.1	2.9	0.4	0	16.6	4.5	3	2.6	0	0	0	0	0.4	0	286.4	40.9	0	0	0	0	0	45.5	0	0	0	0	0	0	0	1.1	0	0.1	0	0	0	0.6	16.3	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0.2	0.1	0	20.1	0	0	Ciliated cells
NEK5		ENSG00000197168	NIMA related kinase 5	Q6P3R8	13	52033611-52129078	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 11.8;fallopian tube: 12.7;testis: 15.7	Cell type enriched	Detected in many	4	Ciliated cells: 172.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		basophil: 2.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		JURKAT: 3.5;OE19: 6.4;T-47d: 3.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA035565, HPA041399	Enhanced											HPA035565: AB_10672095, HPA041399: AB_2677453	unprognostic (4.14e-2)	unprognostic (1.49e-1)	unprognostic (1.89e-1)	unprognostic (5.80e-3)	unprognostic (2.80e-2)	unprognostic (2.47e-1)	unprognostic (3.57e-2)	unprognostic (6.50e-2)	unprognostic (8.82e-2)	unprognostic (1.32e-1)	unprognostic (1.37e-2)	unprognostic (2.94e-1)	unprognostic (2.06e-3)	unprognostic (1.83e-3)	unprognostic (1.10e-1)	unprognostic (1.19e-3)	unprognostic (9.44e-3)	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0	0.7	0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0	0.4	0.5	0.3	1.7	0.2	1.1	2.2	0	0	0	0.2	0.1	1.1	0.5	0.2	0	0.1	0.4	0.2	0.4	0	0.1	0.3	0.6	0.6	0.4	0.3	1.1	1.3	0.3	0.8	0.1	0.6	0.4	0.2	3.5	1.2	0.8	0	1.3	0.6	0.8	0.5	6.4	0.6	0.2	0.1	0	1.9	0.5	0.6	0.8	0.4	0	1	1	3.3	1.3	0.4	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1	0	1.3	2.2	1.7	0	8	1.6	2.5	172.6	21.6	7	13.7	2.2	1.7	1.1	43	1.7	0.8	0	2.6	1.5	1.1	3.2	2.3	0.9	1	12.7	1.7	0.6	0	24.4	2	0.8	0	1	0.3	2.4	0.7	0	2.1	1	11.4	6.5	0.3	21.1	12	0.1	1.6	0	1	0.8	Ciliated cells
CFAP43	bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96	ENSG00000197748	Cilia and flagella associated protein 43	Q8NDM7	10	104129888-104232362	Predicted intracellular proteins	Cilium biogenesis/degradation		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3	Cell type enriched	Detected in many	6	Ciliated cells: 424.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		T-reg: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		CAPAN-2: 8.2;U-266/70: 6.5;U-266/84: 5.3	Low region specificity	Detected in many																				unprognostic (1.20e-2)	unprognostic (3.05e-2)	unprognostic (3.61e-2)	unprognostic (6.46e-3)	unprognostic (2.03e-1)	unprognostic (3.35e-2)	unprognostic (1.07e-1)	unprognostic (1.78e-1)	unprognostic (1.56e-1)	unprognostic (2.80e-1)	unprognostic (6.88e-3)	unprognostic (2.18e-1)	unprognostic (1.76e-1)	unprognostic (3.41e-1)	unprognostic (3.35e-2)	unprognostic (9.11e-4)	unprognostic (6.67e-2)	0.5	0.9	5.3	0.6	15.3	0.5	2.4	0.9	4.4	4.6	0.6	7.1	3.2	0.7	2.7	21.6	0.5	37.7	1.1	0.5	6	7.5	2.5	0.8	9.1	0.6	1.1	1.9	5.2	1.3	4.3	10.9	0.7	25.5	1.3	0.6	1.8	1.2	1.5	0.5	1.1	0.8	0.6	1.7	0.6	0.9	40.3	2.9	0	4.1	0.1	0.6	0.7	0.3	0	0	0.5	0.4	0	1.1	0	3.2	1.2	1.1	2.1	0	0.7	0.2	0	0.9	0.7	0.5	0.2	8.2	0	0.1	0	3	1.1	0.2	1.2	1.5	0.4	1.4	0	0.5	0.5	0.2	0	0.3	0.8	1.1	0.9	0.6	1.8	0.3	0.6	2.3	0.2	0	2	0.2	0.4	0.3	0.8	0.5	0.2	0	0	2.9	0	1.8	1.8	0.8	0.1	1.6	1.1	1.1	0	0.1	0.3	0.7	1	0.4	6.5	5.3	0.7	0.5	0.2	0.2	0	0.4	0	0	0	0.3	0	0.1	0	0	0	0.1	0.2	0.5	0	0	0	1.1	0	5.3	15.3	0.9	4.4	6	7.5	1.1	1.9	25.5	2.9	3	5.9	0	0.7	0	1.1	0.8	0	424.3	70.5	1.8	9.8	0.1	0	0.7	71.7	0.3	0	0	0	0.1	0	0.9	5.8	0	0.1	0	3.5	0.6	0	43.4	1.4	0	0	1	0	1.2	0.2	0	2.1	1	8.9	0	0	53.3	3.8	0	0	0	0	0.3	Ciliated cells
ZNF273	HZF9	ENSG00000198039	Zinc finger protein 273	Q14593	7	64870172-64930966	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Ciliated cells: 95.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many											HPA077549			Approved	Nucleoplasm						Nucleoplasm		HPA077549: AB_2732352	unprognostic (7.01e-2)	unprognostic (3.10e-1)	unprognostic (1.80e-2)	unprognostic (5.87e-4)	unprognostic (1.83e-1)	unprognostic (2.31e-1)	unprognostic (1.97e-2)	unprognostic (1.65e-2)	unprognostic (2.02e-5)	unprognostic (2.54e-1)	unprognostic (5.76e-2)	unprognostic (1.33e-1)	unprognostic (3.43e-2)	unprognostic (1.04e-2)	unprognostic (3.14e-1)	unprognostic (9.48e-2)	unprognostic (1.85e-2)	2.8	1.5	1.9	1.7	4.1	5.5	4.8	8.6	3.7	3.5	1.5	2.1	1	1.4	2.6	0.7	2.9	3.4	0.9	1.7	2.7	1.6	1.7	1.8	1.8	5	4.4	2.6	3.7	1.7	0.9	2.8	2.1	5.2	1.9	1.9	0	1.8	1.7	1.9	12.1	1.6	1.4	2.6	3.8	1.7	9.2	5.1	11.5	5.8	4.2	3.5	2.2	1.8	3.2	1.8	5	0.7	0.7	2.5	1	2.2	1.6	3.6	5.2	0.5	1.2	3	1	0.7	1.5	2.8	2.5	2	5.9	3.2	0.4	2.8	0.7	7.2	1.4	1.2	2.9	2.6	3.1	0.9	0.8	0.2	3.1	2.1	0.8	0.9	2.5	2.4	1.1	1.4	8.8	8.3	2.2	1.8	2	6.5	3.1	7.1	1.2	2.5	6.9	5.6	3.5	0.8	1.3	3.3	3.4	2.8	1.4	1.6	7.3	2.6	4.2	0.7	1.8	1.9	1.3	2.1	2.2	2.9	8.7	0.5	3	1.3	5	0.6	3.1	1	0.7	1.9	3.2	2.1	1.4	1.7	2.4	1.7	2.5	1	0.7	0.5	1.8	2.2	1	1.9	4.1	8.6	3.7	2.7	1.6	4.4	2.6	5.2	5.1	3	2.9	8.7	5.1	22.1	5.3	3.7	2.5	95	13.6	1.8	0	5.2	6.6	2.6	20.2	8	0.3	23.3	2.5	10.4	7.5	3.1	3.5	0.8	3.1	4.8	0	6.7	4.3	8.2	5.8	3.7	5	3.6	1.7	2.9	2.6	5.8	3.2	1.1	2.6	0	3.3	16.7	7.9	16.6	2.4	7.2	3.3	2.5	Ciliated cells
BPIFA1	bA49G10.5, LUNX, PLUNC, SPLUNC1	ENSG00000198183	BPI fold containing family A member 1	Q9NP55	20	33235995-33243311	Plasma proteins, Predicted secreted proteins	Immunity, Innate immunity	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9	Cell type enriched	Detected in some	26	Ciliated cells: 116.4	Cancer enriched	Detected in many	27	lung cancer: 262.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6					Not detected	Not detected			CAB025669	Supported				Secreted in other tissues				1200000			CAB025669: 						unprognostic (1.06e-1)		unprognostic (1.53e-1)						unprognostic (3.65e-1)		unprognostic (1.80e-1)		0	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.2	0	0	0	0	0	0	16.9	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0.8	0	0.1	0	11.9	25.2	2.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	1.3	0	2.2	0	0	1.2	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.3	0	0	1.6	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0.6	0	0	0	0	0	0	116.4	4.5	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
KCNRG		ENSG00000198553	Potassium channel regulator	Q8N5I3	13	50015254-50020922	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		fallopian tube: 27.7;ovary: 17.1	Cell type enriched	Detected in some	8	Ciliated cells: 92.3	Low cancer specificity	Detected in single			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001027			Uncertain	Vesicles						Vesicles		HPA001027: 	unprognostic (1.85e-3)	unprognostic (1.66e-2)	unprognostic (1.08e-2)	prognostic favorable (2.61e-5)	unprognostic (3.15e-1)	unprognostic (1.47e-1)	unprognostic (1.27e-1)	unprognostic (5.39e-3)	unprognostic (1.26e-1)	unprognostic (1.09e-1)	unprognostic (1.71e-1)	unprognostic (5.91e-1)	unprognostic (1.65e-2)	unprognostic (4.98e-2)	unprognostic (4.69e-2)	unprognostic (1.52e-1)	unprognostic (9.16e-2)	0.4	0.2	0.3	0.3	0.3	1.1	0.6	0.9	0.3	1.8	0.3	0.5	0.3	0.3	1	4.8	0.6	27.7	0.3	1	0.3	0.5	0.6	0.3	9.1	0.3	0.3	0.3	17.1	0.3	0.4	0.4	0.3	0.5	0.5	0.8	0.3	0.3	1.7	0.4	0.8	0.4	0.4	0.3	0.4	0.3	1.7	0.3	0.3	0.4	0.3	0.6	0.3	0.3	2.7	1.2	4.4	1.1	1.3	1.4	0.4	0.9	0.9	2.9	0.9	0.9	1.4	0.4	0.1	2.3	1.9	0.1	3.4	0.9	1.8	0.6	2.8	1.2	1.2	2.2	0.8	1.4	1.3	1.4	3.8	1.4	1.6	2.7	3.1	1.1	1.9	2.1	1.4	3.5	1.6	3.7	6.8	1.5	0.4	2.3	1.1	3.4	3.1	2	2.3	1.3	2.5	0	0	1.7	2.4	2.5	5.3	1	1.8	1.7	1.5	1.4	1	1.2	1.7	0.7	1.1	0.7	0.2	0.4	2	0.6	1.3	0.4	3.2	1.1	0.7	0.5	1.1	0.7	1.5	0.7	1	0.9	2.7	0.8	0.9	4.4	1.3	0.8	1.2	1.4	0.4	0.3	0.3	0.9	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0	2.4	0	0.7	0.1	0.6	0.5	0	92.3	6.8	0	2	0.6	0	0.5	11.5	0.1	0.5	0	1.2	0.4	0.8	0.6	0	0.2	0.5	3.2	4.1	0	0	8.9	0.6	0	0	1	1.1	0.8	0.4	0	0.7	1.5	1	0	0.3	3.4	1.5	0.1	0.6	0	0.6	1	Ciliated cells
ECT2L	ARHGEF32, C6orf91, FBXO49, LFDH	ENSG00000203734	Epithelial cell transforming 2 like	Q008S8	6	138795926-138904070	Predicted intracellular proteins		Guanine-nucleotide releasing factor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	4	brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4	Cell type enriched	Detected in some	6	Ciliated cells: 133.8	Not detected	Not detected			Region enriched	Detected in many	7	pons and medulla: 8.1	Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEL: 2.8;SCLC-21H: 2.9	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA035488	Uncertain											HPA035488: AB_10672865	unprognostic (2.88e-2)	unprognostic (7.88e-2)	unprognostic (2.52e-2)	unprognostic (5.53e-3)	unprognostic (3.48e-2)	unprognostic (8.45e-3)	unprognostic (9.42e-2)	unprognostic (2.44e-2)	unprognostic (1.18e-1)	unprognostic (7.03e-2)	unprognostic (5.90e-4)	unprognostic (2.32e-1)	unprognostic (5.21e-2)	unprognostic (1.38e-2)	unprognostic (7.27e-2)	unprognostic (7.07e-3)	unprognostic (2.65e-3)	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0	0.2	0.6	7.7	1	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0	0.4	0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0	0.2	0.1	0.2	0.8	0	0.5	1.2	0	0	0.1	0.1	0.8	0.8	0.8	0.3	0	0.3	0.3	0	0	0.9	0.2	0.5	2.8	0.2	0	0.1	0.9	0.4	1.3	1	0	0	0.6	0	0.2	0.2	0.9	0	0.3	0.6	1	0.6	0.2	0.6	0.5	0.3	0.2	0	0.7	2.9	0.7	0.2	0.8	0.4	0.5	0.3	1.2	0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.8	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0	8.1	0.8	0	0.6	0	0.5	0.5	2.2	1.2	0	133.8	21.6	0	2	0.1	0	0	4.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	3.6	0	0	0	0	0	2.2	0	0	0	0	3.1	0	0	0.5	0.1	0	0.2	0	0	0.3	Ciliated cells
LDLRAD1		ENSG00000203985	Low density lipoprotein receptor class A domain containing 1	Q5T700	1	54007299-54018186	Predicted intracellular proteins, Predicted membrane proteins		Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	fallopian tube: 64.2;lung: 16.1;ovary: 20.5	Cell type enriched	Detected in some	15	Ciliated cells: 499.2	Cancer enhanced	Detected in many		endometrial cancer: 5.7	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	CAPAN-2: 3.7;Hep G2: 15.0	Not detected	Not detected			Not detected	Not detected			HPA052489	Enhanced		Uncertain	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA052489: AB_2681850	unprognostic (6.53e-3)	unprognostic (2.05e-2)	unprognostic (2.51e-1)	prognostic favorable (9.21e-4)		unprognostic (1.59e-2)	unprognostic (1.67e-1)	unprognostic (1.97e-1)		unprognostic (1.32e-1)	unprognostic (8.07e-3)	unprognostic (2.43e-1)		unprognostic (2.86e-1)	unprognostic (5.23e-1)		unprognostic (4.27e-2)	0	1.1	0	0	0	0	0.2	0	0	2.6	0.1	0.1	0	0	0.6	2.1	0.4	64.2	1.1	0	0	0	0	0	16.1	0	0	0	20.5	0.1	0	1.5	0.1	0.2	0.5	0	0	2.7	0	0	0.1	0.1	0	0	0	0.8	1.1	0	0	0	0.8	4.8	0	0	0.7	0.5	2.1	0.4	0.4	0.5	0	0.2	0	0	0	0	0	0.2	0.1	0	0	0.2	0.1	3.7	0	1.9	0	0.1	0.6	0	0.1	0	0	0.1	0.3	0.8	15	0	0.1	0.1	0	0	0	0	0.1	0	0.1	0.1	1	0	0.3	0.1	0.1	0	0.1	0	0.1	0	0.2	0.1	0.6	0.3	0	0.1	1	0	0.1	0.8	0.1	0	0.3	0.2	0.1	0.1	0.4	0	0.1	0.3	0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0	0	0	0	0	0	0	0	0	0.2	0	6	7.4	0	0.2	0	0	0	0	499.2	34.2	0	0	0	0	0.2	0	0	0	0	0.2	0	0	3.6	4.7	0	0.1	0	20.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	Ciliated cells
ANKUB1	C3orf16	ENSG00000206199	Ankyrin repeat and ubiquitin domain containing 1	A6NFN9	3	149761100-149968385	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		fallopian tube: 12.2;lung: 11.9;ovary: 10.4	Cell type enriched	Detected in some	5	Ciliated cells: 100.4	Not detected	Not detected			Region enhanced	Detected in many		pons and medulla: 5.2	Cell type enriched	Detected in single	8	neutrophil: 4.8	Lineage enriched	Detected in single	10	granulocytes: 4.8	Cell line enhanced	Detected in some		OE19: 4.6					Low region specificity	Detected in all			HPA053749	Uncertain											HPA053749: AB_2682248	unprognostic (1.71e-2)	unprognostic (1.89e-4)	unprognostic (1.01e-1)	unprognostic (4.20e-2)	unprognostic (1.98e-1)	unprognostic (1.18e-1)	unprognostic (2.42e-1)	unprognostic (1.61e-2)	unprognostic (1.48e-1)	unprognostic (9.61e-2)	unprognostic (1.52e-2)	unprognostic (2.35e-1)	unprognostic (2.18e-9)	unprognostic (3.06e-1)	unprognostic (2.96e-1)	unprognostic (3.17e-1)	unprognostic (7.07e-4)	0	0	0.8	0.2	1.2	0.6	0	0	0.3	2.1	0	1.8	0	0.2	0.9	0.1	0	12.2	0.1	0	1.5	1.7	0	0	11.9	0.1	0	0	10.4	0.1	0	1.1	0.1	5.2	0.1	0	0	0.5	0	0.1	0.6	0.1	0	0.3	0.2	0.3	2.2	0.8	0	0	0.6	0.1	0.1	0	0.4	0.3	4.8	0.4	0.2	0.3	0	0.4	0.6	0.6	0.2	0	0.1	0.5	0.2	0	0	0	0.9	0.9	0.8	0.2	0	0.2	1.4	0.4	0.4	0.2	0.5	0.3	0.8	1.9	0.4	0	0.4	0.7	0.1	0	0	0.1	0.1	0	0.4	0.4	0.8	0	0.3	0.5	0.8	0.4	4.6	0.5	0.9	0.6	0.5	0	0.8	0.5	0.1	0.4	0.4	0	0.3	0.7	0.2	0	0.6	0.5	0.2	0.3	0.5	0.4	0.8	0.4	0.7	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0	0.8	1.2	0	0.3	1.5	1.7	0	0	5.2	0.8	0	1.7	0	0.6	0.5	0	0.3	0	100.4	20.5	0	0	0	0	0	9.8	0	0	0	0	0	0.2	0.3	0	0	0.1	0	0	0	0.6	3.3	0.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.1	0	0	0	0.5	Ciliated cells
CFAP44	FLJ11142, WDR52	ENSG00000206530	Cilia and flagella associated protein 44	Q96MT7	3	113286947-113441610	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 38.2;epididymis: 20.2;testis: 20.3	Cell type enriched	Detected in many	4	Ciliated cells: 192.7	Low cancer specificity	Detected in many			Region enhanced	Detected in all		pons and medulla: 38.2	Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Low cell line specificity	Detected in many			Low region specificity	Detected in many							HPA067258	Uncertain											HPA067258: AB_2685814	unprognostic (2.83e-1)	unprognostic (7.07e-2)	unprognostic (1.65e-1)	unprognostic (1.06e-1)	unprognostic (2.35e-1)	unprognostic (3.39e-3)	unprognostic (7.51e-4)	unprognostic (6.73e-2)	unprognostic (1.10e-1)	unprognostic (2.89e-1)	unprognostic (1.62e-2)	unprognostic (2.18e-3)	unprognostic (2.13e-6)	unprognostic (8.77e-2)	unprognostic (1.04e-1)	unprognostic (1.77e-2)	prognostic favorable (7.09e-6)	1.5	1.2	2.8	1.5	10.1	1.4	3.6	3.9	2.3	2.8	2.3	15.4	0.7	1.1	3.2	20.2	1.6	11.1	1.6	1.7	6.1	1.3	2.6	1.9	7	2.1	1.2	1	8.8	4	6	5.8	1.1	38.2	3.9	3.9	0.8	5.7	1.9	1.3	3.7	2.9	1.2	2	1.8	3.5	20.3	5.9	0.9	3.4	0.7	1.9	2.6	2.6	1.3	0.3	0.8	0.2	0.1	0.7	0	3.9	2.6	4.2	4.5	2.8	4	5.6	1.8	0.9	1.2	2.3	1.3	2.3	4.4	0.6	1.1	1.5	4.8	2.8	1.4	2.4	1.9	3	3	7.9	1.5	0.1	4.9	3	0.9	3.3	1	1.1	4.5	0.9	4.3	1.2	2.8	1.5	2.5	2.7	4.9	2.7	5.3	6.1	3.3	1.1	0.7	2.1	6.3	4.3	4.7	2.7	0.6	2.6	2.5	3.3	3.5	2.8	3.4	3.7	1.3	1.7	3.9	2.2	0.4	2.1	3	2.7	0	0.2	0.8	0.4	0.1	0.4	0.4	0.5	0	0	1.3	0.7	0.4	0.6	0.1	0	0.3	0.2	0	2.8	10.1	3.9	2.3	6.1	1.3	1.2	1	38.2	5.9	8.9	10.7	0	1.8	0	7	5.3	0	192.7	34.2	3.5	19.6	0.8	0	1.9	46.7	2.2	1	0	2.6	0.8	0.7	3.3	10.5	3	0.5	7.9	0	0.6	1.2	38.2	5.8	0	0	0	5.2	5.3	2	0	6.3	1.1	20.3	0	0.9	25	4.8	0	0.7	0	3.7	1.7	Ciliated cells
FAM187A		ENSG00000214447	Family with sequence similarity 187 member A	A6NFU0	17	44899712-44905390	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 21.2;testis: 37.0	Cell type enriched	Detected in single	67	Ciliated cells: 6.7	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		classical monocyte: 2.9	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		RPTEC TERT1: 12.4;U-87 MG: 14.1									HPA043131			Approved	Cytosol						Cytosol		HPA043131: AB_10796686																		0.7	1.3	5.8	0.6	8.9	0.7	1.4	1	5	2.5	0.9	3.1	1.7	0.3	1.9	2.7	0.5	21.2	3	0.6	5.4	6.7	3.7	0.5	2	0.7	5.3	4.1	3.7	1.6	2.2	2.2	0.3	4.5	1.1	1	1.7	1.3	1.9	0.4	0.6	0.6	1.1	4.2	0.4	0.6	37	1.1	0.3	4.5	0.2	0.6	0.9	0.3	0.8	1.8	1.9	2.9	0.2	0.8	2	1.7	8.8	2.2	1.8	2.7	3.1	1.4	0.5	4.3	2.5	3.1	2.6	4.7	0.2	1.4	1.6	5.9	5.2	0.5	2.3	1.1	5.2	2.1	0.7	3.7	0.7	1.1	1	0.7	0.4	3	4.7	1	4.2	1.1	1.1	1.6	0.1	0.9	1.2	0.1	1.3	0.7	3	1.2	0.8	0.3	0.4	12.4	0.8	5.9	1.4	0.5	0.1	0.7	1.7	6.3	1	0.6	1	2.2	1.2	1	0.2	0.2	0.4	14.1	0.8	1.1	0	2.9	1.9	0.2	0.8	0	0	0	0.8	1.8	0.8	0	0.1	0	0.2	0.3	0	0.6	2	5.8	8.9	1	5	5.4	6.7	5.3	4.1	4.5	1.1	0	0	0	0	0	0	0	0	6.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
DCDC2B		ENSG00000222046	Doublecortin domain containing 2B	A2VCK2	1	32209094-32216196	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		epididymis: 11.1;fallopian tube: 26.6;lung: 10.1	Cell type enriched	Detected in some	13	Ciliated cells: 115.1	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in single		myeloid DC: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 1.6;hTERT-RPE1: 2.9;TIME: 3.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045832	Uncertain											HPA045832: AB_10962048	unprognostic (6.45e-3)	unprognostic (3.71e-2)	unprognostic (1.32e-2)	unprognostic (3.89e-3)	unprognostic (2.18e-1)	unprognostic (1.87e-3)	unprognostic (7.66e-3)	unprognostic (6.35e-2)	unprognostic (4.84e-2)	unprognostic (3.33e-1)	unprognostic (2.71e-3)	unprognostic (8.73e-2)	unprognostic (6.18e-4)	unprognostic (8.53e-2)	unprognostic (2.00e-1)	unprognostic (4.76e-2)	unprognostic (4.39e-3)	0	0.1	0	0.1	0.1	0	0	0	0	1.2	0	0.2	0	0	0.3	11.1	0	26.6	0.2	0	0	0	0	0	10.1	0	0	0	5.5	0	0	0.6	0	0.5	0	0	0	0	0	0	0	0.1	0	0	0	0.1	3.3	0	0	0.1	0	0.2	0	0	0.2	1	0.6	0.1	0.2	0.3	0	0.1	0.8	1.6	0.3	0	0	0.2	0.4	0	0	0	0	1	0.3	0.1	0	0.1	0.1	0.1	0	0	0	0.2	0.4	0.8	0	0	0	0.5	0	0.1	0	0.2	2.9	0	0.9	0.1	0.5	0	0	0.2	0.2	0	0	0	0	0.6	0.1	0	1.2	0.4	0	0	0.6	0.2	0.5	0.8	0.1	3.6	0.1	0.7	1	0.7	1.4	0.1	0	0	0.2	0	0	0.1	0	0.3	0	0	0.2	0.1	0	1	0.1	0	0	0.6	0.2	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0	0.3	0	0	0	2.7	0	0	115.1	9.1	1.8	3.9	0	0	0	4.7	0	0	0	0	0	0	0.1	1.1	0	0	3.2	0	0	0	7.5	0	0	0	0	0	0	0	0	0	0	4.4	0	0	2.7	0.2	0	0	0	0	0	Ciliated cells
PRR29	C17orf72, DKFZp761M2312, FLJ11724	ENSG00000224383	Proline rich 29	P0C7W0	17	63998351-64004304	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 17.9;fallopian tube: 48.7;testis: 23.5	Cell type enriched	Detected in some	8	Ciliated cells: 164.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 6.8;REH: 7.0;TIME: 5.6									HPA051264			Uncertain	Nucleoli						Nucleoli		HPA051264: 	unprognostic (2.05e-2)	unprognostic (6.46e-2)	unprognostic (2.87e-2)	unprognostic (2.92e-3)	unprognostic (4.71e-3)	unprognostic (3.22e-2)	unprognostic (3.84e-1)	unprognostic (3.95e-2)	unprognostic (1.04e-2)	unprognostic (1.44e-1)	unprognostic (2.63e-3)	unprognostic (5.76e-2)	unprognostic (1.30e-3)	unprognostic (6.48e-2)	unprognostic (1.80e-1)	unprognostic (1.32e-1)	unprognostic (9.98e-3)	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4	0.5	8.3	0.4	0.6	1	17.9	0.6	48.7	1	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1	0	2.5	0	0.7	1	0	1	0.7	3.1	1.8	1	3	1.6	0	0	0	0	0	1.3	0.5	0.2	0	0	0.4	0	6.8	0	0.7	0	1.5	0	0.1	0.5	0.2	0	0	2.3	0	0.3	0	0	0.1	0	0	0.3	0	0.8	0.2	1.9	1	0	0	0	2.4	0	0.2	1.4	0.2	7	0.1	2.9	0.5	0	0.4	2.1	0	0.3	0.4	1.1	1.1	0	5.6	0.2	2.4	0.7	0.2	0.7	0.2	0.5	0.9	0.3	0	3.1	0.9	0	2	1.8	0.4	0.7	1.7	1	0.7	1	3	1.7	0.8	1	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1	0	3.2	0.5	0	0	0	0.1	0	164.6	18.2	3.5	0	0	0	0	7.5	0.1	0	0	0	0.1	0.4	0	0	0	0.3	0	0	2.5	0	4.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0	21.8	1.4	0	0.2	0	0	0	Ciliated cells
SAPCD1	C6orf26, NG23	ENSG00000228727	Suppressor APC domain containing 1	Q5SSQ6	6	31762799-31764851	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		retina: 8.8;skin 1: 14.7	Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 7.3;JURKAT: 6.4	Not detected	Not detected			Low region specificity	Detected in many			HPA071699			Approved	Vesicles,Cell Junctions						Vesicles	Cell Junctions	HPA071699: AB_2686433	unprognostic (9.25e-4)	unprognostic (1.32e-1)	unprognostic (3.41e-2)	unprognostic (3.28e-1)	unprognostic (9.34e-2)	unprognostic (8.02e-4)	unprognostic (1.63e-2)	unprognostic (3.80e-2)	unprognostic (2.01e-1)	unprognostic (8.16e-3)	unprognostic (1.56e-2)	unprognostic (2.25e-1)	unprognostic (8.15e-10)	unprognostic (2.65e-2)	unprognostic (4.45e-1)	unprognostic (3.57e-1)	unprognostic (7.98e-5)	0.8	0.3	0.7	1.6	1	4.8	1.8	0.7	1.3	2	1	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0	0.5	0.2	0.1	0	0.7	0	0.5	0	0	0.5	0.4	0.8	0.8	0.4	0.2	0.2	0	2.8	1	0.8	0.1	0.2	0	1.6	0	0.7	0.1	0	3.1	3.8	7.3	1	0.2	0.3	0.1	0.2	0	1.1	1.4	0.3	0.5	6.4	0.4	1.1	0	3.7	2.8	2.3	0	0.3	0.8	0.4	0.9	0	0.6	0.7	1.2	0.6	0.3	0.7	0.4	0.9	0.3	0	0.2	0.1	2.9	0	0.3	2.1	2	2	0.2	2.7	0.1	0	0	0	0.7	0	0	0	0	0.2	0	0	0	0	0.2	0	0.1	0.5	0	0	0.7	1	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
ANKRD66		ENSG00000230062	Ankyrin repeat domain 66	B4E2M5	6	46746917-46759506	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1	Cell type enriched	Detected in some	10	Ciliated cells: 210.1	Cancer enhanced	Detected in single		endometrial cancer: 1.0	Region enhanced	Detected in many		pons and medulla: 15.0	Cell type enriched	Detected in single	6	myeloid DC: 1.0	Lineage enriched	Detected in single	6	dendritic cells: 1.0	Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all																			unprognostic (1.67e-3)	unprognostic (2.52e-1)			unprognostic (2.44e-2)		unprognostic (2.03e-2)		unprognostic (9.36e-2)		unprognostic (4.30e-3)	unprognostic (2.19e-1)			0.1	0.2	2	0.2	4.3	0.1	0.2	0	0.6	1.7	0.1	5.9	0	0.1	0.9	12.1	0.1	36	0.1	0.1	3	3	0.1	0.1	7.1	0.2	0	0	11.1	0.1	0.1	0.5	0.2	15	0.2	0.1	0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0	0.2	0.1	0.2	0.2	0	0	1	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	4.3	0	0.6	3	3	0	0	15	1.9	0	0.3	0	0	0	0	0	0	210.1	20.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
TSPAN19		ENSG00000231738	Tetraspanin 19	P0C672	12	85014311-85036277	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		lung: 9.7;pituitary gland: 20.0	Cell type enriched	Detected in some	8	Ciliated cells: 360.0	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 5.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		SCLC-21H: 6.4;SK-BR-3: 4.3					Low region specificity	Detected in all			HPA057066	Uncertain											HPA057066: AB_2683325				unprognostic (1.94e-1)	unprognostic (9.81e-4)	unprognostic (8.57e-2)		unprognostic (8.37e-2)	unprognostic (2.33e-1)	unprognostic (6.57e-2)	unprognostic (2.26e-3)	unprognostic (9.52e-2)	unprognostic (5.09e-3)		unprognostic (2.22e-1)	unprognostic (3.78e-2)		0.4	0.8	1.5	0.5	1.9	2.3	0.2	1	2.6	0.5	0.4	1.4	0	1.1	0.5	2.5	0.8	1.8	0.8	0.4	3.2	4.4	0.7	0.1	9.7	0.5	2.3	4.4	0.4	1.6	0.4	20	0.5	4.9	1	0.2	2.4	0.8	0	1.6	4.5	0.6	0	1.6	0.5	0.5	8.4	1.4	0	4.1	1.3	0.2	0.5	0.2	1.8	0.9	5.4	1	0.8	1.1	0	0.9	0	1.6	0.5	0.9	1.4	1.8	0.9	0.1	0	0.5	0.8	0	1	0.1	0	1.1	0.3	0.2	0.3	0	0.8	1.6	0	0.5	0.7	2.1	1.5	1.7	1	1.1	0.9	0.6	3.2	0	0.8	0.1	0	0	0	0	0	1.3	0.8	0	1.4	0.2	0	0	0.3	6.4	2.7	0	4.3	0.9	0.7	1	0.3	1.2	3	0.9	1.3	0.8	3.8	0	0.5	3.3	0	1.4	1.1	1	1.1	1	0.7	0.7	0.9	0.8	0.5	0.1	1.8	1.1	1	5.4	0.8	0.4	0.9	0.3	0	1.5	1.9	1	2.6	3.2	4.4	2.3	4.4	4.9	1.4	3	1.3	0	0	0.1	2.4	0.8	0	360	34.2	0	7.9	0	0	0	46.9	0.1	0	0	0	0	0.2	0.8	0	0	0	0	0	0	0	2.5	0	0	0	0	0	4.7	0	0	0.4	0	7.9	6.5	0	0.9	0.5	0	0	0	0	0	Ciliated cells
RAB6D	RAB6CL, WTH3DI	ENSG00000233087	RAB6D, member RAS oncogene family		2	131361111-131364142	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level			Tissue enriched	Detected in some	7	parathyroid gland: 13.4	Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Cancer enhanced	Detected in some		prostate cancer: 1.3					Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		MOLT-4: 6.4;OE19: 2.6;REH: 2.5;U-2 OS: 2.5									HPA059131	Uncertain		Approved	Golgi apparatus						Golgi apparatus		HPA059131: AB_2683916	unprognostic (4.19e-2)	unprognostic (8.54e-2)	unprognostic (1.16e-1)	unprognostic (3.03e-2)	unprognostic (4.08e-1)	unprognostic (4.79e-2)		unprognostic (4.41e-2)	unprognostic (1.01e-1)	unprognostic (1.87e-2)	unprognostic (2.42e-1)	unprognostic (3.21e-1)	unprognostic (2.55e-2)	unprognostic (2.61e-2)	unprognostic (2.50e-1)	unprognostic (1.82e-1)	unprognostic (2.12e-1)	0	0		0		0	0		1.1	0	1.1			0	0	0.2	0	0	0	0			0	0	0	0			0	0	13.4		0		1.9	1		0	0	0	0	0.8	0		0	0	1			0		0	0		0.2	0.3	1.4	0.4	0.5	0.5	0.5	0	0.1	0	0.1	0	0	0.4	0	0	0	0	0.2	0.1	0	0	0	0	0	0.4	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.6	6.4	0.1	0.9	2.6	0	2.5	0	0	0.1	0.1	0	0.1	0	0	0.1	0.4	0.1	0.1	0	0	2.5	0.2	0	0	0.7	0	0	0	0.1	1.4	0.3	0.5	0.4	0.4	0.4	0.1	0.5	0.3	0.3	0.2	0.5	0.4	0.2	0.5	0.4	0.1	0.5	0.5											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
MFRP	C1QTNF5, FLJ30570, NNO2, rd6	ENSG00000235718	Membrane frizzled-related protein	Q9BY79	11	119338942-119346673	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins			Disease mutation, Microphthalmia, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	40	brain: 54.9;retina: 112.9	Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Not detected	Not detected			Region enriched	Detected in some	10	pons and medulla: 54.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTERT-RPE1: 1.5;JURKAT: 1.0;NB-4: 1.8	Group enriched	Detected in many	4	basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9	Low region specificity	Detected in some																																	0.9	0.3	0.6	0	0.4	0.1	0.1	0.2	2.8	0.2	0.1	14.6	0	0.2	0.3	0	0.1	0.2	0.1	0.2	5.5	0.5	0.2	0.1	0.3	0.2	0.8	0	0.1	0.1	2	0.5	0.6	54.9	0.1	0	112.9	0.1	0.1	0.5	0.1	0.2	0.4	0.4	0.3	0.2	0.5	0	0	0.1	0	0.1	0.1	0.1	0	0	0	0.5	0	0	0	0	0	0	0.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	1.5	0.3	1	0	0	0	0	0	1.8	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.6	0.4	0.2	2.8	5.5	0.5	0.8	0	54.9	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
UBE2L5	UBE2L5P	ENSG00000236444	Ubiquitin conjugating enzyme E2 L5		13	30422488-30428616	Enzymes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level			Tissue enriched	Detected in some	9	testis: 31.5	Cell type enriched	Detected in single	4	Ciliated cells: 1.4	Low cancer specificity	Detected in single							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many							Low region specificity	Detected in single			HPA045609, HPA062415	Approved		Uncertain	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA045609: AB_10961322, HPA062415: AB_2684756	unprognostic (2.09e-1)	unprognostic (1.18e-2)	unprognostic (8.01e-3)	unprognostic (6.41e-4)	unprognostic (1.78e-1)	unprognostic (7.13e-2)	unprognostic (2.20e-1)	unprognostic (1.65e-1)	unprognostic (1.19e-1)	unprognostic (6.49e-3)	unprognostic (1.78e-1)	unprognostic (8.00e-2)	unprognostic (3.50e-2)	unprognostic (9.37e-2)	unprognostic (2.60e-1)	unprognostic (2.44e-2)	unprognostic (8.75e-2)	0.2	0	0	0	0.7	0.1	0	0.3	0.3	0	0.1	0.4	0	0	0.3	0	0	0	0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0	0	0	0.1	0.5	0.1	0	0	0	0	0.1	0.3	0	0.1	0	0	0	31.5	0.1	0	0	0	0	0.1	0	3.2	1.9	2.7	3.6	1.9	2	2.8	0.7	0.3	1.3	1.6	0.6	0.7	0.7	1.2	0.6	0.4	0.2	0	3.1	1.4	0.6	1.3	1.3	0.6	0.8	0.4	1.1	2.5	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	1.4	0.9	0.9	0.8	1.3	0.3	0	1.6	2.6	1.4	0.2	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.9	0.6	2.4	0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2	2.7	1.9	1.6	1.9	2	2.8											0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AMY1A	AMY1	ENSG00000237763	Amylase, alpha 1A (salivary)	P04745	1	103655290-103664554	Enzymes, Predicted secreted proteins	Carbohydrate metabolism	Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	100	salivary gland: 654.0	Cell type enriched	Detected in some	11	Ciliated cells: 38.8	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		NTERA-2: 1.4;SH-SY5Y: 2.4									CAB004310, HPA045394, HPA045399, HPA046980	Enhanced				Secreted to digestive system				68000000			CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889																		0	0	0	0	0	0	0	0	0	6.5	0			0	0	0	0.1	1.5	0	0	0	0	0	0	0.5	0	0		0	3.7	0	0	0		0	0		654	0	0.1	0	0	0	0	0	0	0			0.2		0	0	0.1	0.1	0.3	0.3	0.6	0	1.1	0.7	0.1	0.3	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.8	0	0	0	0.2	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	1.4	0	0	0	0.1	0	0	0	0	2.4	0	0	0	0	0	0	0	0.2	0.1	0.2	0	0.4	0	0	0	0	0.1	0	0.3	0.3	0.1	0.6	0	0.1	1.1	0.1	0.3	0.1	0	0.7	0.2	0	0.5	0	0.1	0.7											3	2.1	0	0.8	0.6	0	2.4	0	38.8	3.4	0	0	0	0	0	1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	Ciliated cells
WFDC6	C20orf171, dJ461P17.11, WAP6	ENSG00000243543	WAP four-disulfide core domain 6	Q9BQY6	20	45534196-45539495	Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	7	epididymis: 79.9;testis: 25.5	Cell type enriched	Detected in some	16	Ciliated cells: 56.2	Cancer enhanced	Detected in some		endometrial cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	U-87 MG: 7.8														Secreted in male reproductive system								unprognostic (3.68e-3)			unprognostic (2.21e-3)				unprognostic (1.26e-2)		unprognostic (8.74e-2)					unprognostic (2.91e-2)			0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	1.1	0.1	0.1	7.6	0	0.2	79.9	0.1	2.8	0.1	0.1	0.1	0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0	25.5	0.1	0.1	0.3	0.1	0.3	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	56.2	3.4	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.9	0.2	0	0	0	0	0.1	Ciliated cells
CFAP57	FLJ32000, WDR65	ENSG00000243710	Cilia and flagella associated protein 57	Q96MR6	1	43172149-43254358	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 25.6;testis: 29.2	Cell type enriched	Detected in some	7	Ciliated cells: 156.6	Low cancer specificity	Detected in some			Region enhanced	Detected in many		pons and medulla: 12.7	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HaCaT: 6.9;HDLM-2: 4.5	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA002736, HPA028623	Enhanced		Approved	Cytosol						Cytosol		HPA002736: AB_2272982, HPA028623: AB_10603234	unprognostic (1.15e-2)	unprognostic (2.29e-3)	unprognostic (2.16e-1)	prognostic favorable (6.02e-4)	unprognostic (2.50e-2)	unprognostic (3.71e-1)	unprognostic (2.42e-2)	unprognostic (1.02e-1)	unprognostic (1.39e-1)	unprognostic (4.11e-1)	unprognostic (2.05e-2)	unprognostic (1.38e-1)	unprognostic (3.46e-2)	unprognostic (1.43e-1)	unprognostic (1.80e-1)	unprognostic (1.34e-2)	unprognostic (7.78e-2)	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0	0.3	1	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0	1.9	0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1	0.8	0.6	0.2	0.2	0.9	1.1	1.8	1.4	1.4	0.9	1.2	0.3	1.3	2.4	0.8	6.9	0.4	0.9	2.6	4.5	0.2	0.4	0.6	0.6	0.5	0	0.3	0.2	1.2	1.1	0.4	1.9	2	0.4	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.2	0.1	0.4	1	0.2	3	0.5	1.2	0.5	1.4	0.2	1.1	0.8	1.7	0.5	3.9	0.2	1.5	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.9	0.5	1.1	0.7	1.4	2	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4	6	0.3	0	0.1	0	0.4	0.4	0	156.6	10.3	0	5.9	0.8	0	0.3	22.1	0	0.2	0	0.2	0.1	0.2	0.1	0	0.2	0.1	1.6	0	0.6	0	21.6	0.9	0	0	3.6	0	0.5	0.2	0	0.7	1.4	0.8	0	0	18.7	3.3	0	0	0	0	0.1	Ciliated cells
TUBA4B	FLJ13940, TUBA4	ENSG00000243910	Tubulin alpha 4b	Q9H853	2	219253243-219272188	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	7	fallopian tube: 29.7	Cell type enriched	Detected in some	8	Ciliated cells: 152.6	Cancer enriched	Detected in some	6	endometrial cancer: 8.4					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 3.1;SCLC-21H: 3.6																						unprognostic (3.20e-5)	unprognostic (1.47e-4)	unprognostic (1.85e-1)	unprognostic (3.70e-3)	unprognostic (9.63e-2)	unprognostic (8.97e-2)	unprognostic (2.18e-3)	unprognostic (7.32e-2)	unprognostic (9.50e-2)	unprognostic (6.56e-2)	unprognostic (2.50e-1)	unprognostic (2.12e-1)	unprognostic (2.41e-3)	unprognostic (3.78e-2)	unprognostic (9.57e-2)	unprognostic (3.91e-2)	unprognostic (4.08e-1)	0	0		0		0	0		0	0	0			0	0.2	0.4	0	29.7	0	0			0.4	0	2	0			0	0	0		0		0	0		0	0	0.1	0	0	0		0	0	0			0		0	0		1	0.2	2.4	0.6	0.6	1.5	4	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0.4	0.5	0.7	0	0.3	0.7	0	0.7	0	0.4	0.2	0.2	0.6	3.1	0	0	0.2	0	0	0	0	0	0	0	0	0.6	0	0	0	0.6	0.1	0	0	0	0.2	0.1	0	0.1	3.6	0.1	0.9	0.3	0	0	0.2	0.4	0	0	0.5	0.3	0.1	0.4	0	0.6	0.8	0.5	0	0.7	0.4	1.4	0.7	0.4	0.8	1	1.5	1.2	0.2	0.8	1.2	1.4	2.4	0.6	0.6	0.1	1.3	4											0	2.7	0	0.3	0	0	0.8	0	152.6	7.9	1.8	0	0	1.7	0	1.3	0	0	0	0.2	0	0	0.2	0	0.2	0	0	1.7	0	0	0.6	0	0	0	0	0	0	0.1	0	0	18.8	0	0	0	0	0	0	0	0	0	0.1	Ciliated cells
CCDC153	LOC283152	ENSG00000248712	Coiled-coil domain containing 153	Q494R4	11	119189638-119196769	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0	Cell type enriched	Detected in many	7	Ciliated cells: 151.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in many		neutrophil: 15.1	Lineage enriched	Detected in many	6	granulocytes: 15.1	Cell line enhanced	Detected in many		T-47d: 13.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA041497	Uncertain		Uncertain	Cytosol						Cytosol		HPA041497: AB_10794378	unprognostic (4.66e-2)	unprognostic (1.86e-2)	unprognostic (3.88e-2)	unprognostic (1.45e-2)	unprognostic (1.53e-1)	unprognostic (3.22e-2)	unprognostic (6.87e-2)	unprognostic (2.23e-3)	unprognostic (5.19e-2)	unprognostic (9.43e-3)	unprognostic (1.36e-1)	unprognostic (2.36e-1)	unprognostic (2.92e-3)	unprognostic (1.15e-1)	unprognostic (3.80e-1)	unprognostic (1.52e-3)	unprognostic (1.98e-3)	1.4	1.1	2.2	0.6	4.8	3.8	0.8	0.5	0.9	1.4	0.6	2	0.5	0.5	1.1	5.3	1.5	15.8	3.1	2	2.6	3.9	1.5	0.6	5.2	0.5	0.5	0.5	1.7	0.5	3.3	20	1.3	9.8	0.5	0.6	0.5	0.7	1.6	0.5	1.4	0.8	0.7	1.2	0.8	1.6	2.8	2.4	0.5	1.1	0.5	0.9	0.7	0.5	0.4	1.6	15.1	2.4	0.3	0.6	0.7	2.2	3	1.8	1.8	0.3	0.3	4.4	1.3	1.5	0.6	0.7	4.9	7.7	1.5	6.4	0.3	2.2	1.6	0.4	1.5	0.1	3	2.5	7.2	2.2	3.3	1.1	2.3	0.9	0.7	1	1.6	0.4	2.4	1.5	1.6	2.1	2.9	0.1	8.9	1.5	2.2	0.9	3.2	5.2	2	2.5	1.4	0.5	2.2	2.4	1.2	3	1.5	1.7	1.2	13.1	2.7	3	3.3	2.6	2	2.7	1.2	1.8	1.2	1.5	1.3	4	0.4	2.4	3.8	0.3	1.5	0.2	0.4	0.2	0.4	1.6	0.4	0.6	0.5	15.1	0.3	1.5	1.6	0.4	0.7	2.2	4.8	0.5	0.9	2.6	3.9	0.5	0.5	9.8	2.4	0	6.7	0	1.3	2.5	0	0.2	0	151.3	20.5	7	0	3.5	0	0.8	2.5	1.5	3.3	0	1.8	2.9	1.3	0.9	0	1.3	3.1	0	1.7	3.1	3.5	4.8	0.3	3.4	3.3	5.4	2.7	0.9	1	7	2.5	2.9	1.9	6.5	6.2	6.6	3.4	1.9	2.7	0	1.8	2	Ciliated cells
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	ATP5MF-PTCD1 readthrough		7	99419749-99466197	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	8	Ciliated cells: 1.4	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA020106, HPA047679	Uncertain		Approved	Mitochondria						Mitochondria		HPA020106: AB_2176551, HPA047679: AB_2680119	unprognostic (1.15e-3)	unprognostic (3.63e-2)	unprognostic (1.73e-1)	unprognostic (2.83e-1)	unprognostic (3.29e-2)	unprognostic (3.51e-1)	unprognostic (1.18e-3)	unprognostic (2.84e-2)	unprognostic (6.44e-2)	unprognostic (2.18e-1)	unprognostic (3.50e-2)	unprognostic (1.28e-1)	unprognostic (1.70e-1)	unprognostic (2.04e-1)	unprognostic (7.45e-2)	unprognostic (2.00e-2)	unprognostic (7.50e-2)	9.3	10.3	7.5	8.6	9.2	1.2	8.1	8.2	13	9.6	12.4	3.6	9.2	8.7	10.4	8.1	14.8	11	8.3	18.6	8.3	6.7	14.5	23.6	7	7.8	6.2	10.2	9	15.6	11.5	7.1	8.3	8.3	12.3	7.2	6.8	13.9	12.1	35.7	8.7	15	8.4	6.7	8.3	8.9	14.2	5.4	12.7	8.7	24.8	8.6	14.1	10.4	4.2	8.7	1.8	8.3	6.2	6.1	6.8	5.5	6.1	5.1	14.4	6.3	3.7	10.9	3.8	4.6	9.7	8.8	23.3	9.2	7.3	9.5	3.6	9	5.5	8.7	7.9	4.1	8.1	8.2	4.2	4.1	4.8	6.7	5.7	4.5	6.3	7.1	8.7	7.1	3.6	4	8.6	13.9	11.1	6.2	11.6	13.1	7.5	9	9.6	7.9	7.1	4.8	19.3	5.2	1.9	6.7	6.7	8.2	14	8.3	3.6	6.9	9.1	2.4	6.8	6.1	14.2	10	8.9	7.6	11.5	5	6.5	12.1	1.8	6.3	1.7	5.5	8.3	5.8	3.6	4.6	4.6	8.7	4.2	4.9	6.1	0.5	6.2	4.8	4.3	3.5	6.8	7.5	9.2	8.2	13	8.3	6.7	6.2	10.2	8.3	5.4	0	0	0	0	0	0	0	0	1.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	EPPIN-WFDC6 readthrough	O95925	20	45536986-45547426	Predicted secreted proteins		Antimicrobial, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	48	epididymis: 25.8;testis: 68.0	Cell type enriched	Detected in some	6	Ciliated cells: 6.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-87 MG: 2.7									HPA067335	Supported				Secreted in male reproductive system							HPA067335: 										unprognostic (1.46e-3)					unprognostic (6.38e-2)			0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0.2	0	0.9	25.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.2	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	68	0	0	0.2	0	0	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	6.7	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Ciliated cells
REELD1		ENSG00000250673	Reeler domain containing 1		4	146214515-146230878	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level			Tissue enhanced	Detected in some		breast: 1.3;epididymis: 1.5;skin 1: 1.7	Cell type enriched	Detected in single	17	Ciliated cells: 2.7	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	87	HDLM-2: 14.6																						unprognostic (6.26e-3)	unprognostic (1.40e-1)		unprognostic (3.81e-2)	unprognostic (8.94e-2)	unprognostic (3.77e-2)	unprognostic (7.75e-2)	unprognostic (7.88e-2)	unprognostic (1.36e-1)	unprognostic (2.88e-1)	unprognostic (1.04e-2)	unprognostic (1.40e-1)	unprognostic (3.55e-6)	unprognostic (2.19e-2)	unprognostic (3.14e-1)	unprognostic (3.90e-1)	unprognostic (3.13e-2)	0.1	0		0.9		0.4	1.3		0.2	0.4	0			0	0	1.5	0	0.2	0	0			0.1	0.7	0.2	0.2			0	0.4	0		0		0.3	0		0	0	0.5	1.7	0	0		1	0	0.1			0		0.7	0		0	0	0	0	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0.5	0	0	0	0	0	0.2											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC010255.3		ENSG00000250803	Uncharacterized protein LOC100505841 		5	122129622-122183949	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	14	testis: 59.7	Cell type enriched	Detected in single	63	Ciliated cells: 10.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 3.0;GAMG: 1.3;HUVEC TERT2: 1.7;U-2197: 1.7;U-266/84: 1.3;U-87 MG: 1.8	Not detected	Not detected																					unprognostic (8.24e-2)		unprognostic (3.81e-3)	unprognostic (3.43e-2)	unprognostic (1.42e-1)		unprognostic (8.28e-2)		unprognostic (1.76e-1)				unprognostic (4.18e-1)		unprognostic (5.54e-2)		0	0	0	0	0.4	0	0	0	0	0.6	0	2.3	0	0	0.1	2.2	0	1.7	0	0	0.3		0	0	2.8	0	0	0	2.6	0	0	0.1	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	59.7	0.2	0	0.1	0	0	0.1	0	0	0	0	0	0	0.4	0	0.4	0	0	0	0	0	0	0.5	0.1	0.1	0.1	3	0	0	0.1	0.9	1.3	0	0	0	0	0	0.2	0	0.3	0	0	0	0.1	0	0	0	0	0	1.7	0.2	0	0.1	0.3	0	0	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.8	0.1	1.7	0.1	0	1.3	0	1.8	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	10.7	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC093899.2		ENSG00000251569			2	169479480-169525922	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		testis: 19.1	Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		ASC TERT1: 9.0;HSkMC: 6.4;LHCN-M2: 9.1									HPA046125	Uncertain											HPA046125: AB_2679549																		2.4	2.4	3.7	0.9	7.8	0.5	4.8	3.1	8.6	3	2.5	4.1	2.9	0.9	5.5	5	2.3	5.8	5.1	5.5	7.8	2.7	3.6	2.1	3.2	1.1	2.4	5.8	4	2.5	5	8.5	1.6	7.7	5.7	2.5	10.5	3.1	4.5	6.7	2.3	2.2	3.5	2.5	2	2.4	19.1	2.6	0	5.5	2	2	2.4	2.4	0	0.2	0	0	0	0.6	0	0	0	2.1	1	2.9	9	0	1.9	1	1	1	0	0	0	0.3	1.9	2.2	0.1	1.4	0.1	2.4	0.3	0	0.1	0.1	0.3	0.7	1.1	0	6.4	2	2.7	0.8	2.4	3.2	1.5	0.3	0	9.1	0	0.3	0.5	0.2	0	0	0	0.3	0	1.8	0	1.3	0.4	0.3	0	2.4	0.3	0.5	0	0	1.9	0.5	0.2	0.5	0	1	0	0.2	0.3	0.2	0	0	0	0.6	0	0	0	0.3	0	0	0	0.6	0.2	0	0	0	0.2	0	0	3.7	7.8	3.1	8.6	7.8	2.7	2.4	5.8	7.7	2.6	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AP001458.2		ENSG00000255432			11	62649694-62665178	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	4	Ciliated cells: 1.4	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		JURKAT: 2.1;K-562: 2.0;REH: 2.6;U-266/84: 2.7;WM-115: 3.4																																							6.8	4.4	4.9	3.4	5.1	3.6	3.1	4.1	6.8	2.7	4.7	3	2.6	2.7	3.2	2.7	4	2.7	3.1	6.4	4.2	4.4	6.3	11.5	3.4	3.9	3.8	2.8	4.4	3.5	2.7	3.1	4.2	3.8	3.8	2.7	1.6	3.5	3.2	13.9	3	7	4	3.5	6.3	2.9	3.4	2.6	7.7	4.7	3.7	5.2	3.3	2.7	2.9	2.3	3.3	2.4	2.4	3.4	1	0.6	0	0	0	0	0	0	0	0	0	1	0	0	0	1.5	0	0.4	0	1.4	1.4	0.7	0	0	0	0	0	0	0	0	1.2	0	0	0	0.5	0	2.1	2	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0.6	0.5	0	0	0	0	0.9	0	0	0	0.5	0	1	0	2.7	0.7	0	0	3.4	3.3	1.4	2.6	1.1	2.4	1.8	2.7	1.8	2.1	2.3	2.9	1.5	2.4	0.6	2.4	1.3	1.6	3.4	1	4.9	5.1	4.1	5.5	4.2	4.4	3.8	2.8	3.8	2.6	0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
DNAAF4	CILD25, DYX1C1, EKN1, FLJ37882	ENSG00000256061	Dynein axonemal assembly factor 4	Q8WXU2	15	55410525-55508234	Disease related genes, Predicted intracellular proteins	Neurogenesis		Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 26.6	Cell type enriched	Detected in some	7	Ciliated cells: 187.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		RPTEC TERT1: 17.1					Low region specificity	Detected in all			HPA051048	Uncertain		Supported	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA051048: AB_2681325	unprognostic (5.97e-4)	unprognostic (3.60e-2)	unprognostic (1.69e-1)	unprognostic (7.45e-4)	unprognostic (1.74e-1)	unprognostic (5.30e-3)	unprognostic (4.05e-2)	unprognostic (3.08e-2)	unprognostic (8.24e-2)	unprognostic (2.91e-1)	unprognostic (9.47e-2)	unprognostic (1.75e-1)	unprognostic (5.29e-2)	unprognostic (3.85e-2)	unprognostic (3.06e-2)	unprognostic (1.34e-1)	unprognostic (1.84e-1)	1.8	3	11.4	1.8	14.7	1.6	4.9	1.8	8	4.3	2.1	3.2	5.9	1.1	7	15.3	1.8	15.7	3.4	1.6	9.2	7.8	7.2	1	6.2	1.5	4.2	8.9	4.8	3.5	13.6	26.6	1.2	9.1	3.2	1.5	6.9	2.4	3.2	1.3	2.4	1.3	3.1	3.7	2	1.7	14.6	4.5	0.1	14.3	0.9	1.3	2.8	2	2.9	4.2	4.3	1.8	0.7	1.1	0.4	6.5	4.4	4.7	10.1	1.9	3.3	1.5	0.9	2.4	3.1	3.6	0.9	2.6	0.5	4.2	2	5	1.8	1.8	2.6	3.7	2	2.1	2.3	2.8	1.5	1.8	5	4.1	2	5.5	7.5	2.8	4.9	7	2.1	0.7	0.3	4.6	2.3	0.9	4.3	2.6	10.1	3.6	0.8	2.3	0.8	17.1	2.3	4.8	10.5	4.3	1.1	5.8	4.4	6	1.2	2.3	5	2.5	4.1	4.8	1.8	4.8	1.4	8.2	1	1.1	0	1.8	1.3	0.6	1.2	0.4	2.9	0.9	0.7	1.2	2.6	1.1	0.8	4.3	0.7	1.2	4.2	0.9	0.4	11.4	14.7	1.8	8	9.2	7.8	4.2	8.9	9.1	4.5	11.9	15.9	0	0	0	0	0	0	187.4	28.4	12.2	0	1.6	5	11.3	0	0	0	0	4.4	1.1	0	0	2.3	0	18.2	0	0	0	0	0	0	0.6	0	0	0	0	3.9	0	0	19.5	0	0	0	0	0	0	0.5	0	0	0	Ciliated cells
AP002748.4		ENSG00000256349			11	66509079-66533613	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in some		pancreas: 3.4	Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Group enriched	Detected in some	6	NTERA-2: 16.3;THP-1: 4.1									HPA058283	Uncertain		Uncertain	Midbody						Midbody		HPA058283: AB_2683667																		0.2	0.9	0	0	0.6	0	0.3	0.7	0.2	0.5	0.3			0	1	0	0.1	0.3	0.5	0	0.7	0.3	0.7	1	0.3	1.4	0.2		0.3	3.4	0	0.2	0.1		0.3	0.1		0.4	0.2	0.9	0	0.3	0.7	0.3	0.5	0.4	0			0.5		0.4	0.7	0.1	0	0.7	0	1.2	0.6	0.8	1	0.9	0	0.6	0	0	0	0.5	0.5	0.5	0	0	0	0.2	0.3	0.6	0	0.3	0	0	0	0	0.7	0.3	0	0	0.7	0	0.3	1.2	0	0	0.3	1.7	0.2	0	1.8	0.2	0.8	0	0.6	0.2	0.5	16.3	0.9	0	0.9	0	0	0.3	0.8	0.3	0	0.3	0.4	0.6	0.2	1.4	4.1	0	0.7	0.1	0	0.1	0	0.2	0.7	0	0.2	0.4	0	0.2	0	0.2	1.2	0.7	0	0.3	0.5	0.7	0	0.3	0	0	0.6	0.3	0.5	0.8	1											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
TRIM6-TRIM34		ENSG00000258588	TRIM6-TRIM34 readthrough		11	5596725-5644398	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in many	6	kidney: 30.3;salivary gland: 9.5;testis: 8.0	Cell type enriched	Detected in single	9	Ciliated cells: 2.7	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	6	A549: 10.1									HPA077996			Uncertain	Nucleoli,Centrosome						Centrosome	Nucleoli	HPA077996: AB_2686873																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8	0	0	1.7	0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0	10.1	0	0	0.2	0.8	1	1.4	0	0	0	0	0.1	0	0.2	0.3	1.1	0	0	0.7	0.6	0.6	0	0.5	0.4	0	0	0	0	0	0	0	1.1	0	0.4	0	0	0	0	0.4	0	0	0	1.6	0.2	0.6	0	0	0	0.8	0	0	0	0	0	0.6	0.1	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0	0.3	0	0	0.3	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC012184.2		ENSG00000260537			16	70299194-70372582	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		REH: 22.6;U-698: 22.3									HPA046380, HPA066668	Approved		Uncertain	Nucleoplasm						Nucleoplasm		HPA046380: AB_2679645, HPA066668: 																		12.9	11.6	2.6	10.2	4.7	10.4	7.2	12.9	6.3	4.8	7.4	5.6	5.2	9.8	5.7	5.2	9.8	4.2	7.1	10.8	2.9	2.7	7.2	14.6	6.6	8.8	3.6	3.7	4.5	13.7	0.8	7.1	4.3	4.9	4.7	7.5	7.7	8.7	5.8	23.5	15.9	7	6	3.2	7	7.3	2.6	4.5	6.8	8	6.6	13.3	13.4	5.2	8.8	14.7	12.3	16	12	17.9	11.1	1.4	4.9	4.2	9.8	0	4.7	8.2	4.6	5.5	7.9	8.4	9	12.6	8.3	5.8	4.7	1.5	5	0	3.4	6.2	2.5	6.2	5.4	4.1	0.6	5.1	8.2	4.4	3	0.8	8.2	0	2	5.6	2.3	3.1	2.2	3.3	3.7	0.1	0	5.1	0.7	1.1	22.6	1.7	15.2	2.5	6.3	5.3	5.1	11.7	2.1	2.3	1.3	4.3	2	5.2	5.4	5.6	2.2	2.9	7.7	5.1	22.3	0.7	5.2	9.7	12.3	13	9.2	13.5	16	11.2	8.8	11.9	13.2	14.7	8.3	10.2	9.9	1.8	12	11.5	3	17.9	11.1	2.6	4.7	12.9	6.3	2.9	2.7	3.6	3.7	4.9	4.5	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AL139260.3		ENSG00000274944			1	38864501-38881617	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 7.3;testis: 15.5	Cell type enriched	Detected in some	5	Ciliated cells: 8.1	Not detected	Not detected							Cell type enhanced	Detected in many		plasmacytoid DC: 7.3	Low lineage specificity	Detected in many			Low cell line specificity	Detected in many											HPA041188, HPA078331	Uncertain		Approved	Nucleoplasm,Mitochondria						Nucleoplasm	Mitochondria	HPA041188: AB_10794405, HPA078331: AB_2686882	unprognostic (8.00e-2)	unprognostic (3.86e-2)	unprognostic (2.54e-1)	unprognostic (2.00e-1)	unprognostic (9.72e-3)	unprognostic (4.27e-4)	unprognostic (4.64e-7)	unprognostic (2.59e-2)	unprognostic (4.01e-2)	unprognostic (1.22e-1)	unprognostic (6.52e-2)	unprognostic (9.54e-3)	unprognostic (6.09e-6)	unprognostic (1.30e-2)	unprognostic (3.69e-1)	unprognostic (1.27e-1)	unprognostic (2.32e-3)	1.2	0	0.4	1.3	0.9	0	0.4	0.4	1	0.4	3.3	0.6	0.4	2	0.4	0.4	3	0	0.4	0.4	0.4		0.5	1.5	0.4	2.7	0.4	0.4	0.4	0.4	0	0.4	0.8	0.6	0.4	2.3	1.8	2.3	0.4	0.4	1.5	2.1	0.4	0.4	0.4	2.4	15.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3	7.3	2.8	4	0	1.7	0	12.4	1.3	3.3	0	0.6	0	3.6	0.4	0	0	0.5	6.7	13.3	2.4	11.3	0.2	0.5	9.2	0	0.9	0	7.9	2.1	2.8	2.5	2.2	0	17	5	0	0	1.6	1.1	1.5	2	0.5	6.4	4.6	1.7	3.3	6.8	16.1	6.5	9.8	7.7	7.9	8	12.6	0	7	6.3	3.4	7.7	7.3	1.5	3.6	4.2	5.2	5.8	2.3	6.5	6.3	11.5	1.5	11.7	9.4	5.7	7.4	2.6	0	1.3	0.2	0.5	1.9	1.1	3	0.2	0.5	4.2	2	0.4	0.4	2.8	0	4	7.3	1.7	0											0	1.7	0	0	0	0	0	0	8.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Ciliated cells
KCNE1B		ENSG00000276289	Potassium voltage-gated channel subfamily E regulatory subunit 1B	A0A087WTH5	21	7816675-7829926	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	5	blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8	Cell type enriched	Detected in single	5	Ciliated cells: 2.7	Not detected	Not detected							Cell type enhanced	Detected in some		basophil: 3.0;eosinophil: 4.0	Group enriched	Detected in many	17	granulocytes: 4.0;monocytes: 1.6	Cell line enhanced	Detected in some		CACO-2: 5.6;SK-MEL-30: 2.4;SuSa: 3.9																						unprognostic (5.41e-4)	unprognostic (8.78e-2)		unprognostic (7.14e-3)	unprognostic (1.35e-1)	unprognostic (3.34e-2)		unprognostic (1.78e-2)	unprognostic (3.08e-1)	unprognostic (7.47e-2)	unprognostic (3.24e-1)		unprognostic (1.73e-3)	unprognostic (6.59e-2)	unprognostic (1.49e-1)			0	0		0		0	1		0	0	0			0	0	0	0	8.2	0	8.3			3.8	0.4	1.2	0			0	0	0.8		0		0	0		0	0	0	0	0	0.9		0	0	1.2			0		0	0		0	0	4	1.6	0	0.1	0.2	0	0	0	0	0	0	0	0.4	0.9	0.7	0.5	5.6	0.2	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0	0.2	0.2	0	0	0	0	0.6	0	0	0	0	0.1	0.2	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	2.4	3.9	0	0	0	0	0	0	0	1	0	0	0	0.1	0	3	1.6	4	0	0.4	0	0	0	0	0	0	0	0	0.8	0	0.6	0	0.1	0.2											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC007906.2		ENSG00000277639			16	53035690-53052873	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	7	fallopian tube: 29.9	Cell type enriched	Detected in some	7	Ciliated cells: 385.4	Cancer enhanced	Detected in many		ovarian cancer: 31.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		ASC diff: 9.3;ASC TERT1: 7.9;BEWO: 12.7;HSkMC: 7.9;RPTEC TERT1: 8.1	Low region specificity	Detected in all																				unprognostic (1.97e-2)	unprognostic (8.34e-3)	unprognostic (1.63e-1)	unprognostic (5.38e-3)	unprognostic (1.70e-1)	unprognostic (5.75e-2)	unprognostic (2.54e-1)	unprognostic (1.06e-1)	unprognostic (3.34e-1)	unprognostic (2.25e-2)	unprognostic (1.54e-2)	unprognostic (5.02e-2)	unprognostic (6.07e-2)	unprognostic (5.68e-2)	unprognostic (1.32e-1)	unprognostic (1.02e-2)	unprognostic (4.46e-3)	0	0		0		0	1.7		0	4.3	1			0	0.4	0	2.8	29.9	3.4	0			3.8	0	3	0			0	3.7	0		0		3.1	1.4		0.8	0.5	0	0	0	0		0	0	0			0		0	0.1		0	0	0	0.9	0	0	0	0.1	2.7	4.5	2.3	9.3	7.9	12.7	1.3	1	0.1	0	0.3	1.8	0.2	2.3	1.8	0.8	0.7	0	1.7	0.5	0.2	0.1	0	0.1	0.6	1.8	0	2	7.9	6.8	2.5	0.8	2.6	1.8	0.1	0.1	0.1	4.1	0.1	0.1	0	4.9	0.4	0.6	1.1	0	0	8.1	1.7	0.2	0	0.3	0	0.1	4	0.9	0.1	2.1	3	3	0.1	0	0	0	0	3.6	0.4	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0											0	4.3	0	0	0	0	0	0	385.4	55.7	24.4	0	0.1	5	3	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	2.9	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC104662.2		ENSG00000281028			4	25160663-25277306	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA004099	Uncertain		Uncertain	Cytosol						Cytosol		HPA004099: AB_1855353					unprognostic (3.59e-2)													1.7	2.3	6.7	5.5	11.1	6.7	3.7	9.7	9.3	2	4.1	4.3	5	7.8	1.7	2.5	5.4	3.5	1.6	1.5	7.3		2.8	10.1	4	4.4	10	2.4	1.5	1.8	2.9	14.9	2.8	7.1	1.1	5.4	2.1	4.5	2.5	1.8	0	6	2.6	11.3	2.5	3.6	9.2	10.6	6.1	5.3	1.6	5.3	3.1	4.8	2.1	2	7.5	1.9	1.4	4.3	0.9	5.3	3.7	4.4	2.4	3.2	6.1	4.1	8.9	9.1	11.4	12.2	4	7.5	13.5	2.1	11.4	10.7	2.9	9.3	3.8	6.9	5.8	2.6	6.3	9.1	3.8	0.6	12.4	3.6	3.1	0.7	4.5	4.6	2.2	3.9	6	4.2	15.7	3.5	6.1	10.8	0.9	3.6	6.7	2.4	6.3	12	5.9	2.7	9.8	5	1	3.6	1.3	2.6	4.4	2.9	1.7	7.4	6.3	1.8	2.9	5.2	10.6	12	19.1	5.4	6.5	4.6	7.5	1.9	6.2	2.4	1.8	1.6	2.1	2.4	2.3	1.4	1.9	1.8	2.1	3.2	1.4	1.3	2	4.3	0.9											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
FAM237B		ENSG00000283267	Family with sequence similarity 237 member B		7	90316503-90321308	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		prostate: 1.1;testis: 1.7	Cell type enriched	Detected in single	20	Ciliated cells: 2.7									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HSkMC: 1.0;U-266/70: 1.0	Group enriched	Detected in some	6	hypothalamus: 1.9;thalamus: 5.4	Low region specificity	Detected in all																																	0	0.2		0.3		0.1	0		0.1	0	0			0.2	0.2	0	0	0.1	0.1	0			0.5	0	0.8	0			0	0	0		0		1.1	0		0.2	0	0	0.2	0	0		0.1	0	1.7			0.3		0	0		0	0	0	0	0	0	0	0.2	0	0	0.2	0	0.2	0.1	0	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.2	0	1	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0.6	0	0.2	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0.2	0.1	0.7	0	1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
CFAP97D2		ENSG00000283361	CFAP97 domain containing 2		13	114154691-114223084	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 7.7;brain: 8.4;fallopian tube: 22.4;pancreas: 7.8	Cell type enriched	Detected in some	8	Ciliated cells: 34.8									Cell type enriched	Detected in single	12	naive CD8 T-cell: 7.7	Lineage enriched	Detected in single	78	T-cells: 7.7	Cell line enhanced	Detected in some		HL-60: 1.8;NTERA-2: 1.0																																							0	0	0.5	0	7	0.8	0	0	1.4	0.3	0	8.4	0	0	0	2.1	0	22.4	0	0	1.9		0	0	2.6	0.3	0	2	3.6	7.8	0	0.1	0	8.3	0	0	0	0	0	0	0	0	0	0	0.2	0	2.1	2.4	1	0	0	0.1	0	0	0	0	0	0	0	7.7	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0.3	0	1	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0.1	0	0	0	0.3	0	0	0	0	0	0.6	0	0	0	0.1	0.1	0	0	0.6	7.7	0	0	0	0	0	0.7											0	0	0	0	0	0	0	0	34.8	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AP001273.2		ENSG00000284057			11	93741664-93812378	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in some	7	Ciliated cells: 8.1									Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		OE19: 6.5									HPA040511, HPA046619	Approved		Approved	Nuclear speckles,Cytosol						Nuclear speckles	Cytosol	HPA040511: AB_10795369, HPA046619: 																		2.4	3	1.8	4.2	3.4	0.6	2.7	2.8	2.4	3.6	6.1	3.5	3.6	8.2	2.6	3	2.9	2.5	3.3	4	2		16.9	17.6	3.6	1.7	3.9	1.9	4.8	5.4	5.3	5.9	2.8	3.2	4.5	2.7	4.2	3.8	2.8	4.2	3.7	11.1	2.9	4.5	1.9	3.7	2.6	3.6	4.2	5.7	2	1.8	3	1	2.7	2.9	4.4	2.9	3	3.8	2	0.2	0	4.5	0.8	3.3	0	0.6	0	1.4	0.9	1.9	1.5	1.1	0.3	4	2.4	0	1.7	5	0.7	0	1.3	0	0	1.5	0	0.8	0	0.9	0	0.7	0	0.5	3.4	0	2.6	0.9	0.5	5.2	0	2.1	3.5	1.9	6.5	0	1	2.6	1.7	4.8	0	0.3	0.4	0	1.3	3.5	3.8	2	0.9	2.2	0	0.8	0.7	1.8	0.9	0.9	3.7	0.3	1.1	1.6	2.9	2.9	4.4	3.2	2.1	3	2.7	2.6	2.6	2.9	1	2.9	3.6	4.4	3	2.3	1.5	3.8	2											0	1.1	0	0	0	0	0	0	8.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Ciliated cells
THSD8		ENSG00000284491	Thrombospondin type 1 domain containing 8		19	12802031-12813581	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in some	5	pancreas: 2.5;testis: 8.9	Cell type enriched	Detected in single	14	Ciliated cells: 1.4									Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	BEWO: 3.4	Not detected	Not detected																																					0	0	0	0	0	0.7	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0		0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0.9	1.1	0	0	0	0	0	8.9	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
UPK3BL2		ENSG00000284981	Uroplakin 3B like 2	E5RIL1	7	102538417-102543849	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level		Tissue enhanced	Detected in many		esophagus: 12.2;lymphoid tissue: 12.8	Cell type enriched	Detected in single	14	Ciliated cells: 1.4									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA011403	Approved											HPA011403: AB_2668503																		0.8	0		1.5		6.5	1		0.3	0	0.6			1	0.7	0.4	12.2	0.9	0.6	0			0	0.1	0.8	3.4			0.4	0.7	0.2		0.3		1.2	0.8		1.5	3.6	2.7	2.8	0.9	0.1		3.2	0.4	0			4.5		12.8	2.5		5	8.4	6.1	3.7	1	7.9	1.3	5.8	9	3.9	6.8	1.9	0.6	13.4	10.7	13.4	13.5	16.7	3.1	9.8	6.6	5.3	4	1.4	18.9	0.4	5	3.7	7.3	11	2.3	14.8	5.3	7.8	5.7	7.3	6.5	7.4	3.9	3.6	3.1	6.1	8.6	6.1	15.3	4.9	23.9	6.4	9.6	1.5	2.8	1.8	5	2.1	9.6	7.6	22.9	5	5.5	6	2.9	5.4	7	3.1	5.4	2.7	7.2	3.2	4.6	4.3	15.3	4.8	4.1	2	10.3	5.2	0.2	3.7	2.6	7.9	1.9	2.9	4.7	3.1	2.5	1.5	5	5.6	2.8	6.1	1	2	8.4	3	1.3											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AL035078.4		ENSG00000285283	Reticulocalbin-1 	Q15293	11	31812391-32104665	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 16.2	Cell type enriched	Detected in single	4	Ciliated cells: 1.4									Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BJ: 63.7;RH-30: 39.5;RT4: 43.1									HPA038474	Uncertain		Supported	Endoplasmic reticulum					2300000	Endoplasmic reticulum		HPA038474: AB_10672595																		4.7	0.9	1.6	7.5	2.4	0	0.3	16.2	3.2	0.3	5.9	1.7	0.3	0.9	3.8	0.3	1.7	4.3	0.3	0.3	3.1		0.4	2.8	1.4	0.3	2.2	1.9	6.1	0.3	0	1.8	1.6	3	0.3	0.8	6.9	0.3	0.3	3.3	0	2.4	4.6	3.6	0.5	2.2	0.3	1	0.3	0.5	0.3	0.7	1.9	0.3	0.6	5.3	0.4	3.5	3.2	2.1	1.7	7.4	12.4	12	11.5	3.4	2.1	6.7	63.7	21.2	11.2	10.4	6	9.6	0	21	24	16.2	6.5	9	7.2	12.3	5	1.5	3.6	9	0.7	0	3.1	1.5	10.6	1.4	12.3	8.1	3.9	15.8	2	1.2	3.9	0.1	2.6	4.9	0	5.1	0	0.1	2.7	39.5	1.6	0	43.1	5	1.9	12.4	0.8	7.6	3.1	9.1	0.1	37.7	28.7	12.1	17.3	24.3	0	0	0.1	30.4	1.2	13.1	0	3.5	0	2.1	3.4	1.9	0.6	0.2	1.8	5.3	0.1	0.3	0.9	0.4	3.2	2	0.6	0	1.7											0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
